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ABSTRACT 
This thesis explores the synthesis of cyclometalated gold(III) complexes functionalized 
by alkynyl ligands, as well as the study of the interaction of the studied complexes with 
DNA secondary structures. In this work, bidentate and tridentate ligands, in particular 
derived from both phenylpyridine and diphenylpyridine, respectively, have been 
employed as framework structure in order to stabilize the studied gold complexes.  
Chapter 1 studies the synthesis of cyclometalated gold(III) complexes functionalized by 
alkynyl derivatives. The main feature of the employed alkynyl derivatives was its 
functionalization by amino ester terminal groups, suitable to be converted to amino 
acids, which are overexpressed in cells and may promote the interaction of the studied 
complexes with DNA. 
Chapter 2 explores a study of the interaction of the synthesized gold(III) complexes 
with DNA secondary structures. Making use of a variety of analytical techniques, such 
as circular dichroism (CD), FRET melting experiments, FRET titration and UV 
difference spectrum, we have observed that a selection of the studied gold complexes 
may exert interaction with certain DNA secondary structure in physiological media. 
Chapter 3 reports the attempts to conduct the synthesis of a family of cyclometallated 
(C^N) gold(III) complexes capable of bearing two functionalisable substituents. In 
recent years, our research group has proven the excellent reactivity of certain tridentate 
(C^N^C) gold (III) complexes as mild base, allowing C–H or N–H activation to 
synthesize gold aryls, alkynyls and heteoaryls derivatives. However, the rigidity of the 
tridentate framework has limitated the reactivity of this system. Accordingly, the aim of 
this chapter is the synthesis of bidentate gold (III) derivatives, which may provide a 
wide range of reactivity possibilities because of the presence of two functionalisable 
positions.
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INTRODUCTION 
Nowadays, cancer is widely prevalent in today’s society, being one of the leading 
causes of death among population. Cancer is characterized by uncontrolled division of 
cells and the ability of these cells to invade other tissues leading to the formation of 
tumour mass, vascularization, and metastasis1.  
Chemotherapy is one of the major approaches to treat cancer by delivering a cytotoxic 
agent to the cancer cells. During the last decades, investigations in order to find 
therapeutic applications of metal-based compounds have been widely studied. In 1965 
Rosenberg et al.2 discovered the antiproliferative activity of a platinum complex called 
cisdiamminedichloroplatinum (cisplatin) (Figure 1), which was successfully employed 
in testicular cancer therapy. 
 
 
 
Figure 1. Chemical structure of cisplatin. 
 
Cis-diamminedichloroplatinum (cisplatin) and some of its analogues have been widely 
administered as drugs against prostate, ovarian, head and neck tumours, small-lung 
carcinoma and bladder cancer cells. 
However, DNA interaction is considered to be the primary target for metal-based 
complexes, and the cytotoxic effects of them may be a consequence of a direct 
interaction with nuclear DNA.  
Despite the remarkable effectiveness of cisplatin against certain cancer cells, some 
tumours have started to show an intrinsic resistance to this drug. This fact and the 
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significant side effects, such as loss of fertility and appetite, have inspired the search of 
alternative metal – based complexes capable to exhibit anti-tumour effect.  
 
1. Gold (III) complexes as alternative to cisplatin. 
In recent years, gold compounds have drawn special attention as a new generation of 
anticancer agents, showing anti-tumour properties both in vitro and in vivo.3 From a 
chemical point of view, the similarities between gold(III) and platinum(II) atoms, both 
isoelectronic, featuring a square-planar coordination geometry (corresponding to the 5d8 
outer shell electronic configuration),  have encouraged a variety of investigations in the 
last years in order to study gold(III) compounds as alternative to cisplatin in both DNA 
interaction and cancer treatment.  
 
2. The ligand influence in biological applications of metal-based complexes.  
In the course of investigations, the limited stability of gold(III) complexes has been the 
main obstacle in biological studies. Gold(III) complexes have exhibited a low stability 
in physiological media, reductive elimination to gold(0) being the preferred route. 
Stability in physiological media is considered the most important and necessary feature 
that complexes must meet in order to be suitable to exert anti-tumour activity. 
Accordingly, the proper choice of ligands has become the most important aspect in the 
synthesis of metal-based complexes with biological applications, allowing the 
establishment of an equilibrium of the hydrophilic and lipophilic properties of the 
complex.4 The use of bi, tri or poly-dentate ligand frameworks coordinated to the gold 
metallic centre plays a key role in order to reach this stabilization. Bi-dentate ligands of 
the type (C^N) and tri-dentate ligand types (C^N^C), (N^N^N) and (N^N^C), 
surrounding the gold metallic centre, are examples of ligands that can provide a 
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considerable redox and thermodynamic stability to gold complexes. The coordination of 
these ligands to the gold atom can modify the steric and electronic properties of the 
complex, which can be reflected in an increase of the lipophilic character. In addition, 
the coordination of these nitrogen donor ligands prevents ligand exchange in solution 
state, a commonly observed phenomenon which leads to the reduction of Au(III) in 
biological solutions.4 
 
3. The role of amino acids and peptides as good carriers. 
One of the main issues for cancer chemotherapeutics and, in particular for gold(III) 
complexes, is to cross the cell membrane, a key factor of anti-tumour action and DNA 
binding.  Accordingly, the presence of appropriated substituents, such as amino acids 
and peptides, is a key factor in order to reach this goal. 
In spite of the wide number of gold complexes that have shown activity in biological 
systems, the number of gold complexes with amino acids and peptides is very scarce. 
There are only a few reports of gold(III) complexes with amino acids, such as cysteine.5 
The introduction of amino acids and peptides as substituents can play an important role 
in the biological activity of the complexes. The presence of amino acids and peptides in 
the complex can cause a considerable reduction of the side effects associated to the 
biological activity of the complex. In addition, as these groups are over-expressed 
receptors in some type of tumours, they can act as good carriers, allowing the transport 
of the gold atom to the biological target. 
In this thesis we report the synthesis of bi- and tri-dentate cyclometallated gold(III) 
complexes functionalized by amino ester derivatives, as well as study of the interaction 
and binding of them with secondary DNA structures 
 
 4  
 
 
 
 
 
CHAPTER 1 
BI– AND TRI–DENTATE CYCLOMETALATED GOLD (III) 
COMPLEXES FUNCTIONALIZED BY ALKYNYL LIGANDS. 
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1.1. INTRODUCTION 
Chelating ligands around gold(III) centre are commonly used in order to avoid reductive 
elimination reactions. Recent work has proven the efficiency of the use of some 
examples of (N^N) and (C^N) type bidentate ligands such as 2,2’–bipyridyl or 2–
phenylpyridine respectively, to stabilize species including gold chloride complexes, 
terminal anilides, acetylides and cis-diarylgold(III) species6 (Figure 2). 
 
 
 
 
 
 
 
 
Figure 2. Examples of gold(III) centers stabilized by chelating ligands. 
 
In this chapter we focus on the synthesis of cyclometalated gold(III) complexes 
functionalized by alkyne derivatives, employing (C^N^C) and (C^N) ligands to 
stabilize the gold (III) complexes. 
For the synthesis of these complexes and incorporation of the alkynyl ligand into the 
cyclometalated gold(III) moiety, chlorogold(III) precursors have been used as starting 
materials. In recent years, both direct auration and transmetallation from organomercury 
derivatives have been the frequently used route to synthesize chlorogold(III) precursors 
(C^N)AuCl2 and (C^N^C)AuCl. 
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a. Direct auration. 
Chlorogold(III) precursors type (C^N)AuCl2 can be synthesized by direct auration 
between the ligand and [AuCl4]–. The direct auration of aromatic ligands was firstly 
achieved in 1931 by Kharasch7 but it was not for a further 50 years that other concrete 
examples were obtained. Constable and co-workers reported the ortho–metalation of 2–
phenyl–pyridine,8a giving stable five–membered C^N–chelates. Other substituted 
pyridines were shown to undergo similar reactions,9,10 as well as more recent 
examples,8b,11,12 forming five– or six–membered chelates (Scheme 1). 
 
 
 
 
Scheme 1. Examples of synthesis of chlorogold(III) precursors type (C^N)AuCl2 by 
direct auration. 
 
As it shown on Scheme 1, direct auration of chlorogold(III) precursors type 
(C^N)AuCl2 is a two step reaction. The first step implies the synthesis of the 
intermediate (HC^N)AuCl3. This intermediate can be synthesized making use of both 
H[AuCl4] and [AuCl4]– salt as reagents. The synthesis of the intermediate (HC^N)AuCl3 
using H[AuCl4] as reagent has been carried out in both ethanol8a  and methanol8b at 
room temperature. The formation of a yellow precipitate was observed after 30 minutes, 
which was filtered off and dried under vacuum. Yields of over 90% have been reported 
by this method. In addition, this intermediate can be also prepared using [AuCl4]– 
derivatives such as Na[AuCl4] and K[AuCl4], in acetonitrile/water at room 
temperature.8a,11 The second stage involves the formation of chlorogold product 
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(C^N)AuCl2. The preparation of this complex has been carried out from the 
(HC^N)AuCl3 intermediate in refluxed acetonitrile, in order to activate the Au–C bond. 
Yields over 35% have been reported. 
In spite of the advantage that mercury salts are not used in the synthesis, which is 
beneficial from an ecological point of view, the main disadvantages are both the lower 
yield obtained by this method (over 35 %) and the longer reaction times compared to 
the transmetalation pathway. 
b. Transmetalation from organomercury compounds. 
Transmetalation from organomercury compounds is the most commonly employed 
strategy for the synthesis of (C^N)AuCl2 and (C^N^C)AuCl derivatives. Over the last 
decades, this has been the preferred route to synthesize several of these complexes6,7 and 
is still commonly employed14,15 (Scheme 2 and 3).  
  Hg(OAc)2, ethanol reflux. b. LiCl, methanol. c. K[AuCl4], 
acetonitrile/dichloromethane. 
Scheme 2. Literature example for the synthesis of chlorogold(III) complexes 
(C^N)AuCl2 by transmetalation from the (C^N)HgCl organomercury compounds. 
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a. Hg(OAc)2, ethanol reflux. b. LiCl, methanol. c. K[AuCl4], 
acetonitrile/dichloromethane. 
Scheme 3. Synthetic route of (C^N^C)AuCl by transmetalation from an organomercury 
precursor. 
The first step shown in Schemes 2 and 3 involves the mercuration using Hg(OAc)2 as 
reagent in refluxed ethanol, and the consequent metathesis employing LiCl, to afford 
(C^N)HgCl and (C^N^C)HgCl derivatives, respectively. The second stage involves the 
transmetalation step making use of K[AuCl4] or Na[AuCl4], in 
acetonitrile/dichloromethane as solvents, at room temperature.  
In general terms, transmetalation route has been proven to be more efficient, giving 
cleaner products by quicker reactions. In addition, slightly better yields than the direct 
auration8 can be obtained.  
Our efforts focused on the functionalization of the synthesized chlorogold(III) 
precursors (C^N)AuCl2 and (C^N^C)AuCl with different alkynyl derivatives. In recent 
years, several examples of gold(III) alkynyl complexes have been reported. In 1977, 
Johnson et al.17,18 reported the synthesis of mononuclear gold(III) complexes type 
[Au(C≡CCF3)Me2(L)] and [Au(C≡CR)Me2(PPh3)], containing one alkynyl ligand. Yam 
et al.16,19,20 synthesized (C^N^C)gold(III) mono–alkynyl complexes type 
[Au(C^N^C)(C≡CR)], carrying out studies of luminescence behaviour. Mononuclear 
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gold(III) complexes substituted by two, three and four alkynyl ligands type 
[(phenylpyridine)Au(C≡CR)2],21 [Au(C≡CR)3(L)] and four alkynyl ligands 
[ER4]+[Au(C≡CR)4]– 22, 23 respectively, have been also reported (Figure 3). 
 
Figure 3. Examples of gold(III) mono–, di–, and tetra–alkynyl complexes. 
The study of the luminescence behaviour has been the main application of alkynyl gold  
complexes. In contrast to the gold(I) systems, bi– and tri– dentate gold(III)  complexes 
have been rarely observed to be photo-emissive, and even if they do emit, they usually 
do at low temperature in the solid state, with very few examples that would emit at 
room temperature in solution.24 Nevertheless, the rigid structure from the alkynyl group, 
as well as its ability to interact with the metal centre and its δ–electron delocalization 
can strengthen the metal–carbon bonds, favouring the design of luminescent 
organometallic materials.  
The applications of Au(I) and Au(III) complexes as anticancer agents have also gained a 
considerable importance over the last years.26,27 Recent studies have shown that 
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mononuclear alkynyl gold complexes type alkynyl(triphenylphosphine)gold(I) (Figure 
4) exhibit a promising potential as future anti-tumour agents.28, 29 
 
Figure 4. Examples of cytotoxic gold(I) alkynyl complexes. 
These promising results with gold(I) alkyne complexes encouraged us to extend our 
research to the study of gold(III) alkynyl complexes. Accordingly, in this chapter we 
report the synthesis of (C^N) and (C^N^C)Au(III) complexes functionalized by 
different alkynyl derivatives, such as 4–ethynylbenzaldehyde and 1–ethynyl–4–benzyl–
L–amino esters.  
In recent years three pathways have been developed in order to attach alkynyl 
derivatives to the gold(III) atom:  
§ Method a 
In 2012, Bochmann et al.30 reported the synthesis of (C^N^C)AuOH. This complex 
showed an excellent reactivity as a mild metal base, being able to activate C–H and N–
H bonds. The reaction of (C^N^C)AuOH with alkyne derivatives was studied (Scheme 
4), giving cleanly (C^N^C)Au(III) alkynyl complexes. 
 
Scheme 4. Synthesis of (C^N^C)Au(III)phenylacetylide from (C^N^C)Au(III)OH. 
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As it is shown in Scheme 4, the reported synthesis (C^N^C)Au(III)phenylacetylide 
involves an acid–base reaction, which requires high temperatures in order to activate the 
Au–OH bond.  
This result encouraged us to investigate the synthesis of (C^N)Au(OH)2, as well as its 
reactivity as a base. In addition, the synthesis of (C^N)Au(OH)2 would be a significant 
advance in order to establish a successful novel method to synthesize dialkynyl 
(C^N)Au(III) complexes. The preparation of this complex was explored by different 
pathways (detailed in Chapter 3), such as the previously detailed method reported by 
Bochmann et al.,30 using (C^N)AuCl2 precursor as starting material and cesium 
hydroxide as reagent, in a mixture of toluene/tetrahydrofuran/water (1:1:1) at room 
temperature.  Nevertheless, our efforts to synthesize (C^N)Au(OH)2 were unsuccessful, 
generating mixtures of different products, which could not be converted into 
(C^N)Au(III) dialkynyl complexes. 
§ Method b 
Yam et al.19 reported the synthesis of (C^N)Au(III)dialkynyl complexes by the reaction 
of the corresponding dichlorogold(III) precursor with different alkynyllithium reagents 
(Scheme 5). 
 
Scheme 5. Synthesis of (phenylpyridyl)Au(–C≡C–C6H4–4–OCH3)2  from (C^N)AuCl2 
precursor. 
 
n-­‐butyllithium	  1.6	  M	  in	  hexanes,	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§ Method c 
Venkatesan et al.21 introduced a modification regarding the previously reported methods 
of synthesis of (C^N)Au(III)dialkynyl complexes. Utilizing the dichlorogold(III) 
precursor and the corresponding alkynyl ligand as starting materials, this method 
introduces the use of NEt3, which serves as a mild enough base for an in situ 
deprotonation of the acidic acetylenic proton, and the substitution is supported by the 
addition of a catalytic amount of CuI (Scheme 6). 
 
Scheme 6. Reaction mechanism of synthesis of (C^N)Au(III)dialkynyl complexes. 
In this chapter we report the synthesis of bi– and tri–dentate gold(III) complexes 
functionalized by alkynyl derivatives. The synthesis of (C^N)Au(III) mono–alkynyl and 
(C^N)Au(III) di–alkynyl complexes has been only explored by methods a and c 
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1.2. RESULTS AND DISCUSSION 
1.2.1. Synthesis of tri-dentate gold(III) complexes functionalized with alkynyl 
derivatives. 
1.2.1.1. Synthesis of precursors. 
The synthesis of ligand L1 has been carried out via a single step Suzuki cross–coupling 
of the commercially available 4–tert–butylphenyl boronic acid and 2,6–
dibromopyridine, employing Pd(PPh3)4 as catalyst (Scheme 7). 
 
Scheme 7. Synthesis for the ligand L1. 
Ligand L1 has been subjected to ortho–mercuration employing Hg(OAcF)2, followed by 
salt metathesis with LiCl to yield the organomercury(II) species (HC^N^C)HgCl (1). 
Next step involves transmetallation and C–H activation with K[AuCl4] in refluxing 
acetonitrile, following the procedure reported in the literature,31 to give the 
corresponding cyclometallated gold(III) chloride (C^N^C)AuCl (2) in moderate yield 
(35%) (Scheme 8). 
 
Scheme 8. Synthesis of (C^N^C)AuCl (2) 
The synthesis of complex 3 was carried out following the experimental procedure 
reported in the literature.30 10 equiv. of CsOH were added to a suspension of complex 2 
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in THF/Toluene/Water (1:1:1). The mixture was allowed to stir for 16 hours at 60°C. 
The mixture was filtered off, to yield a yellow solid. A mixture of 
dichloromethane/water (1:1) was added. The mixture was allowed to stir overnight at 
room temperature. The observed precipitate was filtered off and it was washed with 
petrol ether 40/60, to yield a palid yellow precipitate (Scheme 9). 
 
a. CsOH, THF/toluene/water, 60°C, 16h. b. CH2Cl2/water, r.t. 
Scheme 9. Synthesis of (C^N^C)AuOH (3). 
The synthesis of the ligands L2, L3 and L4 has been achieved by reaction of (L)–alanine 
methyl ester hydrochloride, (L)–serine methyl ester hydrochloride and glycine ethyl 
ester hydrochloride, respectively, with 4–ethynylbenzaldehyde and the consequent 
reduction step employing sodium borohydride,32 to afford ligands L2, L3 and L4 (Figure 
5).  
 
Figure 5. Chemical structure of ligands L2 — L4. 
The experiment was carried out in dry dichloromethane, in presence of triethylamine, 
employing a stoichiometric amount of the amino ester derivatives and anhydrous 
b	  
 16  
MgSO4 as dehydrating agent. The reaction mixture was allowed to stir for 16 hours at 
room temperature. 
Scheme 10. Mechanism of imine (Schiff Base) formation. 
The formation of the imine derivative (Scheme 10) is an equilibrium reaction. 
Therefore, the use of dehydrating agent becomes necessary in order to move the 
equilibrium and promote the formation of the aryl imines. 
After 16 hours, an aliquot from the crude of reaction was taken in order to check by 1H–
NMR spectroscopy the reaction progress. Although the 1H–NMR spectrum showed the 
aryl imine derivative as the main product, a small percentage of 4–ethynylbenzaldehyde 
was observed. Identical result was observed after 24 hours. Despite the fact that the 
reaction had not proceeded quantitatively, the second stage of the reaction was carried 
out. As it is known, imine derivatives are susceptible to be hydrolysed in presence of 
water or under acidic conditions. In order to avoid this step and simplify the reaction 
conditions for the consequent experiments of synthesis of gold(III) complexes, 
reduction of the –C=N bond to –C–NH was planned. Accordingly, the reaction mixture 
was filtered off and dichloromethane was removed under vacuum. The residue was 
dissolved in dry methanol and sodium borohydride was slowly added at 0 oC. After 12 
hours, the 1H–NMR spectrum from the crude reaction showed a mixture of the expected 
aryl amine derivative and another product, identified as (4–ethynylphenyl)methanol 
(Figure 6) by comparison with the reported 1H–NMR spectroscopic data for this 
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compound.33 The formation of this product can be explained due to the reduction of the 
aldehyde function from 4–ethynylbenzaldehyde in presence of sodium borohydride.  
 
Figure 6. Products obtained after reduction employing sodium borohydride. 
A modification of the synthetic procedure was introduced, in order to drive the reaction 
to completion. Excess of the starting amino ester derivatives was employed and 
anhydrous MgSO4 was replaced by activated molecular sieves, which is known to be a 
more effective water scavenger. These reaction conditions allowed us to obtain imine 
intermediates LA, LB and LC in situ as pure products and the corresponding ligands L2, 
L3 and L4 by reduction employing sodium borohydride as reagent. These ligands were 
isolated as pale yellow oils in yields over 60% (Scheme 11). 
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Scheme 11. Synthesis of ligands L2— L4. 
Ligands L2, L3 and L4 have demonstrated to be soluble in non-polar solvents, such as 
chloroform and dichloromethane. In addition these ligands have also exhibited a 
considerable solubility in protic media, being soluble in ethanol and partially soluble in 
water.  
Ligands L2 – L4 have been characterized by 1H–NMR, 13C{1H}–NMR and IR 
spectroscopy. 
Ligand L2 shows a weak band at 2105 cm-1 in the stretch of C≡C and a strong band at 
1732 cm-1 corresponding to the vibration mode of C=O from the ester function. Ligands 
L3 and L4 show IR absorption bands of similar intensity and located in the same region 
than the observed ones for ligand L2. 
The chemical shifts corresponding to 1H–NMR spectrum for ligand L2 in CDCl3 at 
room temperature are recorded in Table 1.  
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Table 1. 1H–NMR data of ligand L2 in CD2Cl2, δ(ppm) and multiplicity. 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Comparison between 1H–NMR spectrum of ligand L2 (red spectrum), 4–
ethynylbenzaldehyde (blue spectrum) and Intermediate LA (green spectrum) in CD2Cl2. 
Figure 7 shows the reaction progress through a comparison between 1H–NMR spectrum 
of 4–ethynylbenzaldehyde (blue spectrum), intermediate LA (green spectrum) and 
ligand L2 (red spectrum). Both the absence of the singlet signal corresponding to the 
aldehyde function (red circle) and the presence of a new singlet signal at δ 8.29 (blue 
LIGAND L2 ASSIGNMENT 1H (ppm) 
 
a  1.37 (d,  J = 7.0 Hz, 3H) 
b 2.76 (s, 1H) 
c 3.17 (q, J = 7.0 Hz, 1H) 
d, e 3.65 (d, J = 13.5, 1H), 3.81 (d, J = 13.5, 1H) 
f 3.31 (s, 3H) 
g, h  7.32 (d, J = 8.3 Hz, 2H), 7.43 (d, J = 8.3 Hz, 2H) 
CHDCl2
  
Triethylamine 
 20  
circle) indicate the formation of the imine group of intermediate LA. The addition of 
sodium borohydride led the reduction of C=N bond to –C–NH and formation of pro–
ligand L2. 
The chemical shifts corresponding to 13C{1H}–NMR spectrum of pro-ligand L2 in 
CD2Cl2 at room temperature have been recorded in Table 2.  
Table 2: 13C{1H}–NMR data of ligand L2 in CD2Cl2 (δ(ppm)).  
 
Figure 8: 13C NMR spectrum of ligand L2 in CD2Cl2. 
 
LIGAND L2 ASSIGNMENT 1H (ppm) 
 
i 18.7 
g, h, k 51.3, 51.7, 55.8 
a, b 73.9, 83.4 
Aromatic region 120.6 (Cipso, c or f), 128.2 (d or e), 132.0 (d or 
e), 132.4 ( Cipso, c or f) 
j 175.6 
j 
a, b 
i 
g,h,k  
CD2Cl2
  
 
Cipso 
Cipso 
d, e 
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As it is shown in Figure 8, the 13C NMR spectrum of ligand L2 in CD2Cl2 exhibits a 
signal at δ 175.6 corresponding to the carbon atom of C=O group from the ester 
function (f). The signal corresponding to an aldehyde group, which would be shown in 
the region between δ 190 – 200, is not observed, indicating that the aryl amine 
derivative has been formed. In addition, two chemical shifts at δ 73.9 and 83.4 (a and 
b), corresponding to the alkyne function, were observed on the spectrum.  
The chemical shifts corresponding to the 1H–NMR spectrum for ligand L3 in CDCl3 at 
room temperature are presented in Table 3.  
Table 3. 1H–NMR data of ligand L3 in CDCl3, δ(ppm) and multiplicity. 
                                                                  
LIGAND L3 ASSIGNMENT 1H (ppm) 
 
a  3.12 (s, 1H) 
–NH/–OH 2.36(br, s, 2H) 
b 3.29 (q, J = 4.5 Hz, 1H) 
d 3.56-3.62 (m, 2H) 
e, f 3.72 (d, J = 8.1 Hz, 1H), 3.89 (d, J = 8.1Hz, 1H) 
c 3.63 (s, 3H) 
g, h  7.18 (d, J = 8.1 Hz, 2H), 7.35 (d, J = 8.1 Hz, 2H) 
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Figure 9. 1H-NMR spectrum of ligand L3 in CDCl3. 
As it is shown in Figure 9, 1H–NMR spectrum of ligand L3 in CDCl3 exhibits a singlet 
signal at δ 2.98 integrating for one proton corresponding to proton Ha. The expected AB 
system corresponding to He and Hf is overlapped with protons Hd, showing as multiplet 
signal at δ 3.45 – 3.86. Both the chemical shifts corresponding to He and Hf and the 
absence of the chemical shift of the aldehyde proton (it would be shown over δ 10.00) 
indicate that the amine product has been formed. Regarding the chemical shifts 
corresponding to the –NH and the –OH functions, the only signal observed that may 
correspond with one of them is a broad signal at δ 2.65 integrating by two protons. As 
we will check later in the thesis for complex 13 (C^N derivative with ligand L3 
coordinated to the metallic centre) the addition of a drop of D2O will suppose the 
absence of this broad signal for this complex, which prove that it corresponds to the –
NH or the –OH functions. 
 
 
g, h 
d,e,f 
a 
b 
 
 
c 
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Figure 10: Comparison between 1H–NMR spectra of ligand L3 (red spectrum), 4–
ethynylbenzaldehyde (blue spectrum) and Intermediate LB (green spectrum) in CD2Cl2. 
As it is shown in Figure 10, the 1H–NMR spectrum of intermediate LB (green spectrum) 
does not show any starting material, represented by the absence of the singlet signal 
corresponding to proton –CHO from the aldehyde function (red circle). In addition, a 
new singlet signal at δ 8.25, corresponding to the proton from the imine group of 
intermediate LB was observed (blue circle). The subsequent addition of NaBH4 allowed 
the reduction of C=N bond to C–NH and formation of pro–ligand L3, represented in 
1H–NMR spectrum of ligand L3 (red spectrum) by the absence of the singlet signal at δ 
8.25, previously shown in the 1H–NMR spectrum of intermediate LB (green spectrum). 
The chemical shifts corresponding to the 13C{1H}–NMR spectrum of ligand L3 in 
CDCl3 at room temperature have been recorded in Table 4.  
 
 
 
CHDCl2 
Triethylamine 
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Table 4: 13C{1H}–NMR data of ligand L3 in CDCl3 (δ(ppm)). 
  
 
Figure 11: 13C{1H}–NMR spectrum of ligand L3 in CDCl3. 
According to Figure 11, the 13C{1H}–NMR spectrum of ligand L3 in CDCl3 shows a 
signal at δ 173.5 corresponding to the –C=O function from the ester group. No signal 
corresponding to the carbon –CHO from the aldehyde function was observed, indicating 
that the condensation product has been formed. In addition, two chemical shifts 
LIGAND L3 ASSIGNMENT 1H (ppm) 
 
k, h  51.7, 52.2 
g, i 61.9, 62.6 
a, b 77.3, 83.5 
Aromatic region 120.1 (Cipso, c or f), 128.2 (d or e), 132.3 (d or e), 
139.7 (Cipso, c or f) 
j 173.5 
 
 
 
 
Cipso Cipso 
d, e 
CDCl3
  
j 
k,h,g,i 
 
NH
CH2OH
O
H3CO
a
b
c
f
d
e
g
 a,b 
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corresponding to the carbons from the alkyne group were observed at δ 73.9 and 83.4, 
one of these overlapped with the signal corresponding to CDCl3. 
The chemical shifts corresponding to the 1H–NMR spectrum for ligand L4 in CD2Cl2 at 
room temperature are recorded in Table 5.  
Table 5. 1H–NMR data of ligand L4 in C2DCl2, δ(ppm) and multiplicity. 
 
 
Figure 12: 1H–NMR spectrum of ligand L4 in CD2Cl2. 
LIGAND L4 ASSIGNMENT 1H (ppm) 
 
a  1.25 (t, J =7.0 Hz, 3H) 
b 3.11 (s, 1H) 
c,d and e,f 3.36 (bs, 2H), 3.79 (bs, 2H) 
g 3.31 (q, J =7.0 Hz, 2H) 
h,i  7.31 (J = 8.1 Hz, 2H), 7.44 (J = 8.1 
Hz, 2H). 
 
Ethyl 
acetate 
Ethyl 
acetate Ethyl acetate 
h,i a 
b 
c,d,e,f 
Water 
CHDCl2   
g 
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Figure 12 shows the 1H–NMR spectrum of ligand L4 in CD2Cl2. The spectrum exhibits 
a triplet signal at δ 1.25 and a quartet signal at δ 4.16 corresponding to protons Ha from 
methyl group and Hg from methylene group, respectively. Although the expected 
integrations of these signals should be three and two protons respectively, it is slightly 
higher because of the presence of the triethylamine in the sample. The chemical shift 
corresponding to the proton Hb is observed as a singlet signal at δ 3.11. Protons Hc, Hd, 
He and Hf are represented as two broad singlet signals at δ 3.36 and 3.79 integrating for 
two protons each. Although these protons and the one corresponding to the HC≡C– 
group did not undergo remarkable variations compared to the starting material (Figure 
13), the absence of the proton –CHO from the aldehyde function is the main indication 
that the condensation product was achieved. Protons Hh and Hi from the aromatic ring 
are represented as an AB system at δ 7.31 and 7.44.  
 
Figure 13: Comparison between 1H–NMR spectra of ligand L4 (green spectrum), 4–
ethynylbenzaldehyde (blue spectrum) and Intermediate LC (red spectrum) in CD2Cl2. 
 
CHDCl2  
 
Triethylamin
e 
 
 
i l i e 
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According to the Figure 13, the comparison between 1H–NMR spectra of 4-
ethynylbenzaldehyde and intermediate LC shows a new singlet signal at δ 8.26 
integrating for one proton corresponding to the proton of the imine group from 
intermediate LC (blue circle). Both this chemical shift and the absence of the singlet 
signal corresponding to the proton –CHO from the aldehyde function (red circle) of 4–
ethynylbenzaldehyde are indicative that intermediate LC was prepared. The reduction of 
the C=N bond of intermediate LC to C–NH bond is achieved by addition of sodium 
borohydride, to afford the formation of ligand L4 (green spectrum). 
The chemical shifts corresponding to 13C{1H}–NMR spectrum of ligand L4 in CD2Cl2 
at room temperature have been recorded in Table 6.  
 
Table 6: 13C{1H}–NMR data of ligand L4 in CD2Cl2 (δ(ppm)). 
 
 
LIGAND L4 ASSIGNMENT 1H (ppm) 
 
k 14.3 
g, h 50.4, 52.0 
j 61.0 
a, b 77.2, 83.8 
Aromatic region 121.0 (Cipso, c or f), 128.5 (d or e), 
132.2 (d or e), 141.5 (Cipso, c or f) 
i 172.6 
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Figure 14: 13C{1H}–NMR spectrum of ligand 4 in CD2Cl2. 
The 13C{1H}–NMR spectrum of ligand L4 in CD2Cl2 shows a weak signal δ 172.6 
corresponding to the –C=O group from the ester function. The absence of the signal 
corresponding to the carbon –CHO from the aldehyde function indicates that pro-ligand 
L4 has been formed.   
 
1.2.1.2. Synthesis of complexes. 
We focused on the synthesis of bi– and tri–dentate gold(III) complexes functionalized 
by alkynyl derivatives. The incorporation of alkynyl ligands into the cyclometalated 
gold(III) moiety has been achieved by two methodologies. In method a, the reaction of 
(C^N^C)AuOH (3) with the alkynyl derivative allowed the formation of the 
[(C^N^C)AuC≡CR] derivatives. In method c, a reaction mixture of the chlorogold(III) 
precursor (C^N^C)AuCl (2), the alkynyl ligand, triethylamine, and a catalytic amount 
of copper(I) iodide led to the formation of the [(C^N^C)AuC≡CR] derivatives.16 
 
d,e 
i 
k 
a,b g,h,j 
CD2Cl2  
  
  
  
Cipso 
Cipso 
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According to method a, the reaction of the (C^N^C)AuOH (3) with 4-
ethynylbenzaldehyde and the previously synthesized N–1–ethynylbenzyl methyl ester of 
(L)–alanine (ligand L2), N–1–ethynylbenzyl methyl ester of (L)-serine (ligand L3) and 
N–1–ethynylbenzyl ethyl ester of glycine (ligand L4) was studied. The corresponding 
alkynyl derivative was added to a solution of (C^N^C)AuOH in toluene. The mixture 
was allowed to stir for 24 hours under reflux, to afford the complexes 5, 6, 7 and 8, 
respectively, as yellow solids in moderated yields, over 50 % (Scheme 12). In this 
method, the use of high temperatures became necessary in order to activate the Au–OH 
bond. In addition, although a water molecule was also obtained in these reactions, no 
reversible steps were observed, and the addition of any dehydrating agent was not 
needed. 
 
 
 
 30  
 
24—48 hours, toluene, reflux. a: 4–ethynylbenzaldehyde (yield : 75 %) (4), N–1–
ethynylbenzyl methyl ester of (L)–alanine (yield : 32 %) (5), (L)–serine (yield : 45 %) 
(6), glycine (yield : 40 %) (7). 4-ethynylbenzaldehyde, sodium borohydride, 2 hours, 
metanol, 0oC (8) (yield : 63.5 %). 
Scheme 12. Synthesis of tri-dentate gold(III) complexes functionalized with alkynyl 
derivatives. 
Complexes 4—8 were soluble in non-polar solvents, such as toluene, dichloromethane 
and chloroform. As we will explain during this thesis, the synthesis of these complexes 
was also checked by the copper method (method c), using the chlorogold precursor 
(C^N^C)AuCl (2) as starting material. In this experiment, it was possible to observe the 
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remarkable change in solubility in protic media when the alkynyl ligand was introduced, 
compared to the starting material. In contrast to (C^N^C)AuCl (2), complexes 4 – 8 
exhibited high solubility in protic solvents. This feature was a useful tool in order to 
isolate these complexes as pure products by extraction with ethanol, when the reaction 
was unfinished and (C^N^C)AuCl (2) was still in the reaction medium. 
In addition, these complexes are air and moisture stable, showing partial reductive 
elimination to gold(0) in solution after one week.   
  
1.2.1.2.1. Synthesis of (C^N^C)Au–C≡C–C6H4–4–CHO (4). 
The reaction of 1–ethynylbenzaldehyde and (C^N^C)AuOH (3) (2:1 ratio) in refluxed 
toluene for 24 hours gives the formation of complex 4 (75%). Complex 4 is a yellow 
solid, air stable, soluble in toluene and dichloromethane and not soluble in petrol ether 
40/60 (Scheme 13). 
 
 
 
 
 
       4 
          Scheme 13. Synthesis of complex 4. 
Complex 4 was characterized by 1H–NMR, 13C{1H}–NMR, IR spectroscopy and 
elemental analysis.  
The IR spectrum for complex 4 shows a strong absorption peak at 1595 cm-1 
corresponding to the aldehyde C=O stretch, and a weak absorption band at 2149 cm-1, 
corresponding to the stretch of the C≡C bond of the di-substituted alkyne group.11,16  
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The chemical shifts corresponding to 1H–NMR spectrum for complex 4 in CDCl3 at 
room temperature are recorded in Table 7.  
Table 7: 1H–NMR data of complex 4 in CDCl3, δ(ppm) and multiplicity. 
 
COMPLEX 4 ASSIGNMENT 1H (ppm) 
 e  1.37 (s, 18H) 
H2O 1.56 (br, s) 
d 7.32 – 7.26 (m, 2H) 
b,c  7.40 (d, J = 8.0 Hz, 2H),  
7.50 (d, J = 8.0 Hz, 2H) 
g,h 7.86 (d, J = 8.1 Hz, 2H), 7.72 (d, J = 
8.1 Hz, 2H) 
a 7.80 (t, J = 7.9 Hz, 1H) 
f  8.16 (d, J = 1.8 Hz, 2H) 
i  10.01 (s, 1H) 
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Figure 15: 1H–NMR spectrum of complex 4 in CDCl3. 
As is shown in Figure 15, the 1H–NMR spectrum exhibits a singlet signal at δ 1.37 
corresponding to protons He from the tert–butyl groups. Regarding the aromatic region, 
proton Hf is shown as a doublet signal at δ 8.16, as is coupled to Hd. This fact has been 
also observed in complexes 5 – 8. In addition, this signal provided the most 
considerable proof that complex 4 was synthesized. The remarkable shift exhibited by 
this signal compared to the precursor (C^N^C)AuOH (3) represented the main 
indication that complex 4 had been formed (Figure 16). The chemical shifts 
corresponding to the aromatic ring from the 4–ethynylbenzaldehyde bonded to the gold 
metallic centre are observed as an AB system at δ 7.72 and 7.86 integrating for four 
protons (Hg and Hh). The proton Hi from the aldehyde function of the 4–
ethynylbenzaldehyde bonded to the metallic centre is shown as a singlet signal at δ 
10.01. These chemical shifts did not undergo remarkable variations compared to the 
ones showed by the free ligand 4-ethynylbenzaldehyde (Figure 16). 
 
  
i 
b,c,g,h f 
a 
d 
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Figure 16: Comparison between 1H–NMR spectrum of complex 4 (red spectrum), 
(C^N^C)AuOH (green spectrum) and 4–ethynylbenzaldehyde (blue spectrum) in 
CD2Cl2.  
According to Figure 16, proton Hf (doublet signal at δ 8.16) is shifted with respect to 
the corresponding proton from the (C^N^C)AuOH, that is shown as a doublet signal at 
δ 7.65 (blue circle). This shift and the absence of the singlet signal corresponding to the 
proton from the alkynyl functional group of 4–ethynylbenzaldehyde (red circle), 
indicate that complex 4 (red spectrum) has been synthesized, through the coordination 
of one 4–ethynylbenzaldehyde molecule to the metal centre. 
The chemical shifts corresponding to 13C{1H}–NMR spectrum of complex 4 in CDCl3 
at room temperature have been recorded in Table 8.  
 
 
 
 
 
 
 
H2O 
H
f
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Table 8: 13C{1H}–NMR data of complex 4 in CDCl3 (δ(ppm)). 
 
 
Figure 17: 13C{1H}–NMR spectrum of complex 4 in CDCl3. 
The 13C{1H}–NMR spectrum of complex 4 shows a chemical shift at δ 191.8 
corresponding to the carbon atom of –C=O group from the aldehyde function of the 4–
COMPLEX 4 ASSIGNMENT 13C (ppm) 
 r 31.2 
d 35.0 
k, l 100.9 (weak signals. One of the carbon 
atoms from this group is not shown) 
Aromatic region 116.1 (i), 123.9 (e), 125.0 (f), 129.7 (n or 
o), 132.2 (a), 133.5 (n or o), 134.4 (Cipso, 
m or p) 142.2 (g), 146.3 (j), 155.5 (c), 
165.0 (h), 166.9 (a) 
q 191.8 
 
r CDCl3  
Aromatic region 
q 
k, l 
 
d 
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ethynylbenzaldehyde molecule coordinated to the metal centre. The signals 
corresponding to the carbons of the alkyne group are observed as weak signals at δ 
100.9. One of the carbon atoms from this group is not shown in the spectrum. These 
signals are shifted compared to the ones reported in the literature for the carbon atoms 
of the alkyne group of 4–ethynylbenzaldehyde (δ 81.02, 82.09).34 
 
1.2.1.2.2. Synthesis of (C^N^C)Au–C≡C–C6H4–4–[CH2–NH–CH(CH3)–COOCH3] 
(5) 
The reaction of 1–ethynyl–4–benzyl–L–alanine methyl ester (L2) and (C^N^C)AuOH 
(3) (2:1 ratio) in refluxed toluene for 24 hours gives complex 5 as a yellow solid (32%). 
Complex 5 is air stable, soluble in toluene, dichloromethane and ethanol, and insoluble 
in petrol ether (40/60) (Scheme 14). 
 
                    3                                         L2                                                   5 
Scheme 14. Synthesis of complex 5. 
Complex 5 has been characterized by 1H–NMR, 13C{1H}–NMR, IR spectroscopy, 
elemental analysis and X-Ray diffraction. 
The IR spectrum shows a weak absorption band at 2151 cm-1, corresponding to the C≡C 
stretch of the di–substituted alkyne.11,16 
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The 1H–NMR chemical shifts of 5 are recorded on Table 9.  
Table 9: 1H–NMR data of complex 5 (CD2Cl2, RT) δ(ppm) and multiplicity. 
 
 
 
 
COMPLEX 5 ASSIGNMENT 1H (ppm) 
 k 1.32 (d, J = 7.0 Hz, 3H) 
e 1.39 (s, 18H) 
j 3.40 (q, J = 7.0 Hz, 1H) 
i 3.68 (d, J = 13.2 Hz, 1H), 3.81 (d, J = 
13.2 Hz, 1H). 
l 3.72 (s, 3H) 
d 7.32 (d, J = 7.0 Hz, 2H) 
b,c,g,h 
(overlapped) 
7.32 (d, J = 8.1 Hz, 2H), 7.46 (d, J = 8.1 
Hz, 2H), 7.55 (d, J = 8.0 Hz, 4H) 
a 7.85 (t, J = 8.0 Hz, 1H) 
f 8.18 (d,  J = 2.0 Hz, 2H) 
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Figure 18:  1H–NMR spectrum of complex 5 in CD2Cl2. 
Figure 18 shows a doublet signal at δ 1.32 associated to the protons Hk corresponding to 
the methyl group bonded to the carbon α of the 1–ethynyl–4–benzyl–L–alanine methyl 
ester molecule bonded to the metallic centre. Proton Hl, corresponding to the methyl 
group from the ester function of the 1–ethynyl–4–benzyl–L–alanine methyl ester 
molecule bonded to the metallic centre, is shown as a singlet signal at δ 3.72. This 
signal is shown in the same region as the AB system associated to the protons Hi (δ 
3.68—3.81). Regarding the aromatic region, proton Hf (doublet signal at δ 8.18) 
represents the main indicator that complex 5 has been synthesized, due to the 
considerable variation exhibited compared to the same proton from the precursor 
(C^N^C)AuOH (Figure 18). Hf is shown as a doublet signal due to its coupling to Hd. 
The chemical shifts corresponding to the aromatic ring of 1–ethynyl–4–benzyl–L–
alanine methyl ester molecule bonded to the metal centre are observed as an AB system 
at δ 7.45 and 7.55 integrating by four protons (Hg and Hh). These signals exhibited a 
slight variation compared to the free ligand 1–ethynyl–4–benzyl–L–alanine methyl ester 
(δ 7.32 and 7.43, Table 1). 
 
 
 
k 
j 
i 
l 
a 
f 
c,d,b,g,h 
H2O CHDCl
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Figure 19: Comparison between 1H–NMR spectra of complex 6 (red), (C^N^C)AuOH 
(blue) and 1–ethynyl–4–benzyl–L–alanine methyl ester in CD2Cl2. 
As is shown in Figure 19, the 1H–NMR spectrum of complex 5 does not show the 
singlet signal corresponding to the proton from the alkynyl functional group of the 1–
ethynyl–4–benzyl–L–alanine methyl ester molecule (green spectrum, blue circle), 
which indicates the coordination of this molecule to the gold atom. In addition, the shift 
showed by Hf (δ 8.18) regarding the same proton from (C^N^C)AuOH (δ 7.65, red 
circle) indicates that Au–C bond has been formed, to afford the complex 5 (red 
spectrum). 
The chemical shifts corresponding to 13C{1H}–NMR spectrum of complex 5 in CD2Cl2 
at room temperature have been recorded on Table 10.  
 
 
 
 
 
 
 
H
f
 
 
Complex 5 
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Table 10: 13C{1H}–NMR data of complex 5 in CD2Cl2 (δ(ppm)). 
 
 
Figure 20: 13C{1H}–NMR spectrum of complex 5 in CD2Cl2. 
COMPLEX 5 ASSIGNMENT 13C (ppm) 
 s 18.9 
v 30.9 
d 35.2 
u, q 51.5, 51.6 
r 56.2 
k, l 91.9, 100.9 (weak signals) 
Aromatic region 116.2 (i), 123.8 (e), 124.9 (f), 125.3 
(Cipso, m or p), 128.0 (n or o), 131.7 
(b), 133.3 (n or o), 139.1 (Cipso, m 
or p), 142.2 (g), 146.6 (j), 155.2 (c), 
164.8 (h), 166.9 (a) 
t 175.9 (weak signal) 
 
d 
v 
Ar 
u, q 
k, l 
t 
CD2Cl2  
 
 
s 
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The 13C{1H}–NMR spectrum of complex 5 in CD2Cl2 shows a weak signal at δ 175.9 
corresponding to the carbon of the –CO group from the ester function of the 1–ethynyl–
4–benzyl–L–alanine methyl ester coordinated to the metallic centre (t). In addition, the 
chemical shifts corresponding to the carbon atoms of the alkyne group are observed as 
weak signals at 91.9 and 100.9 (l and k). These signals underwent a slight shift 
compared to the signals corresponding to the carbon atoms of the alkyne group of the 
ligand 1–ethynyl–4–benzyl–L–alanine methyl ester (δ 73.9 and 83.4, Table 2), which 
indicates the coordination of this molecule to the gold metallic centre. 
Complex 5 was isolated from dichloromethane/petroleum ether 40/60 at room 
temperature as colourless crystals. The structural characterization of complex 5 has 
been solved by X–Ray diffraction.  
A crystal of complex 5 showed two independent molecules. In both, the Au(C^N^C) 
group was well resolved, showing the gold atom bonded to two carbon atoms, the 
nitrogen atom from the pyridine group, and the carbon atom corresponding to the 
alkyne functional group, which is located in trans position to the nitrogen atom from the 
pyridine moiety. However, the ethynyl ligand was less resolved, the atoms of the 
alanine methyl ester group in one molecule were barely resolved and in the second 
molecule only a cluster of electron density was found in this region. Only the gold 
atoms were refined anisotropically; the carbon, nitrogen and oxygen atoms were refined 
with isotropic thermal parameters.  Hydrogen atoms were included (in all but the 
alanine residue of the second molecule) in idealised positions and their Uiso values 
were set to ride on the Ueq values of the parent carbon and nitrogen atoms.   
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Figure 21. ORTEP diagram of complex 5. (X-Ray structure refined and solved by Dr. 
David Hughes) 
Complex 5 gives a distorted square-planar geometry, characteristic of d8 metal 
complexes, producing a N(11)-Au(1)-C(122) angle of 81.9(11)° and N(11)-Au(1)-
C(162) angle of 80.9(10)° about the gold(III) metal center (table 11), found to deviate 
from the ideal 90° angle. Au(1)-N(11), Au(1)-C(122) and Au(1)-C(162) bond lengths of 
1.98(2), 2.00(3) and 2.15(3) Å, respectively, are found in the observed range for another 
similar compounds. 
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Table 11. Most representative angles (°) and bond distances (Å) of complex 5. 
 
 
 
 
 
 
 
 
 
 
1.2.1.2.3. Synthesis of (C^N^C)Au–C≡C–C6H4–4–[CH2–NH–CH(CH2OH)–
COOCH3] (6). 
The reaction of 1–ethynyl–4–benzyl–L–serine methyl ester (L3) and (C^N^C)AuOH (3) 
(2:1 ratio) in refluxing toluene for 24h generated complex 6 as a yellow solid, which is 
air stable, soluble in toluene, dichloromethane and ethanol, and insoluble in petrol ether 
40/60 (Scheme 15). 
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Scheme 15. Synthesis of complex 6. 
BOND LENGHTS (Å) ANGLES(°) 
Au(1)-N(11) 1.98(2) C(17)-Au(1)-N(11) 
 
179.4(11) 
Au(1)-C(122) 2.00(3) C(17)-Au(1)-C(122) 97.7(11) 
Au(1)-C(162) 2.15(3) N(11)-Au(1)-C(122) 81.9(11) 
Au(1)-C(17) 1.97(3) C(17)-Au(1)-C(162) 99.4(11) 
  N(11)-Au(1)-C(162) 80.9(10) 
  C(122)-Au(1)-C(162) 162.4(11) 
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Complex 6 has been characterized by 1H–NMR, 13C{1H}–NMR, infrared spectroscopy 
and elemental analysis.  
The IR spectrum shows a strong absorption peak at 1738 cm-1 and a weak absorption 
peak at 2153 cm-1, for the stretch of C=O and C≡C, respectively.  
The chemical shifts corresponding to the 1H–NMR spectrum for complex 6 in CD2Cl2 
at room temperature are recorded in Table 12.  
Table 12: 1H–NMR data of complex 6 in CD2Cl2, δ(ppm) and multiplicity. 
 
COMPLEX 6 ASSIGNMENT 1H (ppm) 
 e 1.43 (s, 18H) 
k 3.47 (q, J = 4.6 Hz, 1H) 
l 3.81 (s, 3H) 
i,j (overlapped) 3.89-3.72 (m, 4H) 
d 7.36 (d, J = 8.1 Hz, 2H) 
g, h 7.60 (d, J = 8.1 Hz, 2H), 7.50  (d, J = 8.1 
Hz, 2H) 
c, b  7.60 (d, J = 8.1 Hz, 2H), 7.37  (d, J = 8.1 
Hz, 2H) 
a 7.89 (t, J = 9.4 Hz, 1H) 
f 8.21 (d,  J =2.0 Hz, 2H) 
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Figure 22: 1H–NMR spectrum of complex 6 in CD2Cl2. 
Proton Hi and Hj corresponding to the protons of methylene and –CH2OH groups are 
overlapped in the spectrum, observed as a multiplet integrating for four protons. Protons 
Hl of the methyl group from the ester function of the 1–ethynyl–4–benzyl–L–serine 
methyl ester molecule bonded to the metallic centre are shown as a singlet signal at δ 
3.81. The chemical shifts corresponding to the aromatic ring of this molecule are 
observed as AB system at δ 7.45 and 7.55 integrating by four protons (Hg and Hh). 
These signals are shifted compared to the free ligand 1–ethynyl–4–benzyl–L–serine 
methyl ester (δ 7.18 and 7.35, Table 3) . 
 
 
 
CHDCl2 
 
i,j 
k 
l 
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Figure 23: Comparison between 1H–NMR spectrum of complex 6 (red spectrum), 
(C^N^C)AuOH (blue spectrum) and 1–ethynyl–4–benzyl–L–serine methyl ester (green 
spectrum) in CD2Cl2. 
According to Figure 23, the singlet signal corresponding to the proton from the alkynyl 
functional group of the 1–ethynyl–4–benzyl–L–serine methyl ester molecule (green 
spectrum, blue circle) is not shown in the 1H–NMR spectrum of complex 6 (red 
spectrum). Either this feature and the significant shift showed by Hf of complex 6 (δ 
8.21) with respect to the same proton of (C^N^C)AuOH (δ 7.65, red circle) are 
indicative that 1–ethynyl–4–benzyl–L–serine methyl ester molecule is coordinated to 
the metallic centre.  
The chemical shifts corresponding to 13C{1H}–NMR spectrum of complex 6 in CD2Cl2 
at room temperature have been recorded on Table 13.  
 
 
 
H
f
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Table 13: 13C{1H}–NMR data of complex 6 in CD2Cl2  (δ(ppm)). 
 
 
Figure 24: 13C{1H}–NMR data of complex 6. 
COMPLEX 6 ASSIGNMENT 13C (ppm) 
 v 30.9 
d 35.2 
q, r, s, u 51.8, 52.0, 61.3, 62.4 
k, l 92.3, 100.8 
Aromatic region 116.4 (i), 123.8 (e), 124.3 (Cipso, m or p), 
124.9 (f), 128.1 (n or o), 131.8 (n or o), 
133.3 (b), 138.5 (Cipso, m or p), 142.3 (j), 
146.6 (g), 155.2 (c), 164.8 (h), 166.9 (a). 
t This chemical shift is not clearly 
distinguised.  
 
 
Ar 
k, l 
q, r, s, u 
v 
CD2Cl2 
 
 
d 
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As is shown in Figure 24, the chemical shifts corresponding to the carbons from the 
alkyne group are observed at δ 92.3 and 100.8 (k and l) as weak signals. These signals 
exhibited a considerable change compared to the ones from the free ligand 1–ethynyl–
4–benzyl–L–serine methyl ester (δ 77.3 and 83.5, Table 4). The chemical shift 
corresponding to the carbon atom of the –CO group from the ester function of the 1–
ethynyl–4–benzyl–L–serine methyl ester molecule bonded to the metallic centre is not 
properly distinguished in the spectrum. 
 
1.2.1.2.4. Synthesis of (C^N^C)Au–C≡C–C6H4–4–(CH2–NH–CH2–COOCH2CH3) 
(7). 
The reaction of 1–ethynyl–4–benzyl–L–glycine ethyl ester (L4) and (C^N^C)AuOH (3) 
(2:1 ratio) in refluxed toluene for 24 hours affords complex 7. Complex 7 is a yellow 
solid, air and water stable, soluble in toluene, dichloromethane and ethanol, and not 
soluble in petrol ether 40/60 (Scheme 16). 
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Scheme 16. Synthesis of complex 7. 
Complex 7 has been characterized by 1H–NMR, 13C{1H}–NMR, IR spectroscopy and 
elemental analysis. 
 49  
The IR spectrum shows a weak absorption peak at 2149 cm-1, corresponding to the 
vibration mode of the C≡C bond of the di–substituted alkyne group. This peak is shown 
on the same range than the ones reported on the literature for similar examples.16,25 In 
addition, the spectrum exhibits a strong absorption peak at 1737 cm-1 corresponding to 
the C=O stretch. 
The chemical shifts corresponding to the 1H–NMR spectrum for complex 7 in CD2Cl2 
at room temperature are recorded in Table 14. 
Table 14: 1H–NMR data of complex 7 in CD2Cl2, δ(ppm) and multiplicity. 
 
COMPLEX 7 ASSIGNMENT 1H (ppm) 
 n 1.31 (t, J = 7.2 Hz, 3H) 
c 1.43 (s, 18H) 
i,j  3.45 (s, br, 2H) 
3.87 (s, br, 2H) 
m 4.21 (q, J = 7.2 Hz, 2H) 
d 7.32 (d, J = 7.0 Hz, 2H) 
b, e, g, h (overlapped) 7.37 (d, J = 8.1 Hz, 2H), 7.50 
(d, J = 8.1 Hz, 2H), 7.60 (d, J 
= 8.2 Hz, 4H) 
a 7.90 (t, J = 8.0 Hz, 1H) 
f 8.22 (d, J = 2.0 Hz, 2H) 
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Figure 25: 1H–NMR spectrum of complex 7 in CD2Cl2. 
Figure 25 exhibits a triplet signal at 1.31 ppm corresponding to the protons Hn from the 
methyl group of the glycine ester. Protons Hi and Hj represent the methylene groups of 
the 1–ethynyl–4–benzyl–L–glycine ethyl ester molecule. They are observed as two 
broad singlet signals at δ 3.45 and 3.87 integrating for two protons each. Protons Hm 
from the methylene group of the ethyl ester function are observed as a quartet signal 
integrating for two protons.  
The chemical shifts corresponding to the aromatic ring of the 1–ethynyl–4–benzyl–L–
serine methyl ester molecule bonded to the metallic centre are observed as AB system at 
δ 7.50 and 7.60 integrating by four protons (Hg and Hh). These signals are slightly 
shifted compared to the free ligand 1–ethynyl–4–benzyl–L–serine methyl ester (δ 7.31 
and 7.44, Table 5).  
 
  
i,j m 
f 
CHDCl2 
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Figure 26: Comparison between 1H–NMR spectrum of complex 7 (red spectrum), 
(C^N^C)AuOH (blue spectrum) and 1–ethynyl–4–benzyl–L–glycine ethyl ester (green 
spectrum) in CD2Cl2. 
As is shown in 1H–NMR spectrum of complex 7 (red spectrum, Figure 26), the two 
broad singlet signals (δ 3.45 and 3.87) corresponding to the protons Hi and Hj, as well 
as the chemical shift associated to the ethyl ester function (protons Hm and Hn) do not 
show remarkable variations regarding the same signals of the 1–ethynyl–4–benzyl–L–
glycine ethyl ester molecule (green spectrum). However, Hf of complex 7 (δ 8.21) 
shows a significant shift regarding the same proton of (C^N^C)AuOH (δ 7.65, red 
circle). This feature and the absence of the singlet signal corresponding to the proton 
from the alkynyl functional group of the 1–ethynyl–4–benzyl–L–glycine ethyl ester 
molecule (blue circle) indicate that this molecule is coordinated to the metallic centre, 
to afford the complex 7 through formation of an Au–C bond.  
The chemical shifts corresponding to 13C{1H}–NMR spectrum of complex 7 in CD2Cl2 
at room temperature have been recorded on Table 15.  
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Table 15: 13C{1H}–NMR data of complex 7 in CD2Cl2  (δ(ppm)). 
 
 
Figure 27: 13C{1H}–NMR spectrum of complex 7 in CD2Cl2. 
COMPLEX 7 ASSIGNMENT 13C (ppm) 
 
u 14.0 
v 31.0 
d 35.2 
q or r 60.7 (only one signal is observed) 
k, l 100.9, 92.0 
Aromatic region 
116.3 (i), 123.8 (e), 124.9 (f), 125.5 
(Cipso, m or p. One of these carbons is 
not shown in the spectrum), 128.2 (n or 
o), 131.8 (b), 133.3 (n or o), 142.3 (g), 
146.6 (j), 155.2 (c), 164.8 (h), 166.9 (a). 
s Not shown in the spectrum. 
 
Ar 
k, l u 
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As is shown in the 13C{1H}–NMR spectrum of complex 7 in CD2Cl2 (Figure 27), the 
signal corresponding to the carbon atom of the –CO group from the ester function of the 
1–ethynyl–4–benzyl–L–glycine ethyl ester molecule bonded to the gold metallic centre 
(s) is not show in the spectrum. The chemical shifts corresponding to the alkyne group 
(weak signals at δ 92.0 and 100.9) have provided us the most significant datum to 
justify the coordination of the 1–ethynyl–4–benzyl–L–glycine ethyl ester molecule to 
the metallic centre, due to the significant shift compared to the free ligand (δ 77.2 and 
83.8, Table 6). One of the methylene groups from the 1–ethynyl–4–benzyl–L–glycine 
ethyl ester molecule coordinated to the metallic centre (q or r) is not show in the 
spectrum. 
 
1.2.1.2.5. Synthesis of (C^N^C)Au–C≡C–C6H4–4–CH2OH (8) 
In order to expand and develop our studies, we investigated the synthesis of gold(III) 
complexes functionalized by alkynyl–amino acid derivatives. This has been a 
preliminary experiment, carried out in the final stage of our research. The observed 
results have not been conclusive, being required to attempt this approach in depth in 
future investigations. 
In contrast to the previously synthesized gold(III) complexes functionalized by alkynyl–
amino ester derivatives (complexes 4, 5, 6 and 7), the –COOH terminal position of the 
targeted complexes may allow a consequent condensation reaction with other amino 
acids and peptides, expanding our investigations on this field. 
The previously synthesized complex 4 has been employed as precursor on these 
experiments. The –CHO functional group of complex 4 can condense with the –NH2 
function from amino acids, to lead to an imine derivate. This reaction was investigated 
employing D–alanine as amino acid. Amino acids are soluble in polar solvents, such as 
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water and methanol; this solubility behaviour was one of the main disadvantages we 
found in our experiments. The imine formation is an equilibrium that, in presence of 
water in the medium, can be moved to the starting materials (complex 4 and alanine). 
The use of dried methanol as solvent became needed in order to drive the reaction to the 
imine formation. The experiment was conducted under nitrogen atmosphere, employing 
D–Alanine in excess (1:5 ratio) and 4Å molecular sieves as dehydrating agent, in order 
to remove the formed water as second product. The reaction mixture was allowed to stir 
16 hours under reflux. After this time, a 1H–NMR test sample in MeOD confirmed the 
absence of the –CHO signal at δ 10.00. In addition, a new singlet was observed at δ 
8.50, corresponding to the HC=N imine group (Figure 28).  
 
 
Figure 28. 1H–NMR spectrum of crude of reaction from complex 4 in MeOD, before 
addition of sodium borohydride. 
The solvent was removed and the residue was washed under nitrogen atmosphere and 
dried with light petroleum. The yellow residue was then washed quickly with cold 
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water, in order to remove any excess of D-alanine. The product was dried under 
vacuum.  
As it was mentioned previously, the –C=N group is susceptible to hydrolysis in 
presence of water or under acidic conditions, to regenerate the starting carbonyl and 
amine derivatives. In order to avoid this step and simplify the consequent ways to work 
with this complex, reduction of the imine function to –C–NH was planned. As it was 
studied for the synthesis of ligands L2, L3 and L4, the residue was dissolved in dried 
methanol, and sodium borohydride was slowly added at 0oC. The reaction mixture was 
warmed to room temperature and stirred overnight. After 12 hours the solvent was 
removed and dichloromethane was added. Although the complex was not expected to be 
soluble in dichloromethane because of its expected polar character, we observed that 
most of residue was soluble. The product (complex 8) was analysed by 1H–NMR 
spectroscopy in CD2Cl2 (Figure 29).  
 
Figure 29: 1H–NMR spectrum of complex 8 in CD2Cl2. 
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The 1H–NMR spectrum from the residue did not show any chemical shift on the 
aldehyde region. In addition, a doublet signal at δ 4.72 was observed. The analysis of 
this complex was completed through 13C{1H}–NMR spectroscopy (Figure 30). The 
13C{1H}–NMR spectrum showed two signals at δ 92.3 and 100.9 corresponding to the 
carbons of alkyne group. The chemical shift at δ 191.8 corresponding to the carbon 
atom of the –CO group from the aldehyde function of complex 4 was not observed. In 
addition, the signal corresponding to methanol and hexane were observed at δ 51.04 and 
31.4, respectively. Nevertheless, the most interesting signal was observed as a new 
chemical shift at δ 65.3 corresponding to the –CH2OH group.  
 
 
Figure 30: 13C{1H}–NMR spectrum of complex 8 in CDCl3. 
As it was mentioned in the synthesis of ligands L2, L3 and L4, we found that sodium 
borohydride promoted the reduction of the aldehyde group –CHO to –CH2OH34 instead 
of the imine (Figure 6). The obtained results by 1H–NMR and 13C{1H}–NMR 
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spectroscopy showed that the reduction of the aldehyde group of complex 4 had taken 
place, producing a –CH2OH functional group. 
This complex was independently confirmed by its direct synthesis from complex 4. The 
reaction of sodium borohydride and (C^N^C)Au–C≡C–C6H4–CHO (4) (10:1 ratio) in 
dried methanol was allowed to stir for 2 hours at room temperature. Both 1H–NMR and 
13C{1H}–NMR spectroscopy confirmed the same complex than the one previously 
synthesized accidentally. Complex 8 is a yellow solid, air stable, soluble in 
dichloromethane and ethanol, and not soluble in petrol ether 60/40 (Scheme 17). 
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Scheme 17. Synthesis of complex 8. 
The chemical shifts corresponding to 1H–NMR spectrum for complex 8 in CDCl3 at 
room temperature are recorded on Table 16. 
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Table 16: 1H–NMR data of complex 8 in CDCl3, δ(ppm) and multiplicity. 
 
As it is shown in 1H–NMR spectrum of complex 8 (Figure 28, Table 15), the protons 
Hi,j, corresponding to the –CH2OH function, are observed as a doublet signal at δ 4.72. 
Despite the fact that protons Hi,j were expected to be shown as a singlet signal, because 
of the presumably equivalence of these protons, they are shown as a doublet. This can 
be explained because of, when one molecule presents restricted rotation; atoms bonded 
to the same carbon atom may not be equivalent. If this occurs, non-equivalent 1H nuclei 
on the same carbon atom will couple to each other and cause splitting. This fact is also 
observed for proton Hf, shown as a doublet signal at δ 8.21.  
The chemical shifts corresponding to 13C{1H}–NMR spectrum of complex 8 in CDCl3 
at room temperature have been recorded on Table 17.  
 
 
 
COMPLEX 8 ASSIGNMENT 1H (ppm) 
 e 1.39 (s, 18H) 
i, j 4.72 (d, J = 6.0 Hz, 2H) 
b (overlapped with 
CDCl3 residual signal) 
7.32 (m, 2H) 
g, h 7.38 (d, J = 8.1, 2H), 7.37 (d, J = 
8.1, 2H) 
d, c 7.36 (d, J = 8.0, 2H), 7.62 (d, J = 
8.0, 2H) 
a 7.79 (t, J = 8.0 Hz, 1H) 
f 8.21 (d,  J = 2.0 Hz, 2H) 
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Table 17: 13C{1H}–NMR data for complex 8 in CDCl3. 
  
These results allow us to confirm that the (C^N^C)Au(III) alkynyl derivatives 
functionalized by aldehyde groups can be reduced to primary alcohols in presence of 
sodium borohydride. Despite the fact that it is very difficult to figure out any conclusion 
after these results, one explanation may be that the equilibrium has not been completely 
moved to the formation of the imine group and complex 4 and D–alanine are partially 
presented in the medium. For this reaction, dried methanol was used as solvent, in order 
to move the equilibrium to the imine derivative formation. Although the hydrolysis is 
not a fast step, methanol is highly hygroscopic, being able to absorb water after long 
reaction times. If this happens, the equilibrium would not be completely moved to the 
imine formation, and complex 4 and D–alanine would be presented in the medium. In 
this point, the use of IR spectroscopy would be an useful technique in order to check if 
the C=N bond has been formed (an absorption band between 1640–1690 cm-1 would be 
expected). After the addition of sodium borohydride, methanol was removed and the 
residue was extracted with dichloromethane. As it was mentioned before, most of the 
COMPLEX 8 ASSIGNMENT 13C (ppm) 
 r 31.2 
d 35.4 
q 65.3 
k, l 92.3, 100.9 
Aromatic region 116.0 (i), 123.8 (e), 124.9 (f), 126.2 (Cipso, 
m or p), 126.9 (n or o), 132.1 (b), 133.6 
(Cipso, m or p), 142.1 (j), 146.4 (g), 155.2 
(c), 164.9 (h), 167.1 (a). 
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product was soluble in dichloromethane. When dichloromethane was removed, complex 
8 was observed. Because of the polarity of the D–alanine functional group, it would be 
expected  (C^N^C)Au(III) amino acid complexes to be considerably polar, being not 
soluble in dichloromethane. This result may justify that the equilibrium was not 
completely moved in the first stage. Although the residue that was not soluble in 
dichloromethane was checked by 1H–NMR spectroscopy in MeOD, the small amount 
present of this product did not allow to observe signals clearly differentiated, being not 
possible to make any conclusion. 
Despite the fact that conclusive results have not been obtained, some modifications are 
suggested in order to attempt this section of the project in future investigations. Dried 
methanol would be the most convenient solvent to conduct this experiment, under inert 
atmosphere. As it was mentioned before, excess of amino acid would help to move the 
equilibrium to the imine formation, employing IR spectroscopy in order to check the 
C=N formation. At this point, instead of adding in situ sodium borohydride to reduce 
the imine bond, the isolation and characterization of this complex would be our aim, 
washing off first and quickly with cold water (to remove the excess of D–alanine) and 
dichloromethane (to remove starting material in case that the reaction is unfinished), 
and dry it under vacuum. The final step would be the reduction of C=N bond, in dried 
methanol, using excess of sodium borohydride as reducing agent. 
1.2.2. Synthesis of mono– and di–substituted bi–dentate gold(III) complexes 
functionalized with alkynyl derivatives. 
We focused on the synthesis of bidentate gold(III) complexes functionalized by alkynyl 
derivatives. In the first instance, the target of the project was to use complexes 2 and 15 
(these complexes will be discussed later in the thesis) as precursors, and trying to attach 
amino acid and amino ester derivatives from them. However, this approach failed, 
 61  
because the condensation product between aldehyde and amine functional groups was 
not achieved. This result encouraged us to propose an alternative approach, which was 
based on synthesizing the alkynyl derivative first, and attach it to the metallic centre. 
In order to synthesize and characterize these complexes, (2–para–tolylpyridyl)AuCl2 
(10) was employed as precursor, because of the commercial availability of the ligand 
(2–para–tolylpyridine). The synthesis of (2–para–tolylpyridyl)AuCl2 (10) was explored 
by two different pathways: 
a. In the first route we carried out the direct auration of 2–para–tolylpyridine via two 
steps reaction. The first step involves the reaction of (2–para–tolylpyridine) and 
H[AuCl4] in MeOH35 to give the intermediate (HC^N)AuCl3, which reacts further 
to give the cyclometallated complex 10 in moderate yield (35—37%)12 when it is 
refluxed in a mixture of acetonitrile/water (1:1) (Scheme 18).  
 
 
 
Scheme 18. Synthesis of (2–para–tolylpyridyl)AuCl2 10 by direct auration. 
b. The second route involves the initial mercuration reaction of 2–para–Tolylpyridine, 
using Hg(OAc)2 as metallating agent, and the consequent transmetallation step 
employing K[AuCl4].  
The synthesis of the organomercury substrate has been carried out according to the 
experimental procedure reported on the literature3. 2–para–Tolylpyridine has been 
subjected to mercuration with Hg(OAc)2 followed by salt metathesis with LiCl to 
give the complex (N^C)HgCl (9). The mercury salt then undergoes transmetallation 
and C–H activation with K[AuCl4] to yield complex 10 in moderate yield (38 %) 
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(Scheme 19). Partial reductive elimination to gold(0) was observed in the 
transmetallation step.  
 
 
 
 
 
Scheme 19. Synthesis of (2–para–tolylpyridyl)gold(III)Cl2 10 by transmetallation 
reaction. 
The prepared (2–para–tolylpyridyl)AuCl2 derivative by these two pathways was 
analysed by 1H–NMR spectroscopy in DMSO–d6. The observed chemical shifts were 
consistent with the ones reported in the literature for this complex.12 
The use of these two different methods showed us that mercuration of 2–para–
tolylpyridine and consequent transmetallation did not show remarkable improvements 
in terms of yield and reaction times compared to the direct auration. In addition, 
transmetallation step produced partial reductive elimination to gold(0), which was not 
observed during the direct auration. This may be explained because of the reaction 
conditions employed during the mercuration and transmetallation stages. These reaction 
steps have been carried out in refluxed methanol. Methanol can act as reducing agent 
that, at high temperatures, may cause the partial reductive elimination to gold(0). 
However, direct auration is conducted under smoother conditions, avoiding the 
reductive elimination step. 
The incorporation of the alkynyl ligand into the cyclometalated gold(III) moiety has 
been achieved following the experimental procedure reported by Venkatesan et al.,21 
which involves the reaction of (2–para–tolylpyridyl)AuCl2, alkynyl derivative, 
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triethylamine, and a catalytic amount of copper(I) iodide in dichloromethane, to lead to 
the formation of the mono– and di–substituted gold(III) alkynyl derivatives 11, 12, 13 
and 14 as yellow solids in moderated yields, over 50 % (Scheme 20). 
 
 
Reaction conditions: CuI, NEt3, dichloromethane, ligand (Lx). 
Lx:  
       x = 0 : 4–ethynylbenzaldehyde (a).  
       x = 2 : 1–ethynyl–4–benzyl–L–alanine methyl ester (b). 
       x = 3 : 1–ethynyl–4–benzyl–L–serine methyl ester (c). 
       x = 4 : 1–ethynyl–4–benzyl–L–glycine ethyl ester (d). 
Scheme 20. Synthesis of bi–dentate gold(III) complexes functionalized with alkynyl 
derivatives. 
Complexes 11—14 showed high solubility in non-polar solvents, such as 
dichloromethane. This feature played an important role as indicator of absence of 
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starting material. In contrast to complexes 11 – 14, the chlorogold precursor (2–para–
tolylpyridyl)AuCl2 (10) exhibited poor solubility in non-polar solvents. Accordingly, 
when the initial suspensión observed in the experiments turned into solution, it was 
indicative that complexes 11—14 have been synthesized. This change of solubility 
when the alkynyl ligand is coordinated to the metallic centre was also observed in protic 
media. In contrast to the precursor (2–para–tolylpyridyl)AuCl2 (10), complexes 11—14 
exhibited high solubility in protic solvents, such as alcohols, but not in water. This 
feature was a useful tool to isolate these complexes as pure products. 
 
1.2.2.1. Synthesis of (C^N)Au(Cl)C≡C–C6H4–4–CHO (11). 
The reaction of 4–ethynylbenzaldehyde and (2–para–tolylpyridyl)AuCl2 (10) (1:1 ratio) 
in dichloromethane, in presence of excess of triethylamine and a catalytic amount of 
CuI for 2 hours allowed the synthesis of complex 11 (13 mg, 33 %). Complex 11 is a 
yellow solid, air stable, soluble in dichloromethane and ethanol, and not soluble in 
petrol ether 40/60 (Scheme 21).  
 
Scheme 21. Synthesis of complex 11.  
Complex 11 has been characterized by 1H–NMR, 13C{1H}–NMR, infrared spectroscopy 
and elemental analysis.  
10	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The IR spectrum shows a weak absorption peak at 1691 and 2164 cm-1, corresponding 
to the stretch of the C=O bond of the aldehyde function and the C≡C bond of the di-
substituted alkyne group,21,25 respectively.  
The chemical shifts corresponding to 1H–NMR spectrum for complex 11 in CD2Cl2 at 
room temperature are recorded on Table 18.  
Table 18: 1H–NMR data of complex 11 in CD2Cl2, δ(ppm) and multiplicity. 
 
COMPLEX 11 ASSIGNMENT 1H (ppm) 
 a 2.42 (s, 3H) 
c 7.24 (d, J = 7.8 Hz, 1H) 
g 7.46-7.54 (m, 1H) 
d 7.59 (d, J = 7.9 Hz, 1H) 
i,j 7.70 (d, J = 8.2 Hz, 2H), 7.86 (d, J = 8.2 
Hz, 2H) 
e 7.90 (d, J = 7.5 Hz, 1H) 
b 7.98 (s, 1H) 
f 8.10 (td, J = 8.0, 1.5 Hz, 1H) 
h 9.50 (d, J = 5.8 Hz, 1H) 
k 10.01 (s, 1H) 
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Figure 31: 13H–NMR spectrum of complex 11 in CD2Cl2. 
As it is observed in Figure 32, Hh of complex 11 (δ 9.50) is shifted regarding the same 
proton from the (2–para–tolylpyridyl)AuCl2 (δ 9.75, red circle). Both this feature and 
the absence of the proton of the alkynyl function of 4-ethynylbenzaldehyde (blue 
circle) indicate that one molecule of 4–ethynylbenzaldehyde is coordinated to the 
metallic centre through Au–C bond formation.  
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Figure 32: Comparison between 1H–NMR spectra of complex 11 (red spectrum), (2–
para–tolylpyridyl)AuCl2 (blue spectrum) and 4–ethynylbenzaldehyde (green spectrum) 
in CD2Cl2. 
The chemical shifts corresponding to 13C{1H}–NMR spectrum of complex 11 in 
CD2Cl2 at room temperature have been recorded in Table 19.  
Table 19. 13C{1H}–NMR data of complex 11 in CD2Cl2 (δ(ppm)). 
COMPLEX 11 ASSIGNMENT 13C (ppm) 
 s 21.8 
l, m 96.9, 90.2 
Aromatic region 120.15 (d), 123.8 (b or g), 125.4 (Cipso, n or 
q), 129.3 (b or g), 129.4 (o or p), 131.5 (h), 
132.3 (o or p), 135.1 (j), 135.3 (Cipso, n or 
q), 139.6 (c or f), 142.3 (c or f), 143.4 
(Cipso, a, i or k), 147.0 (Cipso, a, I or k), 
147.6 (Cipso, a, i or k), 164.1 (Cipso, e). 
r 191.5 
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Figure 33. 13C{1H}–NMR spectrum of complex 11 in CD2Cl2.  
The 13C{1H}–NMR spectrum of complex 11 in CD2Cl2 shows one signal at δ 191.5 
corresponding to the carbon atom of the –CO group from the aldehyde function of the 
4–ethynylbenzaldehyde molecule coordinated to the metallic centre (r). The signals 
corresponding to the alkyne group are observed as weak signals at δ 90.2, 96.9 (l and 
m). They are a slightly shifted compared to the chemical shifts reported on the literature 
for the carbon atoms of the alkyne group of 4–ethynylbenzaldehyde (δ 81.02, 82.09).34 
 
1.2.2.2. Synthesis of (C^N)Au(Cl)C≡C–C6H4–4–[CH2–NH–CH(CH3)–COOCH3] 
(12). 
The reaction of 1–ethyny–4–benzyl–L–alanine methyl ester and (2–p–
tolylpyridyl)AuCl2(10) (1:1 ratio) in dichloromethane, in presence of excess of 
triethylamine and a catalytic amount of CuI for 2 hours led the synthesis of complex 12 
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(94.5 mg, 41 %). Complex 12 is a yellow solid, air stable, soluble in dichloromethane 
and ethanol, and not soluble in petrol ether 40/60 (Scheme 22). 
 
        12 
Scheme 22. Synthesis of complex 12. 
Complex 12 has been characterized by 1H–NMR, 13C{1H}–NMR, infrared spectroscopy 
and elemental analysis.  
The IR spectrum shows a weak absorption band at 1733 and 2164 cm-1, corresponding 
to the stretch of the C=O bond of the ester group and the C≡C bond of the di-substituted 
alkyne group,21,25 respectively.  
The chemical shifts corresponding to 1H–NMR spectrum for complex 12 in CD2Cl2 at 
room temperature are recorded in Table 20.  
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Table 20: 1H–NMR data of complex 12 in CD2Cl2, δ(ppm) and multiplicity. 
 
 
 
 
COMPLEX 12 ASSIGNMENT 1H (ppm) 
 n 1.30 (d, J = 7.0 Hz, 3H)  
a 2.42 (s, 3H) 
m 3.38 (q, J = 7.0 Hz, 1H)  
k 3.67 (d, J = 13.4 Hz, 1H), 3.82 (d, J 
= 13.4 Hz, 1H) 
l 3.71 (s, 3H) 
c 7.22 (dd, J = 7.9, 0.8 Hz, 1H) 
i, j 7.32 (d, J = 8.0 Hz, 1H), 7.50 (d, J 
= 8.0 Hz, 1H) 
g 7.31 – 7.40 (m, 1H) 
d 7.58 (d, J = 7.9 Hz, 1H) 
e 7.89 (d, J = 8.1 Hz, 1H)  
b 8.02 (d, J = 0.8 Hz, 1H) 
f 8.05-8.08 (m, 1H) 
h  9.48 (dd, J = 5.8, 1 Hz, 1H) 
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Figure 34: 1H–NMR spectrum of complex 12 in CD2Cl2.  
As it is shown in Figure 34, the doublet signal at δ 1.30, associated to protons Hn from 
the methyl group of the carbon α from the 1–ethynyl–4–benzyl–L–alanine methyl ester 
molecule bonded to the gold atom, did not undergo a remarkable shift compared to the 
free ligand (Figure 35, blue spectrum). This was also observed in the case of protons Hi 
Hj Hk and Hl (δ 3.67—3.82). Regarding the aromatic area, proton Hb is observed as a 
doublet signal at δ 8.02 because of its coupling to Hc. 
 
 
 
 
 
 
 
k 
a n 
h m 
l 
CHDCl2 
 
 
 72  
 
Figure 35: Comparison between 1H–NMR spectrum of complex 12 (red spectrum), (2–
para–tolylpyridyl)AuCl2 (green spectrum) and 1-ethynyl–4–benzyl–L–alanine methyl 
ester  (blue spectrum) in CD2Cl2.  
As it is shown in Figure 35, one of the most remarkable features of 1H–NMR spectrum 
of complex 12 is the absence of the chemical shift corresponding to the proton of the 
alkynyl functional group of 1–ethynyl–4–benzyl–L–alanine methyl ester (red circle). 
This feature and the significant shift shown by the proton Hh of complex 12 (δ 9.48) 
compare to the same proton from (2–para–tolylpyridyl)AuCl2 precursor (δ 9.75, blue 
circle) indicate that one 1–ethynyl–4–benzyl–L–alanine methyl ester molecule is 
coordinated to the gold metallic centre, forming an Au–C bond.  
The chemical shifts corresponding to 13C{1H}–NMR spectrum of complex 12 in 
CD2Cl2 at room temperature have been recorded in Table 21.  
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Table 21. 13C{1H}–NMR data of complex 12 in CD2Cl2  (δ(ppm)). 
 
 
 
 
 
 
 
 
 
COMPLEX 12 ASSIGNMENT 13C (ppm) 
 t or w 18.9  
s 21.2 
t or w 21.8  
r, v 51.6, 54.2 
l, m 97.0, 84.3 
 
 
Aromatic region 
 120.1 (d), 123.7 (b or g), 123.8 (b 
or g), 125.3 (Cipso, n or q), 128.0 (o 
or p), 129.1 (h), 131.7 (o or p), 
135.4 (Cipso, n or q), 139.6 (j), 
139.9 (c or f), 142.1 (c or f), 143.2 
(Cipso, a, i or k), 146.9 (Cipso, a, i or 
k), 147.6 (Cipso, a, i or k), 164.1 
(Cipso, e). 
u 176.0 
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Figure 36. 13C{1H}–NMR spectrum of complex 12 in CD2Cl2. 
The 13C{1H}–NMR spectrum of complex 12 in CD2Cl2 exhibits one signal at δ 176.0 
corresponding to the carbon atom of the –CO group from the ester function of the 1–
ethynyl–4–benzyl–L–alanine methyl ester molecule bonded to Au atom (g). The signals 
corresponding to the carbons of the alkyne group are observed as weak signals at δ 84.3, 
97.0 (l and m), slightly shifted compared to the ones observed for the ligand 1–ethynyl–
4–benzyl–L–alanine methyl ester (δ 73.9, 83.4, Table 3). 
 
1.2.2.3. Synthesis of (C^N)Au(Cl)C≡C–C6H4–4–[CH2NH–CH–(CH2OH)–
COOCH3] (13). 
The reaction of 1–ethynyl–4–benzyl–L–serine methyl ester and (2–para–
tolylpyridyl)AuCl2 (10) (1:1 ratio) in dichloromethane, in presence of excess of 
triethylamine and a catalytic amount of CuI for 2 hours led the synthesis of complex 13 
CD2Cl2  
 
 
l, m s, t, w 
u 
Ar 
 
  
r, v 
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(68.0 mg, 38 %). Complex 13 is a yellow solid, air stable, soluble in dichloromethane 
and ethanol, and not soluble in petrol ether 40/60 (Scheme 23). 
 
 13 
Scheme 23. Synthesis of complex 13. 
Complex 13 has been characterized by 1H–NMR, 13C{1H}–NMR, infrared spectroscopy 
and elemental analysis.  
The IR spectrum shows a weak absorption peak at 1731 and 2154 cm-1, corresponding 
to the stretch of the C=O bond of the ester function and the C≡C bond of the di–
substituted alkyne group,21,25 respectively.  
The chemical shifts corresponding to 1H–NMR spectrum for complex 13 in CD2Cl2 at 
room temperature are recorded in Table 22.  
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Table 22: 1H–NMR data of complex 13 in CD2Cl2, δ(ppm) and multiplicity. 
 
 
 
 
 
 
 
 
 
 
 
COMPLEX 13 ASSIGNMENT 1H (ppm) 
 a 2.40 (s, 3H)  
n 3.43 (dd,  J = 5.8, 4.7 Hz, 1H) 
l 3.74 (s, 3H)  
m, k (overlapped) 3.57 – 3.94 (m, 4H) 
c 7.24 (d, J = 7.1 Hz, 1H) 
i, j 7.33 (d, J = 8.0 Hz, 2H), 7.52 (d, J = 
8.0 Hz, 2H) 
g 7.47 – 7.53 (m, 1H) 
d 7.59 (d, J = 7.9 Hz, 1H) 
e 7.90 (d, J = 7.9 Hz, 1H) 
b 8.05 (d, J = 0.7 Hz, 1H) 
f 8.06 – 8.13 (td,  J = 8.0, 1.5 Hz, 1H) 
h  9.51 (d, J = 5.0 Hz, 1H)  
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Figure 37: 1H–NMR spectrum of complex 13 in CD2Cl2. 
As it is shown in Figure 37, the 1H-NMR spectrum of complex 13 shows two broad 
signals integrating by one proton between δ 2—3. These two signals may correspond to 
the chemical shifts from the –NH and the –OH functions, which are expected to be 
observed in that region of the 1H–NMR spectrum. In order to check if these chemical 
shifts correspond to the mentioned functional groups, a drop of D2O was added to the 
NMR tube in CD2Cl2. Because of the enhanced acidity of the hydrogen atom of the –
OH and –NH groups, the addition of a drop of D2O promotes and isotopic exchange, 
which implies a replacing of a hydrogen atom by a deuterium atom. If the observed 
broad signals correspond to the –NH and –OH functions, they should not be observed in 
the 1H–NMR spectrum after addition of D2O. 
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 Figure 38: 1H–NMR spectrum of complex 13 in CD2Cl2, after addition of D2O. 
Figure 38 shows the 1H–NMR spectrum of complex 13 in CD2Cl2, after addition of one 
drop of D2O. As is shown on the spectrum, the two broad singlet signals are not 
presented after adding one drop of D2O. This result confirms that these broad signals 
correspond to the –OH and –NH functional groups, and the addition of D2O has 
prompted the isotopic exchange of the hydrogen atom by deuterium atom.  
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Figure 39: Comparison between 1H–NMR spectra of complex 13 (red spectrum), (2–
para–tolylpyridyl)AuCl2 (green spectrum) and 1–ethynyl–4–benzyl–L–serine ethyl ester 
(blue spectrum) in CD2Cl2. 
As it is shown in Figure 39, proton Hh of complex 13 (δ 9.51, red spectrum) is shifted 
compared to the same proton from (2–para–tolylpyridyl)AuCl2 precursor (δ 9.75, blue 
circle). Although 1H–NMR spectrum of complex 13 does not show remarkable 
variations in the chemical shifts compared to the 1H–NMR spectrum of the ligand 1–
ethynyl–4–benzyl–L–serine ethyl ester (blue spectrum), the absence of the proton of the 
alkynyl functional group (red circle) in the 1H–NMR spectrum of complex 13 indicates 
that 1–ethynyl–4–benzyl–L–serine methyl ester molecule is coordinated to the metallic 
centre.  
The 13C{1H}–NMR spectrum for the complex 13 has been carried out in CD2Cl2 at 
room temperature. The chemical shifts are recorded in Table 23.  
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Table 23. 13C{1H}–NMR data of complex 13 in CD2Cl2  (δ(ppm)). 
 
 
 
 
 
 
 
 
 
 
COMPLEX 13 ASSIGNMENT 13C(ppm) 
 w 21.8 
v 51.3 
r, t 61.0, 62.4 
l, m 84.0, 96.9 
 
 
Aromatic region 
120.0 (d), 123.7 (b or g), 123.8 
(b or g), 125.3 (Cipso, n or q), 
128.1 (o or p), 129.1 (h), 131.8 
(o or p), 135.5 (Cipso, n or q), 
139.3 (j), 139.7 (c or f), 142.2 
(c or f), 143.2 (Cipso, a, i or k), 
146.9 (Cipso, a, i or k), 147.6 
(Cipso, a, i or k), 164.1 (Cipso, e).  
u 173.2 
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Figure 40: 13C{1H}–NMR spectrum of complex 13 in CD2Cl2. 
The 13C{1H}–NMR spectrum of complex 13 in CD2Cl2 shows one signal at δ 173.2 
corresponding to the carbon atom of –CO group from the ester function of the 1–
ethynyl–4–benzyl–L–serine methyl ester molecule coordinated to the metallic centre 
(h). The signals corresponding to the carbon atoms from alkyne group are observed as 
weak signals at δ 84.0 and 96.9 (l and m), slightly shifted regarding the ones observed 
for the ligand 1–ethynyl–4–benzyl–L–serine methyl ester (δ 77.3, 83.5, Table 5). 
 
1.2.2.4.  Synthesis of (C^N)Au–(Cl)C≡C–C6H4–4–[CH2–NH–CH(CH2OH)–
COOCH3] (14). 
The reaction of 1–ethynyl–4–benzyl–L–glycine methyl ester and (2-para-
tolylpyridyl)AuCl2 (10) (1:1 ratio) in dichloromethane, in presence of excess of 
triethylamine and a catalytic amount of CuI for 2 hours gave complex 14 (94.5 mg, 41 
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%). Complex 14 is a yellow solid, air stable, soluble in dichloromethane and ethanol, 
and not soluble in petrol ether 40/60 (Scheme 24).  
 
 Scheme 24. Synthesis of complex 14. 
Complex 14 has been characterized by 1H–NMR, 13C{1H}–NMR, infrared spectroscopy 
and elemental analysis.  
The IR spectrum shows a weak absorption band at 1736 and 2161 cm-1, corresponding 
to the stretch of the C=O bond of the ester function and the C≡C bond of the di–
substituted alkyne group,21,25 respectively.  
The chemical shifts corresponding to 1H–NMR spectrum for complex 14 in CD2Cl2 at 
room temperature are recorded in Table 24.  
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Table 24: 1H–NMR data of complex 14 in CD2Cl2, δ(ppm) and multiplicity. 
 
 
 
COMPLEX 14 ASSIGNMENT 1H (ppm) 
 m 1.26 (t, J= 7.1 Hz, 2H)  
a 2.42 (s, 3H) 
k, l 3.39 (s, b, 2H),3.81 (s, b, 2H) 
n 4.17 (q, J = 7.1 Hz, 3H) 
c 7.23 (d, J = 7.8 Hz, 1H) 
i, j 7.32 (d, J = 8.0 Hz, 2H), 7.51 (d, J = 
8.0 Hz, 2H) 
g 7.48 – 7.51 (m, 1H) 
d 7.59 (d, J = 7.9 Hz, 1H) 
e 7.90 (d, J = 7.9 Hz, 1H) 
b 8.05 (d, J = 0.8 Hz, 1H) 
f 8.05 – 8.13 (td,  J = 8.0, 1.5 Hz, 1H) 
h  9.50 (d, J = 4.8 Hz, 1H)  
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Figure 41: 1H–NMR spectrum of complex 14 in CD2Cl2. 
The comparison between 1H–NMR spectra of complex 14 (red spectrum), (2–para–
tolylpyridyl)AuCl2 (blue spectrum) and 1–ethynyl–4-benzyl–L–glycine ethyl ester 
(green spectrum) in CD2Cl2 shows that both the chemical shifts corresponding to the 
methylene and methyl groups (CH3CH2–O–) of the 1–ethynyl–4-benzyl–L–glycine 
ethyl ester function of complex 14 did not undergo significant variations compared to 
the chemical shifts shown by ligand 1–ethynyl–4-benzyl–L–glycine ethyl ester (Figure 
42). However, Hh of complex 14 (δ 9.50) exhibits a notable shift compared to the same 
proton from (2–para–tolylpyridyl)AuCl2 precursor (δ 9.75, red circle). This feature and 
the absence of the proton of the alkynyl function from 1–ethynyl–4–benzyl–L–glycine 
ethyl ester molecule (blue circle) indicate that coordination of the 1–ethynyl–4–benzyl–
L–serine has taken place successfully.  
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Figure 42: Comparison between 1H–NMR spectra of complex 14 (red spectrum), (2–
para–tolylpyridyl)AuCl2 (blue spectrum) and 1–ethynyl–4–benzyl–L–serine ethyl ester 
(green spectrum) in CD2Cl2.  
The 13C{1H}–NMR spectrum for the complex 14 has been carried out in CD2Cl2 at 
room temperature. The chemical shifts are recorded in Table 25.  
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Table 25. 13C{1H}–NMR data of complex 14 in CD2Cl2  (δ(ppm)). 
 
 
 
 
 
COMPLEX 14 ASSIGNMENT 13C (ppm) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 14.0 
w 21.8 
u 29.0 
s, r 50.1, 60.6 
l, m 97.1, 84.3 
Aromatic region  120.0 (d), 123.7 (b or g), 123.9 
(b or g), 125.3 (Cipso, n or q), 
128.1 (o or p), 129.1 (h), 131.7 
(o or p), 135.5 (Cipso, n or q), 
139.6 (j), 142.1 (c or f), 143.2 
(Cipso, a, i or k), 146.9 (Cipso, a, i 
or k), 147.6 (Cipso, a, i or k), 
164.1 (Cipso, e). 
t This signal is not shown in the 
spectrum. 
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Figure 43: 13C{1H}–NMR spectrum of complex 14 in CD2Cl2. 
As is shown in Figure 43, the signal corresponding to the –CO group from the ester 
function of the 1–ethynyl–4–benzyl–L–glycine ethyl ester molecule coordinated to the 
Au atom is not shown in the 13C{1H}–NMR spectrum. The chemical shifts 
corresponding to the alkyne group were shown as two weak signals at δ 84.3 and 97.1, 
slightly shifted compared to those chemical shifts on the free ligand ligand 1–ethynyl–
4-benzyl–L–glycine ethyl ester (δ 77.2 and 83.8, Table 7).  
 
1.2.3. Synthesis of di–substituted bi–dentate gold(III) complexes functionalized 
with alkynyl derivatives. 
The incorporation of two alkynyl ligands into the cyclometalated gold (III) moiety has 
been achieved following the experimental procedure previously reported on the 
synthesis of mono–substituted derivatives, employing (2–para–tolylpyridyl)AuCl2 as 
precursor, alkynyl ligand, triethylamine, and a catalytic amount of copper(I) iodide in 
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dichloromethane. The [(C^N)Au(C≡CR)2] derivatives 15 and 16 have been isolated as 
yellow solids in moderated yields, over 40% (Scheme 25). 
 
a.4–ethynylbenzaldehyde (15), N–1–ethynylbenzyl methyl ester of (L)–alanine 
(16), CuI, NEt3, dichloromethane. 
Scheme 25. Synthesis of di–substituted bi–dentate gold(III) complexes 
functionalized with alkynyl derivatives. 
As was shown for mono-substituted complexes, 15 and 16 exhibited high solubility in 
non-polar solvents, such as dichloromethane, and protic solvents, such as alcohols. In 
contrast, the chlorogold precursor (2–para–tolylpyridyl)AuCl2 (10) exhibited a poor 
solubility in these media, which provided as an useful tool to isolate pure products and 
also to identify when the reaction had been completed (this was shown once the initial 
suspension turned into solution). 
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1.2.3.1.  Synthesis of (C^N)Au(–C≡C–C6H4–CHO)2 (15). 
The reaction of 4–ethynylbenzaldehyde and (2–para–tolylpyridyl)AuCl2 (10) (2:1 ratio) 
in dichloromethane, in presence of excess of triethylamine and a catalytic amount of 
CuI, was stirred for 2 hours at room temperature, to allow the synthesis of complex 15 
(61.3 mg, 62 %). Complex 15 was isolated as yellow solid, air stable, soluble in 
dichloromethane and ethanol, and not soluble in petrol ether 40/60 (Scheme 26).  
 
 
 
 
 
 
 
Scheme 26. Synthesis of complex 15. 
Complex 15 has been characterized by 1H–NMR, 13C{1H}–NMR, infrared spectroscopy 
and elemental analysis.  
The IR spectrum shows a weak absorption band at 2131 and 2162 cm-1, corresponding 
to the stretch of the C≡C of the di-substituted alkyne group. This chemical shift is on 
the same range than the ones reported on the literature for another similar examples.16,21 
The chemical shifts corresponding to 1H–NMR spectrum for complex 15 in CD2Cl2 at 
room temperature are recorded in Table 26. 
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Table 26: 1H–NMR data of complex 15 in CD2Cl2, δ(ppm) and multiplicity. 
 
 
Figure 44: 1H–NMR spectrum of complex 15 in CD2Cl2.  
COMPLEX 15 ASSIGNMENT 1H (ppm) 
 a 2.42 (s, 3H)  
c 7.23 (d, J = 7.6 Hz, 1H) 
g 7.44 (m, 1H) 
d 7.64 (d, J = 8.1 Hz, 1H) 
i – j, k – l 
(overlapped) 
7.61 – 7.89 (m, 8H) 
e 7.92 (d, J = 8.0 Hz, 1H) 
b 8.02 (s, 1H) 
f 8.09 (d, J = 8.2, 1.3 Hz, 1H) 
h  9.57 (d, J = 5.1 Hz, 1H) 
m, n 9.99 (s, 1H), 10.01 (s, 1H)  
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As it shown in Figure 44, 1H–NMR spectrum of complex 15 exhibits two singlet signals 
at δ 9.99 and 10.01 corresponding to the 4–ethynylbenzaldehyde molecules coordinated 
to the metallic centre. In addition, a comparison between the 1H–NMR spectrum of 
complex 15 (green spectrum), 4-ethynylbenzaldehyde (blue spectrum) and (2–para–
tolylpyridyl)AuCl2 precursor (red spectrum) (Figure 45) shows a remarkable shift of the 
signal corresponding to Hh of complex 15 (δ 9.57), compared to the same proton from 
(2–para–tolylpyridyl)AuCl2 precursor (δ 9.75, blue circle). This feature and the 
absence of the proton from the alkynyl function of 4-ethynylbenzaldehyde (red circle) 
indicate the formation of Au–C bond, and coordination of two 4–ethynylbenzaldehyde 
molecules to the gold metallic centre.  
 
Figure 45: Comparison between 1H–NMR spectra of complex 15 (green spectrum), (2–
para–tolylpyridyl)AuCl2 (red spectrum) and 4-ethynylbenzaldehyde (blue spectrum) in 
CD2Cl2.  
The 13C{1H}–NMR spectrum for the complex 15 has been carried out in CD2Cl2 at 
room temperature. The chemical shifts are recorded in Table 27.  
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Table 27: 13C{1H}–NMR data of complex 15 in CD2Cl2  (δ(ppm)). 
 
 
 Figure 46: 13C{1H}–NMR spectrum of complex 15 in CD2Cl2.  
The 13C{1H}–NMR spectrum of complex 15 in CD2Cl2 shows only one signal at δ 
191.5 corresponding to the carbon of –CO group from the aldehyde function of the 4–
ethynylbenzaldehyde molecule coordinated to me metallic centre. The signals 
COMPLEX 15 ASSIGNMENT 13C (ppm) 
 c 21.8 
a, b, d, e 86.1, 90.7, 103.6  (one signal not 
observed) 
Aromatic region 120.3, 123.7, 123.8, 124.9, 128.5, 
129.4, 132.0, 132.2, 134.7, 135.0, 
136.3, 141.8, 142.6, 142.7, 150.7, 
155.2, 167.0.  
f, g 191.4 (one signal not observed) 
c f, g 
CD2Cl2  
b, c, d, e 
Ar 
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corresponding to the carbon atoms from alkyne group are observed as weak signals at δ 
86.1, 90.7 and 103.6. One of the carbon atoms from these bonds is not shown in the 
spectrum.  
 
1.2.3.2.Synthesis of (C^N)Au[–C≡C–C6H4–4–CH2–NH–CH(CH3)–COOCH3]2 (16). 
The reaction of 1–ethynyl–4–benzyl–L–alanine methyl ester and (2–para–
tolylpyridyl)AuCl2 (10) (4:1 ratio) in dichloromethane, in presence of excess of 
triethylamine and a catalytic amount of CuI for 48 hours  allowed the synthesis of 
complex 16 (43.0 mg, 32 %). Complex 16 is a yellow solid, air stable, soluble in 
dichloromethane and ethanol, and not soluble in petrol ether 40/60 (Scheme 27). 
 
Scheme 27: Synthesis of complex 16. 
Complex 16 has been only characterized by 1H–NMR, 13C{1H}–NMR and infrared 
spectroscopy. 
The IR spectrum shows only one weak broad absorption peak at 2153 cm-1 
corresponding to the stretch of the C≡C bonds of the di–substituted alkyne groups. 
Although it was expected to observe two peaks on this region, corresponding to the two 
10	   L2	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C≡C bonds of each alkyne group, the presence of a broad signal may be because of 
overlapping of them.  
The chemical shifts corresponding to 1H–NMR spectrum for complex 16 in CD2Cl2 at 
room temperature are recorded in Table 28. 
Table 28: 1H–NMR data of complex 16 in CD2Cl2, δ(ppm) and multiplicity. 
*Despite the fact that protons Hf and Hb of complex 16 are shown as overlapped signals 
and they could not be assigned individually (Figure 47), Hf is expected to be a singlet 
signal and Hb a triplet of doublets. 
 
 
 
 
COMPLEX 16 ASSIGNMENT 1H (ppm) 
 o, p 1.30 (d, J = 6.8 Hz, 3H), 1.31 
(d, J = 6.9 Hz, 1H) 
a 2.42 (s, 3H) 
s, t 3.33 – 3.42 (m, 2H) 
m, n (overlapped) 3.62 – 3.84 (m, 4H) 
r, q 3.64 (s, 3H), 3.66 (s, 3H) 
c 7.20 (d, J = 8.0 Hz, 1H) 
g 7.42 (m, 1H) 
d 7.63 (d, J = 8.0 Hz, 1H) 
e 7.90 (d, J = 8.1 Hz, 1H) 
f, b (overlapped)* 8.03 – 8.09 (m, 2H) 
h 9.63 (d, J = 5.1 Hz, 1H) 
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Figure 47: 1H–NMR spectrum of complex 16 in CD2Cl2. 
1H–NMR spectrum of complex 16 in CD2Cl2 shows two doublet signals at δ 1.29 and 
1.31 integrating for six protons, corresponding to protons Ha and Hb from the methyl 
groups of the α-carbons of the 1–ethynyl–4–benzyl–L–alanine methyl ester coordinated 
to the metallic centre (Figure 47). These signals are overlapped with the chemical shifts 
of light petroleum. As it is shown in Figure 48, proton Hh of complex 16 (δ 9.63, red 
spectrum) is shifted regarding the same proton from (2–para–tolylpyridyl)AuCl2 (δ 
9.75, blue circle). In addition, the absence of the proton from the alkynyl function of 1–
ethynyl–4–benzyl–L–alanine methyl ester (red circle) in the 1H–NMR spectrum of 
complex 16 and the presence of two different doublet signals at δ 1.30 and 1.31 
integrating for three protons each, corresponding the methyl group bonded to the carbon 
α, indicate that two molecules of 1–ethynyl–4–benzyl–L–alanine methyl ester are 
coordinated to the gold atom. 
    
  
  
  
 
o,p 
CHDCl2 
 
b 
m,n 
r,q 
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Figure 48: Comparison between 1H–NMR spectra of complex 16 (green spectrum), (2–
para–tolylpyridyl)AuCl2 (red spectrum) and 4-ethynylbenzaldehyde (blue spectrum) in 
CD2Cl2.  
The 13C{1H}–NMR spectrum for the complex 16 has been carried out in CD2Cl2 at 
room temperature. The chemical shifts are recorded in Table 29.  
 
 
 
 
 
 
 
 
 
 
  
Complex 16 
H
h
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Table 29: 13C{1H}–NMR data of complex 16 in CD2Cl2  (δ(ppm)). 
 
 
Figure 49: 13C{1H}–NMR spectrum of complex 16 in CD2Cl2.  
COMPLEX 16 ASSIGNMENT 13C (ppm) 
 h, i 18.9 
c 21.8 
k, j, g, f 51.5, 51.6, 55.4, 55.9 
a, b, c, d 78.1, 80.2, 98.8, 103.7 
Aromatic  region  117.7, 120.1, 123.7, 124.3, 
124.5, 124.7, 128.0, 128.2, 
131.6, 131.7, 136.3, 139.6, 
141.6, 142.5, 142.7, 150.7, 
155.8, 166.9. 
n, o 176.0  
 
a,b,d,e 
Ar 
n,o 
k,j,g,f 
CD2Cl2  
h,i c 
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The 13C{1H}–NMR spectrum of complex 16 in CD2Cl2 showed only one signal at δ 
176.0 corresponding to the carbon of the –CO group from the ester function of the two  
1–ethynyl–4–benzyl–L–alanine methyl ester molecules coordinated to the metallic 
centre. Despite the fact that two signals should be observed, the large number of bonds 
between the substituent and gold metallic centre may explain the presence of the two 
ester functions on the same chemical shift. This fact may also explain the presence of 
only one chemical shift corresponding to the methyl group bonded to the carbon α. The 
signals corresponding to the carbon atoms from alkyne group are observed as weak 
signals at δ 78.1, 80.2, 98.8 and 103.7.  
 
1.3. SUMMARY. 
§    The research work has focused on the synthesis of bi– and tri–dentate gold(III) 
complexes functionalized by alkynyl ligands, such as 4–ethynylbenzaldehyde and 
alkynyl benzyl amino ester derivatives. 
§    (C^N^C)AuCl (2) and (C^N^C)AuOH (3) have been employed as precursors to tri–
dentate gold(III) complexes functionalized by alkynyl ligands. They have been prepared 
according to the experimental procedure reported in the literature.30,31 The incorporation 
of alkynyl ligands into the cyclometalated gold(III) moiety to synthesize the tri-dentate 
gold(III) complexes 4, 5, 6 and 7, has been achieved by reaction of (C^N^C)AuOH (3) 
with the corresponding alkynyl derivative. Complexes 4, 5, 6 and 7 have been obtained 
in moderate yield, over 50%. In addition, the synthesis of complexes 4 and 5 have been 
also successfully tested by reaction of (C^N^C)AuCl (2), alkynyl derivative, 
triethylamine, and a catalytic amount of copper(I) iodide.16 This method has not 
introduced significant improvements in terms of yield compared to the method 
employing (C^N^C)AuOH (3) as precursor. 
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§    The synthesis of complex 8 has been achieved by reduction of the aldehyde terminal 
function of complex 4, employing sodium borohydride as reducing agent. The 
formation of complex 8 was observed in the experiment to incorporate amino acids to 
the cyclometalated gold(III) moiety. This experiment was planned as reaction of 
complex 4 with the amino acid (D–alanine), in order to achieve the condensation 
between the aldehyde functional group of complex 4 with the amine group from the 
amino acid.  
§    (2–para–tolylpyridyl)AuCl2 (10) has been used as precursor on the synthesis of bi-
dentate gold(III) complexes functionalized by alkynyl ligands. This precursor has been 
prepared by direct auration12,8b and transmetalation8 from the organomercury derivative 
(C^N)HgCl. The incorporation of alkynyl ligands into the cyclometalated gold(III) 
moiety has been achieved by reaction of (C^N)AuCl2 (10), alkynyl derivative, 
triethylamine, and a catalytic amount of copper(I) iodide.21 This method has been 
employed to synthesize both mono– and di–substituted bidentate derivatives. 
Accordingly, the synthesis of complexes 11, 12, 13, 14, 15 and 16 has been achieved in 
moderate yields through this route.  
1.4. CONCLUDING REMARKS AND PERSPECTIVES. 
 
We have shown that cyclometallated (C^N^C)Au(III) alkynyl complexes could be 
readily obtained through acid – base reactions, employing (C^N^C)AuOH (3) as 
starting material. In these reactions, the excellent reactivity as a mild metal base showed 
by complex 3 led us the synthesis of complexes 5 – 8 through an acid – base reaction, 
allowing the Au – C bond activation at high temperatures. We also investigated the 
synthesis of these complexes using (C^N^C)AuCl (2) as starting material. By testing for 
complexes 4 and 5, we observed that the addition of a mild base, such as triethylamine, 
may allow the deprotonation of the acidic proton from the alkynyl functional group, in 
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presence of a catalytic amount of CuI, afforing the synthesis of these complexes in 
comparable yields.  
Because we were unable to synthesize (C^N)Au(OH)2 derivative, (C^N)Au(III) alkynyl 
complexes could be only synthesized by the second method previously presented. The 
use of triethylamine, in presence of a catalytic amount of CuI, allowed the 
deprotonation of the acidic proton from the alkynyl functional group, to yield the 
formation of Cu(I) alkynyl compound, which reacts with (2-para-tolylpyridyl)AuCl2 to 
afford the mono- and bi- dentate complexes 11 – 16 and CuCl as reaction products. 
In recent years, some examples of cyclometallated gold(III) complexes have shown a 
remarkable enhancement in terms of stability for biological studies, exhibiting anti-
tumor activity against different cell lines. This fact and the demonstrated ability of 
amino acids derivatives to deliver the gold atom to the biological target35 (because of 
they are overexpressed in tumor cells), have encouraged us to explore the biological 
activity of the synthesized complexes, in particular, the interaction of the studied 
gold(III) complexes with secondary DNA structures.  
 
1.5. EXPERIMENTAL SECTION 
 
1.5.1. GENERAL CONSIDERATIONS 
Unless otherwise stated, all experiments were performed in air using bench solvents. In 
such exceptions, manipulations were performed using standard Schlenk techniques 
under dry nitrogen or a Saffron Scientific glovebox. Nitrogen was purified by passing 
through columns of supported P2O5, with moisture indicator, and activated 4 Å 
molecular sieves. Anhydrous solvents were freshly distilled from appropriate drying 
agents. (HC^N^C)HgCl (1), (C^N^C)AuCl (2), (C^N^C)AuOH30 (3), (C^N)HgCl13 (9) 
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and (C^N)AuCl2 (10) (synthesis of complex 10 explored by transmetalation8 and direct 
auration8b,12) were prepared using literature methods (Figure 50). 2–para–tolylpyridine 
(Aldrich), CsOH·H2O (Aldrich), phenylacetylene (Aldrich), 4–ethynylbenzaldehyde, 
(Fluorochem), glycine ethyl ester hydrochloride (Aldrich), L–serine methyl ester 
hydrochloride (Aldrich), L–alanine methyl ester hydrochloride (Aldrich), copper iodide 
(Aldrich), triethylamine (Aldrich) were commercially available and used as received. 1H 
and 13C{1H} spectrum were recorded using a Bruker DPX300 spectrometer. 1H–NMR 
spectrum (300.13 MHz) were referenced to the residual protons of the deuterated 
solvent used. 13C{1H}–NMR spectrum (75.47 MHz) were referenced internally to the 
proton-decoupled 13C resonances of the NMR solvent. Elemental analyses were 
performed by London Metropolitan University.  
 
Figure 50. Complexes 1, 2, 3, 9 and 10, employed as precursors. 
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1.5.2. SYNTHESIS OF LIGANDS AND COMPLEXES. 
1.5.2.1.  HC≡C–C6H4–CH2–NH–CH(CH3)–COOCH3 (ligand L2). 
          
           1H–NMR assignments      13C{1H}–NMR assignments  
 
4–Ethynylbenzaldehyde (120.0 mg, 0.92 mmol) was added to a solution of L–alanine 
methyl ester hydrochloride (520.0 mg, 3.70 mmol), triethylamine, (0.52 ml, 3.70 
mmol), in dry dichloromethane (20 ml), over 4A molecular sieves. The mixture was 
allowed to stir for 24 hours at room temperature.  The solvent was removed under 
vacuum and the residue was dissolved in dry metanol (20 ml). NaBH4 (170.0 mg, 4.60 
mmol) was added slowly at 0 oC. The mixture was warmed to room temperature and it 
was allowed to stir for 16 hours. The reaction mixture was quenched with water and it 
was extracted three times with ethyl acetate (3x10 ml). The organic layer was dried over 
MgSO4. The organic layer was filtered off and the solvent was removed under vacuum, 
to yield a yellow oil. (126 mg, 0.59 mmol, 64%). 1H–NMR (300 MHz, CDCl3) δ 7.43 
(Hg or Hh, d, J = 8.3 Hz, 2H), 7.32 (Hg or Hh, d, J = 8.3 Hz, 2H), 3.81 (Hd or He, d, J = 
13.5, 1H), 3.65 (Hd or He, d, J = 13.5, 1H), 3.31 (Hf, s, 3H), 3.17 (Hc, q, J = 7 Hz, 1H), 
2.76 (Hb, s, 1H), 1.37 (Ha, d,  J = 7 Hz, 3H). 13C{1H}–NMR (75 MHz, CDCl3) δ  18.7 
(Ci), 51.3 (Cg, Ch or Ck), 51.7 (Cg, Ch or Ck), 55.8 (Cg, Ch or Ck), 73.9 (Ca or Cb), 83.4 
 103  
(Ca or Cb), 120.6 (Cipso, Hc or Cf), 128.2 (Cd or Ce), 132.0 (Cd or Ce), 132.4 (Cipso, Cc or Cf), 
175.6 (Cf). (C≡C): 2105(w) cm-1, ν(C=O): 1732 cm-1. 
 
1.5.2.2. HC≡C–C6H4–CH2–NH–CH(CH2OH)–COOCH3 (ligand L3).  
    
                    
      1H–NMR assignments           13C{1H}–NMR assignments 
 
4–Ethynylbenzaldehyde (100 mg, 0.77 mmol) was added to a solution of L–serine 
methyl ester hydrochloride (480.0 mg, 3.1 mmol), triethylamine, (0.43 ml, 3.1 mmol), 
in dry dichloromethane (20 ml), over 4A molecular sieves.   The mixture was allowed to 
stir for 24 hours at room temperature.  The solvent was removed under vacuum and the 
residue was dissolved in dry metanol (20 ml). NaBH4 (150.0 mg, 3.85 mmol) was added 
slowly at 0 oC. The mixture was warmed to room temperature and it was allowed to stir 
for 16 hours. The reaction mixture was quenched with water and it was extracted three 
times with ethyl acetate (3x10 ml). The organic layer was dried over MgSO4. The 
organic layer was filtered off and the solvent was removed under vacuum, to yield 
yellow oil. (121.8 mg, 0.53 mmol, 68.8%). 1H–NMR (300 MHz, CDCl3) δ 7.18 (Hg or 
Hh, d, J = 8.1 Hz, 2H), 7.35 (Hg or Hh, d, J = 8.1 Hz, 2H), 3.63 (Hc, s, 3H), 3.72 (He or 
Hf, d, J = 8.1 Hz, 1H), 3.89 (He or Hf, d, J = 8.1Hz, 1H), 3.56-3.62 (Hd, m, 2H), 3.29 
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(Hb, q, J = 4.5, 4.5 Hz, 1H), 2.36 (-HN/-OH, br, s, 2H), 3.12 (Ha, s, 1H). 13C{1H}–NMR 
(75 MHz, CDCl3) δ 51.7 (Ck or Ch), 52.2 (Ck or Ch), 61.9 (Cg or Ci), 62.6 (Cg or Ci), 
77.3 (Ca or Cb), 83.5 (Ca or Cb), 120.1 (Cipso, Cc or Cf), 128.2 (Cd or Ce), 132.3 (Cd or Ce), 
139.7 (Cipso, Cc or Cf), 173.5. IR spectroscopy to be made. 
1.5.3. HC≡C–C6H4–CH2–NH–CH2–COOCH2CH3 (ligand L4). 
            
1H–NMR assignments   13C{1H}–NMR assignments 
 
4–Ethynylbenzaldehyde (200.0 mg, 1.54 mmol) was added to a solution of L–glycine 
ethyl ester hydrochloride (860.0 mg, 6.16 mmol), triethylamine, (0.86 ml, 6.16 mmol), 
in dry dichloromethane (20 ml), over 4A molecular sieves.   The mixture was allowed to 
stir for 24 hours at room temperature.  The solvent was removed under vacuum and the 
residue was dissolved in dry metanol (20 ml). NaBH4 (291.2 mg, 7.70 mmol) was added 
slowly at 0 oC. The mixture was warmed to room temperature and it was allowed to stir 
for 16 hours. The reaction mixture was quenched with water and it was extracted three 
times with ethyl acetate (3x10 ml). The organic layer was dried over MgSO4. The 
organic layer was filtered off and the solvent was removed under vacuum, to a yield 
yellow oil. (196 mg, 0.91 mmol, 59%). 1H–NMR (300 MHz, CDCl3) δ 7.31 (Hh or Hi, J 
= 8.1 Hz, 2H), 7.44 (Hh or Hi, J = 8.1 Hz, 2H), 3.31 (Hg, q, J =7.0 Hz, 2H), 3.36 (Hc and 
Hd or He and Hf, bs, 2H), 3.79 (Hc and Hd or He and Hf, bs, 2H), 3.11 (Hb, s, 1H), 1.25 
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(Ha, t, J =7.0 Hz, 3H). 13C{1H}–NMR (75 MHz, CDCl3) δ 14.3 (Ck), 50.4 (Cg or Ch), 
52.0 (Cg or Ch), 61.0 (Cj), 77.2 (Ca or Cb), 83.8 (Ca or Cb), 121.0 (Cipso, Cc or Cf), 128.5 
(Cd or Ce), 132.2 (Cd or Ce), 141.5 (Cipso, Cc or Cf), 172.6 (Ci). (C≡C): 2107(w) cm-1, 
ν(C=O): 1735 cm-1. 
* Note: High resolution mass spectroscopy should be carried out for the reported 
ligands L2 – L4. 
1.5.4. (C^N^C)Au–C≡C–C6H4–CHO (complex 4). 
 
 
 
 
 
 
1H–NMR assignments   13C{1H}–NMR assignments 
 
Method 1: 
1–ethynylbenzaldehyde (76.0 mg, 0.60 mmol) was added to a solution of 
(C^N^C)AuOH (167.5 mg, 0.30 mmol) in toluene (20 ml). The mixture was refluxed 
for 24 hours.  The crude product, which was obtained upon removal the solvent under 
vacuum, was washed off with petrol ether 40/60 (10 ml) and vacuum dried, to yield an 
off yellow solid (150 mg, 0.45 mmol, 75%). 1H–NMR (300 MHz, CDCl3) δ 10.01 (Hi, 
s, 1H),  8.16 (Hf, d, J=1.8 Hz, 2H), 7.86 (Hg or Hh, d, J=8.1 Hz, 2H), 7.72 (Hg or Hh, d, 
J=8.1 Hz, 2H), 7.80 (Ha, t, J= 7.9 Hz, 1H), 7.50 (Hb or Hc, d, J= 8.0 Hz, 2H), 7.40 (Hb or 
Hc, d, J= 8.0 Hz, 2H), 7.32 – 7.26 (Hd, m, 2H), 1.37 (He, s, 18H). 13C{1H}–NMR (75 
MHz, CDCl3) δ 31.2 (Cr), 35.0 (Cd), 100.9 (Ck or Cl), 116.1 (Ci), 123.9 (Ce), 125.0 (Cf), 
 106  
129.7 (Cn or Co), 132.2 (Ca), 133.5 (Cn or Co), 142.2 (Cg), 146.3 (Cj), 155.5 (Cc), 165.0 
(Ch), 166.9 (Ca), 191.8 (Cq). Anal. Calcd. C34H32AuNO (found): C, 61.17 (61.03); H, 
4.83 (4.84); N, 2.10 (2.22). ν(C≡C): 2149 cm-1, ν(C=O): 1595 cm-1. 
 Method 2: 
1–ethynylbenzaldehyde (40.0 mg, 0.29 mmol), triethylamine (40.3 µL, 0.29 mmol) and 
CuI (0.88 mg, 4.62 mmol) were added to a solution of (C^N^C)AuCl (110.4 mg, 0.19 
mmol) in dichloromethane (10 ml). The mixture was allowed to stir for 1 hour at room 
temperature. The solution was washed with water, and the organic layer was isolated. 
The solvent was removed under vacuum and the residue was washed off with petrol 
ether 40/60 (10 ml) and vacuum dried, to yield a yellow solid (71.0 mg, 0.16 mmol, 56 
%). 
 
1.5.5. (C^N^C)Au–C≡C–C6H4–CH2–NH–CH(CH3)–COOCH3 (complex 5). 
 
 
 
 
 
 
 
 
1H–NMR assignments   13C{1H}–NMR assignments 
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Method 1:  
1–Ethynyl–4–benzyl–L–alanine methyl ester (105 mg, 0.05 mmol) was added to a 
solution of (C^N^C)AuOH (140 mg, 0.02 mmol) in toluene (20 ml).  The mixture was 
refluxed for 24 hours.  The crude product, which was obtained upon removal the solvent 
under vacuum, was washed with petrol ether 40/60 (10 ml) and ethanol (10 ml) and 
vacuum dried, to yield an off yellow solid (61 mg, 0.016 mmol, 32%). 1H–NMR (300 
MHz, CD2Cl2) δ 8.18 (Hf, d,  J = 2.0 Hz, 2H), 7.85 (Ha, t, J = 8.0 Hz, 1H), 7.55 (Hb, Hc, 
Hg or Hh (overlapped), d, J = 8.0 Hz, 4H), 7.46 (Hb, Hc, Hg or Hh (overlapped), d, J = 8.0 
Hz, 2H), 7.32 (Hb, Hc, Hg or Hh (overlapped), d, J = 8.1 Hz, 2H), 7.32 (Hd, d, J = 7.0 Hz, 
2H), 3.72 (s, 3H), 3.68 (Hi, d, J = 13.2 Hz, 1H), 3.81 (Hi, d, J = 13.2 Hz, 1H), 3.40 (Hj, 
q, J = 7.0 Hz, 1H), 1.39 (He, s, 18H), 1.32 (Hk, d, J = 7.0 Hz, 3H). 13C{1H}–NMR (75 
MHz, CD2Cl2) δ 175.9 (Ct), 166.9 (Ca), 164.8 (Ch), 155.2 (Cc), 146.6 (Cj), 142.2 (Cg), 
139.1 (Cipso, Cm or Cp), 133.3 (Cn or Co), 131.7 (Cb), 128.0 (Cn or Co), 125.3 (Cipso, Cm or Cp), 
124.9 (Cf), 123.8 (Ce), 116.2 (Ci), 100.9 (Ck or Cl), 91.9 (Ck or Cl), 56.2 (Cr), 51.6 (Cu or 
Cq), 51.5 (Cu or Cq), 35.2 (Cd), 30.9 (Cv), 18.9 (Cs). ν(C≡C): 2151 cm-1, ν(C=O): 1736 
cm-1 Anal. Calcd. C38H41AuN2O2 . 3 H2O  (found): C, 56.43 (56.19); H, 5.86 (4.65); N, 
3.46 (3.70). 
 
Method 2: 
1–ethynyl–4–benzyl–L–alanine methyl ester (0.03 mg, 0.12 mmol), triethylamine (16.7 
µL, 0.12 mmol) and CuI (0.27 mg, 1.42 mmol) were added to a solution of 
(C^N^C)AuCl (35.0 mg, 0.06 mmol) in dichloromethane (10 ml).  The mixture was 
allowed to stir for 1 hour at room temperature. The solution was washed with water, and 
the organic layer was isolated. The solvent was removed under vacuum and the residue 
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was washed off with petrol ether 40/60 (10 ml) and vacuum dried, to yield a yellow 
solid (16.7 mg, 0.044 mmol, 37%). 
Table 30. X-ray crystallography data of complex 5. 
       
Compound 5 
Reference angelbs4 
Formula weight 754.69 
Crystal system orthorhombic 
Space group P 2 21 21 
Unit cell dimensions. a (Å) 13.3617(2) 
b 34.0972(13) 
c 14.7600(2) 
α (°) 90 
β 90 
γ 90 
Volume (Å3) 6724.6(3) 
Z 8 
Calculated density (mg/m3) 1.491 
F(000) 3024 
Absorption coefficient µ(mm-1) 4.410 
Crystal colour, shape colourless plate 
Crystal size (mm3) 0.31 x 0.28 x 0.05 
θ Range (°) 3.008 to 19.994 
No. of unique reflections, Rint 6253 [R(int) for equivalents = 0.069] 
Data/Retrains/Parameters 6253 / 0 / 388 
Final R indices (observed data) R1 = 0.066,wR2 = 0.140 
Final R indices (all data) R1 = 0.074, wR2 = 0.143 
Largest diff. peak and hole (e Å3) 1.81 and -1.63 
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1.5.6. (C^N^C)Au–C≡C–C6H4–CH2–NH–CH(CH2OH)–COOCH3 (complex 6). 
 
 
 
 
 
 
 
1H–NMR assignments         13C{1H}–NMR assignments 
 
1–Ethynyl–4–benzyl–L–serine methyl ester (64 mg, 0.27 mmol) was added to a 
solution of (C^N^C)AuOH (79 mg, 0.14 mmol) in toluene (20 ml). The mixture was 
refluxed for 24 hours.  The crude product, which was obtained upon removal of the 
solvent under vacuum, was washed with petrol ether 40/60 (10 ml) and vacuum dried, 
to yield an off yellow solid (110 mg, 0.12 mmol, 45%). 1H–NMR (300 MHz, CD2Cl2) δ 
8.21 (d,  J =2.0 Hz, 2H), 7.89 (t, J = 9.4 Hz, 1H), 7.60 (Hc or Hb, d, J = 8.2 Hz, 2H), 
7.60 (Hc or Hb, d, J = 8.1 Hz, 2H), 7.50 (Hg or Hh, d, J = 8.1 Hz, 2H), 7.37 (Hg or Hh, 
d, J = 8.1 Hz, 2H), 7.36 (Hd, d, J = 8.1 Hz, 2H), 3.89 - 3.72 (Hi and Hj (overlapped), m, 
4H), 3.81 (Hl, s, 3H), 3.47 (Hk, q, J = 4.6 Hz, 1H), 1.43 (He, s, 18H). 13C{1H}–NMR 
(75 MHz, CD2Cl2) δ 166.9 (Ca), 164.8 (Ch), 155.2 (Cc), 146.6 (Cg), 142.3 (Cj), 138.5 
(Cipso, Cm or Cp), 133.3 (Cb), 131.8 (Cn or Co), 128.1 (Cn or Co), 124.9 (Cf), 124.3 (Cipso, Cm 
or Cp), 123.8 (Ce), 116.4 (Ci), 100.8 (Ck or Cl), 92.3 (Ck or Cl), 62.4 (Cq, Cr, Cs or Cu), 
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52.0 (Cq, Cr, Cs or Cu), 51.8 (Cq, Cr, Cs or Cu), 35.2 (Cd), 30.9 (Cv). ν(C≡C): 2153 cm-1, , 
ν(C=O): 1737 cm-1. Anal. Calcd. C38H41AuN2O3 (found): C, 59.22 (59.19); H, 5.36 
(5.28); N, 3.63 (3.68). 
 
1.5.7. (C^N^C)Au–C≡C–C6H4–CH2–NH–CH2–COOCH2CH3 (complex 7).  
 
 
 
 
 
 
 
1H–NMR assignments         13C{1H}–NMR assignments 
 
1–Ethynyl–4–benzyl–Glycine ethyl ester methyl ester (50 mg, 0.35 mmol) was added to 
a solution of (C^N^C)AuOH (100 mg, 0.17 mmol) in toluene (20 ml).  The mixture was 
refluxed for 24 hours.  The crude product, which was obtained upon removal of the 
solvent under vacuum, was washed with petrol ether 40/60 (10 ml) and vacuum dried, 
to yield an off yellow solid (40 mg, 0.12 mmol, 33%). 1H–NMR (300 MHz, CD2Cl2) δ 
8.22 (Hf, d, J = 2.0 Hz, 2H), 7.90 (Ha, t, J = 8.0 Hz, 1H), 7.60 (Hb, He, Hg, Hh 
(overlapped), d, J = 8.2 Hz, 4H), 7.50 (Hb, He, Hg, Hh (overlapped), d, J = 8.1 Hz, 2H), 
7.37 (Hb, He, Hg, Hh (overlapped), d, J = 8.1 Hz, 2H), 7.32 (Hd, d, J = 7.0 Hz, 2H), 4.21 
(Hm, q, J = 7.2 Hz, 2H), 3.87 (Hi or Hj, s, br, 2H), 3.45 (Hi or Hj, s, br, 2H), 1.43 (Hc, s, 
18H), 1.31 (Hn, t, J = 7.2 Hz, 3H). 13C{1H}–NMR (75 MHz, CD2Cl2) δ 166.9 (Ca), 
164.8 (Ch), 155.2 (Cc), 146.6 (Cj), 142.3 (Cg), 133.3 (Cn or Co), 131.8 (Cb), 128.2 (Cn or 
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Co), 125.5 (Cipso, Cm or Cp. One of these carbons is not shown in the spectrum), 124.9 
(Cf), 123.8 (Ce), 116.3 (Ci), 100.9 (Ck or Cl), 92.0 (Ck or Cl), 60.7 (Cq or Cr), 35.2 (Cd), 
31.0 (Cv), 14.0 (Cu). ν(C≡C): 2149 cm-1, ν(C=O): 1737 cm-1. Anal. Calcd. 
C38H41AuN2O2 (found): C, 60.47 (59.93); H, 5.48 (5.22); N, 3.71 (3.82). 
 
1.5.8. (C^N^C)Au–C≡C–C6H4–CH2OH (complex 8).  
 
 
 
 
 
 
 
1H–NMR assignments         13C{1H}–NMR assignments 
 
NaBH4 (120.0 mg, 0.29 mmol) was added to a mixture of 4 (19.8 mg, 0.03 mmol) in 
metanol (10 ml). The mixture was allowed to stir for 1 hour at room temperature. The 
solvent was removed under vacuum and the residue was dissolved in dichloromethane 
(10 ml) and quenched with water. The organic layer was dried with MgSO4 and the 
solvent was removed. The residue was washed with petrol ether 40/60, to yield a yellow 
solid. (12.6 mg, 0.18 mmol, 64 %). 1H–NMR (300 MHz, CDCl3) δ 8.21 (Hf, d, J=2.0 
Hz, 2H), 7.79 (Ha, t, J= 8.0 Hz, 1H), 7.62 (Hd or Hc, d, J = 8.0, 2H), 7.38 (Hg or Hh, d, J 
= 8.1, 2H), 7.37 (Hg or Hh, d, J = 8.1, 2H), 7.36 (Hd or Hc, d, J = 8.0, 2H), 7.32 (Hb, m, 
2H), 4.72 (Hi or Hj, d, J = 6.0 Hz, 2H), 1.39 (He, s, 18H). 13C{1H}–NMR (75 MHz, 
CDCl3) δ 167.1 (Ca), 155.2 (Cc), 146.9 (Ch), 146.4 (Cg), 142.1 (Cj), 133.6 (Cipso, Cm or 
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Cp), 132.1 (Cb), 126.9 (Cn or Co), 126.2 (Cipso, Cm or Cp), 124.9 , 123.8 (Ce), 116.0 (Ci), 
100.9 (Ck or Cl), 92.3 (Ck or Cl), 65.3 (Cq), 35.4 (Cd), 31.2 (Cr). IR spectrosvopy to be 
made.  
1.5.9. (2–para–tolylpyridyl)Au–(Cl)C≡C–C6H4–CHO (complex 11).  
 
 
 
 
 
 
1H–NMR assignments         13C{1H}–NMR assignments 
 
4–Ethynylbenzaldehyde (9.7 mg, 0.07 mmol), CuI (0.22 mg, 1.15 mmol) and NEt3 
(21.0 µL, 0.15 mmol) were added to a mixture of (2–para–tolylpyridyl)AuCl2 (32.6 mg, 
0.07 mmol) in dichloromethane (10 ml). The mixture was allowed to stir for 1 hour at 
room temperature. The resulting solution was washed with water (10 ml), and the 
organic layer was isolated. The solvent was removed under vacuum and the residue was 
washed with petrol ether 40/60 (10 ml) and vacuum dried, to yield a yellow solid (13 
mg, 0.02 mmol, 33 %). 1H–NMR (300 MHz, CD2Cl2) δ  10.01 (Hk, s, 1H), 9.50 (Hh, d, 
J = 5.8 Hz, 1H), 8.10 (Hf, td, J = 8.0, 1.5 Hz, 1H), 7.98 (Hb, s, 1H), 7.90 (He, d, J = 7.5 
Hz, 1H), 7.86 (Hi or Hj, d, J = 8.2 Hz, 2H), 7.70 (Hi or Hj, d, J = 8.2 Hz, 2H), 7.59 (Hd, 
d, J = 7.9 Hz, 1H), 7.46-7.54 (Hg, m, 1H),  7.24 (Hc, d, J = 7.8 Hz, 1H),  2.42 (Ha, s, 
3H).  13C{1H}–NMR (75 MHz, CD2Cl2) δ 191.5 (Cr), 164.1 (Cipso, Ce), 147.6 (Cipso, Ca, 
Ci or Ck), 147.0 (Cipso, Ca, Ci or Ck), 143.4 (Cipso, Ca, Ci or Ck), 142.3 (Cc or Cf), 139.6 
(Cc or Cf), 135.3 (Cipso, Cn or Cq), 135.1 (Cj), 132.3 (Co or Cp), 131.5 (Ch), 129.4 (Co or 
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Cp), 129.3 (Cb or Cg), 125.4 (Cipso, Cn or Cq), 123.8 (Cb or Cg), 120.1 (Cd), 96.9 (Cl or 
Cm), 90.2 (Cl or Cm), 21.8 (Cs).  ν(C≡C): 2164 cm-1, ν(C=O): 1691 cm-1. Anal. Calcd. 
C21H15AuClNO (found): C, 47.61 (47.45); H, 2.85 (2.75); N, 2.64 (2.80). 
 
1.5.10. (2–para–tolylpyridyl)Au–(Cl)C≡C–C6H4–CH2–NH–CH(CH3)–COOCH3 
(complex 12). 
 
 
 
 
 
 
1H–NMR assignments         13C{1H}–NMR assignments 
 
1–Ethynyl–4–benzyl–L–Alanine methyl ester (85.7 mg, 0.39 mmol), CuI (0.43 mg, 
2.25 mmol) and NEt3 (41.7 µL, 0.30 mmol) were added to a mixture of (2–para–
tolylpyridyl)AuCl2 (66.0 mg, 0.15 mmol) in dichloromethane (10 ml). The mixture was 
allowed to stir for 1 hour at room temperature. The resulting solution was washed with 
wáter (10 ml), and the organic layer was isolated. The solvent was removed under 
vacuum and the residue was extracted with ethanol and washed with petrol ether 40/60 
(10 ml) and vacuum dried, to yield a yellow solid (94.5 mg, 0.16 mmol, 41 %).  1H–
NMR (300 MHz, CD2Cl2) δ  9.48 (Hh, dd, J = 5.8, 1 Hz, 1H), 8.08 – 8.05 (Hf, m, 1H),  
8.02 (Hb, d, J = 0.8 Hz, 1H), 7.89 (He, d, J = 8.1 Hz, 1H), 7.58 (Hd, d, J = 7.9 Hz, 1H), 
7.40 – 7.31 (Hg, m, 1H),  7.32 (Hi or Hj, d, J = 8.0 Hz, 1H), 7.50 (Hi or Hj, d, J = 8.1 Hz, 
1H), 7.22 (Hc, dd, J = 7.9, 0.8 Hz, 1H), 3.71 (Hl, s, 3H), 3.82 (Hk, d, J = 13.4 Hz, 1H), 
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3.67 (Hk, d, J = 13.4 Hz, 1H), 3.38 (Hm, q, J = 7.0 Hz, 1H), 2.42 (Ha, s, 3H), 1.30 (Hn, d, 
J = 7.0 Hz, 3H). 13C{1H}–NMR (75 MHz, CD2Cl2) δ 176.0 (Cu), 164.0 (Cipso, Ce), 
147.6 (Cipso, Ca, Ci or Ck), 146.9 (Cipso, Ci or Ck), 143.2 (Cipso, Ci or Ck), 142.1 (Cc or 
Cf), 139.9 (Cc or Cf), 139.6 (Cj), 135.4 (Cipso, Cn or Cq), 131.7 (Co or Cp), 129.1 (Ch), 
128.0 (Co or Cp), 125.3 (Cipso, Cn or Cq), 123.8 (Cb or Cg), 123.7 (Cb or Cg), 120.1 (Cd), 
97.0 (Cl or Cm), 84.3 (Cl or Cm), 54.2 (Cr or Cv), 51.6 (Cr or Cv), 21.8 (Ct or Cw), 21.2 
(Cs), 18.9 (Ct or Cw). ν(C≡C): 2164 cm-1, ν(C=O): 1733 cm-1. Anal. Calcd. 
C25H24AuClN2O2 (found): C, 48.68 (48.57); H, 3.92 (3.86); N, 4.54 (4.48). 
 
1.5.11. (2–para–tolylpyridyl)Au–(Cl)C≡C–C6H4–CH2–NH–CH(CH2OH)–COOCH3 
(complex 13).  
 
 
 
 
 
 
1H–NMR assignments         13C{1H}–NMR assignments 
 
1–Ethynyl–4–benzyl–L–Serine methyl ester (66.1 mg, 0.28 mmol), CuI (0.63 mg, 3.31 
mmol) and NEt3 (80.0 µL, 0.56 mmol) were added to a mixture of (2–para–
tolylpyridyl)AuCl2 (125.0 mg, 0.28 mmol) in dichloromethane (10 ml). The mixture 
was allowed to stir for 1 hour at room temperature. The resulting solution was washed 
with water (10 ml), and the organic layer was isolated. The solvent was removed under 
vacuum and the residue was extracted with ethanol and washed with ethanol and petrol 
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ether 40/60 (10 ml) and vacuum dried, to yield a yellow solid (68.0 mg, 0.11 mmol, 38 
%).  1H–NMR (300 MHz, CD2Cl2) δ 9.51 (Hh, d, J = 5.0 Hz, 1H), 8.13 – 8.06 (Hf, td,  J 
= 8.0, 1.5 Hz, 1H), 8.05 (Hb, d, J = 0.7 Hz, 1H), 7.90 (He, d, J = 7.9 Hz, 1H), 7.59 (Hd, 
d, J = 7.9 Hz, 1H), 7.53 – 7.47 (Hg, m, 1H), 7.52 (Hi or Hj, d, J = 8.1 Hz, 2H), 7.33 (Hi 
or Hj, d, J = 8.0 Hz, 2H), 7.24 (Hc, d, J = 7.1 Hz, 1H), 3.94 – 3.57 (Hm and Hk 
(overlapped), m, 4H), 3.74 (Hl, s, 3H), 3.43 (Hn, dd,  J = 5.8, 4.7 Hz, 1H), 2.40 (Ha, s, 
3H).  13C{1H}–NMR (75 MHz, CD2Cl2) δ 173.2 (Cu),  164.1 (Cipso, Ce), 147.6 (Cipso, Ca, 
Ci or Ck), 146.9 (Cipso, Ca, Ci or Ck), 143.2 (Cipso, Ca, Ci or Ck), 142.2 (Cc or Cf), 139.7 
(Cc or Cf), 139.3 (Cj), 135.5 (Cipso, Cn or Cq), 131.8 (Co or Cp), 129.1 (Ch), 128.1 (Co or 
Cp), 125.3 (Cipso, Cn or Cq), 123.7 (Cb or Cg), 120.0 (Cd), 96.9 (Cl or Cm), 84.0 (Cl or 
Cm), 62.4 (Cr or Ct), 61.0 (Cr or Ct), 31.2 (Cv), 21.8 (Cw). ν(C≡C): 2154 cm-1, ν(C=O): 
1731 cm-1.Anal. Calcd. C25H24AuClN2O3 (found): C, 47.44 (47.29); H, 3.82 (3.81); N, 
4.43 (4.54). 
 
1.5.12. (2–para–tolylpyridyl)Au–(Cl)C≡C–C6H4–CH2–NH–CH2–COOCH2CH3 
(complex 14).  
 
 
 
 
 
 
 
1H–NMR assignments         13C{1H}–NMR assignments 
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1–Ethynyl–4–benzyl–L–Glycine ethyl ester (81.6 mg, 0.37 mmol), CuI (0.41 mg, 2.15 
mmol) and NEt3 (104.0 µL, 0.74 mmol) were added to a mixture of (2–para–
tolylpyridyl)AuCl2 (164.0 mg, 0.37 mmol) in dichloromethane (10 ml). The mixture 
was allowed to stir for 1 hour at room temperature. The resulting solution was washed 
with water (10 ml), and the organic layer was isolated. The solvent was removed under 
vacuum and the residue was extracted with ethanol and washed with ethanol and petrol 
ether 40/60 (10 ml) and vacuum dried, to yield a yellow solid (94.5 mg, 0.15 mmol, 41 
%). 1H–NMR (300 MHz, CD2Cl2) δ  9.50 (Hh, d, J = 4.8 Hz, 1H), 8.13 – 8.05 (Hf, td,  J 
= 8.0, 1.5 Hz, 1H), 8.05 (Hb, d, J = 0.8 Hz, 1H), 7.90 (He, d, J = 7.9 Hz, 1H), 7.59 (Hd, 
d, J = 7.9 Hz, 1H), 7.51 – 7.48 (Hg, m, 1H), 7.51 (Hi or Hj, d, J = 8.0 Hz, 2H), 7.32 (Hi 
or Hj, d, J = 8.0 Hz, 2H), 7.23 (Hc, d, J = 7.8 Hz, 1H), 4.17 (Hn, q, J = 7.1 Hz, 3H), 3.81 
(Hk or Hl, s, b, 2H), 3.39 (Hk or Hl, s, b, 2H), 2.42 (Ha, s, 3H), 1.26 (Hm, t, J= 7.1 Hz, 
2H). 13C{1H}–NMR (75 MHz, CD2Cl2) δ 176.2 (weak signal), 164.1 (Ct), 147.6 (Cipso, 
Ca, Ci or Ck), 146.9 (Cipso, Ca, Ci or Ck), 143.2 (Cipso, a, Ci or Ck), 142.1 (Cf or Cc), 139.6 (Cj), 
135.5 (Cipso, Cn or Cq), 131.7 (Co or Cp), 129.1 (Ch), 128.1 (Co or Cp), 125.3 (Cipso, Cn or 
Cq), 123.9 (Cb or Cg), 123.7 (Cb or Cg), 120.0 (Cd), 97.1 (Cl or Cm), 84.3 (Cl or Cm), 60.6 
(Cs or Cr), 50.1 (Cs or Cr), 29.0 Cu), 21.8 (Cw), 14.0 (Cv). ν(C≡C): 2161 cm-1. ν(C=O): 
1736 cm-1.Anal. Calcd. C25H24AuN2O2 . H2O(found): C, 47.29 (47.69); H, 4.13 (3.57); 
N, 4.41 (4.53). 
 
 
 
 
 
 
 117  
1.5.13. (2–para–tolylpyridyl)Au(–C≡C–C6H4–CHO)2 (complex 15). 
 
 
 
 
 
 
1H–NMR assignments         13C{1H}–NMR assignments 
 
4–ethynylbenzaldehyde (46 mg, 0.35 mmol), CuI (0.46 mg, 2.41 mmol) and NEt3 (67 
µL, 1.05 mmol) were added to a mixture of (2–para–tolylpyridyl)AuCl2 (70 mg, 0.16 
mmol) in dichloromethane (10 ml). The mixture was allowed to stir for 3 hours at room 
temperature. The resulting solution was washed with water, and the organic layer was 
isolated. The solvent was removed under vacuum and the residue was washed with 
petrol ether 40/60 (10 ml) and vacuum dried, to yield a yellow solid (61.3 mg, 0.10 
mmol, 62 %). 1H–NMR (300 MHz, CD2Cl2) δ  9.99 (Hm or Hn, s, 1H), 10.01 (Hm or Hn, 
s, 1H), 9.57 (Hh, d, J = 5.1 Hz, 1H), 8.09 (Hf, d, J = 8.2, 1.3 Hz, 1H), 8.02 (Hb, s, 1H), 
7.92 (He, d, J = 8.0 Hz, 1H), 7.61 – 7.89 (Hi-j, Hk-l (overlapped), m, 8H), 7.64 (Hd, d, J = 
8.1 Hz, 1H), 7.44 (Hg, m, 1H), 7.23 (Hc, d, J = 7.6 Hz, 1H), 2.42 (Ha, s, 3H). 13C{1H}–
NMR (75 MHz, CD2Cl2) δ 191.4 (Cf or Cg), 167.0 (CAr), 155.2 (CAr), 150.7 (CAr), 142.7 
(CAr), 142.6 (CAr), 141.8 (CAr), 136.3 (CAr), 135.0 (CAr), 134.7 (CAr), 132.2 (CAr), 132.0 
(CAr), 129.4 (CAr), 128.5 (CAr), 124.9 (CAr), 123.8 (CAr), 123.7 (CAr), 120.3 (CAr), 103.6 
(Ca, Cb, Cd or Ce), 86.1 (Ca, Cb, Cd or Ce), 90.7 (Ca, Cb, Cd or Ce), 21.8 (Cc). ν(C≡C): 
2131 cm-1, 2162 cm-1. Anal. Calcd. C30H20AuNO2 (found): C, 57.80 (57.67); H, 3.23 
(3.14); N, 2.25 (2.36). 
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1.5.14. (2–para–tolylpyridyl)Au(–C≡C–C6H4–CH2–NH–CH(CH3)–COOCH3)2 
(complex 16).  
 
 
 
 
 
 
1H–NMR assignments         13C{1H}–NMR assignments 
1–Ethynyl–4–benzyl–L–Alanine methyl ester (80.0 mg, 0.37 mmol), CuI (0.53 mg, 
2.78 mmol) and NEt3 (71.0 µL, 0.37 mmol) were added to a mixture of (2–para–
tolylpyridyl)AuCl2 (74.0 mg, 0.17 mmol) in dichloromethane (10 ml). The mixture was 
allowed to stir for 16 h at room temperature. The resulting solution was washed with 
water (10 ml), and the organic layer was isolated. The solvent was removed under 
vacuum and the residue was washed off with petrol ether 40/60 (10 ml) and vacuum 
dried, to yield a yellow solid (43.0 mg, 0.05 mmol, 32 %). 1H–NMR (300 MHz, 
CD2Cl2) δ 9.64 (Hh, d, J = 5.1 Hz, 1H), 8.03 – 8.09 (Hf and Hb (overlapped), m, 2H), 
7.90 (He, d, J = 8.1 Hz, 1H), 7.63 (Hd, d, J = 8.0 Hz, 1H), 7.42 (Hg, m, 1H), 7.20 (Hc, d, 
J = 8.0 Hz, 1H), 3.64 (Hr or Hq, s, 3H), 3.66 (Hr or Hq, s, 3H), 3.62 – 3.84 (Hm and Hn 
(overlapped), m, 4H), 3.33 – 3.42 (Hs and Ht, m, 2H), 2.42 (Ha, s, 3H), 1.30 (Ho or Hp, 
d, J = 6.8 Hz, 3H), 1.30 (Ho or Hp, d, J = 6.9 Hz, 1H). 13C{1H}–NMR (75 MHz, 
CD2Cl2) δ, 176.0 (Cn or Co) 166.9 (CAr), 155.8 (CAr), 150.7 (CAr), 142.7 (CAr), 142.5 
(CAr), 141.6 (CAr), 139.6 (CAr), 136.3 (CAr), 131.7 (CAr), 131.6 (CAr), 128.2 (CAr), 128.0 
(CAr), 124.7 (CAr), 124.5 (CAr), 124.3 (CAr), 123.7 (CAr), 120.1 (CAr), 117.7 (CAr), 103.7 
(Ca, Cb, Cc or Cd), 98.8 (Ca, Cb, Cc or Cd), 80.2 (Ca, Cb, Cc or Cd), 78.1 (Ca, Cb, Cc or Cd), 
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55.9 (Ck, Cj, Cg or Cf), 55.4 (Ck, Cj, Cg or Cf), 51.6 (Ck, Cj, Cg or Cf), 51.5 (Ck, Cj, Cg or 
Cf), 21.8 (Cc),18.9 (Ch or Ci). ν(C≡C): 2153 cm-1, ν(C=O): 1732 cm-1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 120  
 
 
 
 
 
CHAPTER 2 
INTERACTION OF BI- AND TRI-DENTATE 
CYCLOMETALATED GOLD(III) COMPLEXES WITH 
DNA SECONDARY STRUCTURES. 
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2.1.  INTRODUCTION 
 
2.1.1. Metal complexes in cancer therapy. 
Therapeutic applications of metal-based compounds have been largely studied. 
Although some of these compounds have presented novel medical applications,36 both 
their limited selectivity and toxicity have progressively reduced their interest in favour 
of the more reliable organic compounds.  
In 1965 Rosenberg et al.37 discovered the antiproliferative activity of a platinum 
complex called cisdiamminedichloroplatinum (cisplatin) (Figure 51), which was 
successfully employed in testicular cancer therapy in 1978. This discovery increased the 
interest in metal-based drugs, particularly of the cytotoxicity of other metal-based 
compounds. 
 
 
 
Figure 51. Cisdiamminedichloroplatinum (cisplatin). 
Cisplatin has shown to be highly effective in the treatment of testicular and ovarian 
cancers, and is also employed for treating bladder, cervical, head and neck, 
oesophageal, and small cell lung cancer.38  
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Figure 52. Aquation of cisplatin in cells (adapted from reference39). 
It is generally accepted that its antitumor properties are due to the binding of cisplatin 
to genomic DNA (gDNA) in the cell nucleus.39 The high concentration of chloride ion 
(100 mM) allows cisplatin to maintain a neutral stable conformation until it enters into 
the cell.40 Once cisplatin reaches the cell, the low chloride ion concentration (4-12 mM) 
facilitates cisplatin aquation reaction, exchanging the two chloride ions by water or 
hydroxy ligands, to form the cationic aqua complexes (Figure 52).39 Cationic molecules 
with no hydrocarbon components exhibit difficulties to diffuse through the biological 
membrane. Accordingly, the obtained aqua derivatives from cisplatin may not be able to 
go out from the cell before binding to DNA, being trapped inside the cell. Both this fact 
and that no modification of the chemical structure during passive diffusion, may be 
potential reasons of the high cytotoxicity of cisplatin.39 
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In contrast to the effectiveness of cisplatin, both drug resistance (some tumours have 
developed an intrinsic resistance to cisplatin) and significant side effects (loss of 
fertility, loss of appetite or numbness) have represented limiting factors in its use. These 
limitations encouraged the development of less toxic cisplatin derivatives, such as 
carboplatin and oxaliplatin (Figure 53), which were approved for clinical use in 1983 
and 2003, respectively. 
 
 
Figure 53. Carboplatin and oxiplatin as less toxic alternatives to cisplatin. 
The successful results obtained with these drugs derived from cisplatin encouraged the 
investigation of the cytotoxicity of other different inorganic compounds.  
 
2.1.2. Anti-cancer gold inorganic complexes. 
In recent years, gold compounds have drawn attention as a new generation of anticancer 
agents, showing anti-tumour properties both in vitro and in vivo.41 One of the most 
important reasons to justify the investigations for the potential anti-tumour activity of 
gold complexes is related to the coordination geometry of gold(III) species. Au(III) is 
isoelectronic with Pt(II). Au(III) compounds feature a square-planar coordination 
geometry, corresponding to the 5d8 outer shell electronic configuration for the gold(III) 
atom.42  
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2.1.2.1.  Gold(I) complexes with anti-tumour activity. 
In the last decades, gold(I) complexes have shown to be potent cytotoxic agents, with 
several applications in chrysotheraphy (application of gold compounds in medicine). In 
2000, Mitchell et al.43 reported a study of mortality in rheumatoid arthritisof patients 
being treated by chrysotheraphy, showing that cancer levels remained steady compared 
to not treated patients and, in some cases, lower levels were observed. The gold(I) 
complexes used in chrysotheraphy are generally divided into two classes: gold thiolates 
(aurothiomalate, Figure 54a) and triethylphosphinegold(I) tetraacetyled thioglucose 
species, commonly called Auranofin® (Figure 54b). 
 
Figure 54. Examples of gold complexes used in chrysotheraphy. 
Auranofin is a sulfur-coordinated gold(I) compound, which has been used for the 
treatment of rheumatoid arthritis, based on its anti-flammatory and immunosuppressive 
properties.44,45,46 In recent years, Auranofin has been investigated as an anti–cancer 
agent, showing remarkable results as anti-tumor agent and exhibiting considerable in 
vitro inhibitory effects. In 1979, Lorber et al.47 studied the effects of Auranofin in cells 
proliferation. These studies included assessing DNA, RNA, and protein synthesis as 
measured by incorporation of 3H-thymidine, 3H-uridine, and 3H-leucine into HeLa cells. 
Auranofin was shown to inhibit 3H-thymidine uptake more rapidly than 3H-uridine or 
3H-leucine uptake at a gold concentration of 75- 100 µg/dl. These three parameters were 
inhibited with a 24-hour exposure to 100 µg/dl. The inhibition of 3H-thymidine uptake 
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in HeLa for 6 hours with 50 or 100 µg/dl of gold was found to be irreversible. In 
addition, HeLa cells demonstrated a remarkable decrease in oxygen uptake after 
exposure to Auranofin. These results confirmed the significant inhibitory effect on 
essential biological processes and functions exerted by Auranofin.  
The anti-tumour effects of Auranofin is considerably influenced by the P – Au – S 
arrangement, which has shown to be one the most relevant reasons to explain its 
cytotoxicity. The presence of phosphine and thiolate ligands has been demonstrated to 
increase the cytotoxity of the complex but, the combination of both in the same 
compound have revealed a considerable enhancement of cytotoxicity. The promising 
results shown by Auranofin encouraged an expansion of the field of study towards 
other comparable gold(I) compounds.  
 
Figure 55. Chemical structure of gold(I) dithiocarbamate derivatives. 
The anti-tumour activity of Auranofin derivatives is influenced by the nature of both 
thiolate and phosphine groups. Barrios et al.48 demonstrated that the variations in 
phosphine ligand can introduce a considerable effect in the inhibition of some enzymes, 
such as cathepsin B. In addition, the larger size and more lipophilic character of 
phosphine groups, compared to thiolate groups, play an important role in the 
enhancement of the diffusion of the gold compounds through the biological membrane, 
increasing the gold uptake inside the cell. This effect was also investigated by Tiekink 
et al.,49 reporting a family of gold(I) dithiocarbamate derivatives where is important to 
highlight complex a (Figure 55), with a linear P-Au-S arrangement characteristic from 
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Auranofin, which was found to be more active than cisplatin in various human cancer 
cell lines, exhibiting the maximum effect against the ovarian cell line IGROV and the 
estrogen receptors MCF-7 and EVSA-T. 
 
2.1.2.2.  Gold alkynyl complexes. 
The study of the anti-tumour properties of gold complexes have been expanded in 
different directions, for instance towards gold alkynyl complexes. Although 
luminescence properties have been the most studied area for these complexes, the 
biological studies of these complexes have not been developed in depth, and there are 
only few examples in the literature,50,51,52 most of them of gold(I) complexes. A recent 
study showed that alkynyl(triphenylphosphine)gold(I) derivatives (Figure 56) exhibit a 
significant inhibitor activity over the seleno-enzyme thioredoxin reductase (TrxR), 
showing high selectivity over the enzyme glutathione reductase.52 
 
 
 
Figure 56. Examples of alkynyl(triphenylphosphine)gold(I) complexes. 
 
2.1.2.3.  Gold complexes bearing amino acid moieties. 
In recent years, functionalization of gold(I) complexes with amino acid has been 
studied. From a biological point of view, the amino acids can deliver the gold atom to 
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the biological target and, because of the amino acid receptors are overexpressed in 
tumour cells, these complexes could increase its selecivity towards tumour cells.53 
Examples of gold(I) complexes functionalized by amino acid ligands are quite scarce in 
the literature. Gimeno et al.54 reported the synthesis of gold(I) thiolate complexes, 
functionalized by amino acids esters. They employed [Au(SpyCOOH)(PPh3)] (Figure 
57) as precursor, which was previously synthesized by Nomiya et al.55  
 
 
Figure 57. Chemical structure of [Au(SpyCOOH)(PPh3)]. 55 
 
They considered that the use of Auranofin analogues, containing Au-S bond, and the 
functionalization with amino acids may provide to these complexes with anti-tumour 
activity against different cell lines. Following this theory, they recently reported the 
synthesis of NSHC gold (I) compounds functionalized by peptides (NSHC = N-
allylbenzothiazolin-2-ylidene).56 They studied the cytotoxic activity of three families of 
gold compounds (Figure 58) against three human tumour cell lines A549 (lung 
carcinoma), Jurkat (T-cell leukaemia), and MiaPaca2 (pancreatic carcinoma). These 
complexes exhibited good anti-cancer activity, with IC50 values from 7.4 to 30.5 µM in 
A549 cells, 2.4 to 7.7 µM in Jurkat cells, and 8.2 to 27.2 µM in MiaPaca2, with the 
Jurkat cell line the most active. 
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Figure 58. Chemical structures of NSHC gold (I) compounds functionalized by amino 
acid and amino ester derivatives. 
 
2.1.2.4.  Cyclometalated gold(III) complexes with anti-tumour activity. 
Gold(III) complexes represent a new class of metallodrugs, that have shown remarkable 
anti-tumour applications in recent years. Since Au(III) and Pt(II) are isolectronic36 and 
isostructural,36 the biological applications of several Au(III) complexes have been 
studied. However, the poor stability of Au(III) complexes in physiological media has 
been the main issue, observing reductive elimination to Au(I) or Au(0) in most of 
cases.57  
Pincer ligands provide an alternative to generate cyclometalated gold(III) complexes 
which are characterized by redox and thermodynamic stability. In addition, the 
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modification of the steric and electronic properties of the ligands can enhance the 
lipophilic character of the synthesized gold(III) complexes. Several examples of 
cyclometalated gold(III) complexes functionalized by pincer ligands have been 
reported. Complexes functionalized by bi-dentate (C^N)58, tri-dentate (C^N^C)59, 
(N^N^N)60 and (N^N^C),61 and poly-dentate ligands, such as porphyrin derivatives,62 
have shown a remarkable enhancement in terms of stability for biological studies. 
Pincer ligands stabilize the Au(III) centre, providing a considerable stability in 
physiological media. 
 
2.1.3. Stabilization of secondary DNA structures by gold- based complexes. 
Deoxyribonucleic acid (DNA) represents the major target of antitumor metal 
complexes. The cytotoxic effects of gold compounds may be a consequence of a direct 
interaction of them with nuclear DNA. From the few data available and by comparison 
with platinum(II) complexes, it may be hypothesized that the biological action of 
gold(III) complexes and, specifically, their antitumor activity is possibly mediated by 
direct interaction with DNA.63 A number of studies based on different physicochemical 
techniques suggest that the probable binding sites for gold(III) are N(1)/N(7) atoms of 
adenosine, N(7) or C(6)O of guanosine, N(3) of cytidine, and N(3) of thymidine, which 
are analogous to the possible binding sites for the isoelectronic platinum(II) ion.64  
 
2.1.3.1.  Double stranded DNA structures stabilized by gold complexes. 
Most DNA molecules are two polymer strands, bound together in a helical fashion by 
H-bonding and π-π stacking, forming a double stranded structure (dsDNA). The 
stability of the dsDNA form depends on three factors: 
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-­‐ GC-content: dsDNA is maintained by strongest for G, C stacks, exhibiting 
higher stability with high GC content. 
-­‐  Depending on the sequence: The stacking is sequence specific. 
-­‐  The length of the sequence. Long DNA helices, with a high GC-content 
(stronger-interacting strands), will be more stable than short helices, with high 
AT content (weaker-interacting strands).  
There are only a few examples of gold complexes stabilizing dsDNA conformations. In 
2000, Oriol et al.65 reported the synthesis of chloro glycylhistidinate gold(III) complex 
and its DNA binding studies. The binding studies of this complex with calf thymus 
DNA were carried out by in vitro through circular dichroism (CD) spectroscopy and 
analysis of the temperature dependence of the DNA helix-to-coil transition.  
CD spectra of calf thymus DNA were measured upon addition of increasing amounts of 
chloro glycylhistidinate gold(III) complex. The addition of this complex represented 
only minor changes of the CD spectrum of calf thymus DNA, suggesting that only 
small DNA conformational distortions take place. In order to monitor possible 
alterations of the gold(III) chromophore due to the DNA addition, an excess of calf 
thymus DNA was added to a solution containing chloro glycylhistidinate gold(III) 
complex in the reference buffer while recording the visible CD spectrum of this 
complex. The CD spectrum of the gold(III) chromophore did not show remarkable 
changes after DNA addition, suggesting that gold remains in the +III state and that the 
global conformation of the complex does not undergo significant modifications. 
Following these investigations, Messori et al.66a reported a study about the interactions 
of bipyridyl gold(III) complexes with calf thymus DNA (Figure 59). Although only 
small effects on DNA conformation and stability were observed, the gold(III) 
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chromophore was not significantly modified, showing a very weak binding to calf 
thymus DNA.  
 
Figure 59. Bipyridyl gold(III) complexes, in which binding with calf thymus DNA has 
been studied.66a 
 
In 2006, the same research group66b reported the synthesis of dinuclear gold(III) 
compounds derived from the condensation of two square-planar gold(III) moieties. The 
interactions of bipyridyl gold(III) complexes with calf thymus DNA was studied.  One 
of the studied complexes called AuOxo666b (Figure 60) exhibited a remarkable binding 
to the DNA double helix. CD spectrum revealed that calf thymus DNA adopts its native 
B-type conformation, characterized by a positive band at 275 nm and a negative one at 
about 242 nm. In presence of AuOxo6, a decrease of the negative band at 242 nm was 
observed, which was attributed to a partial loss of the DNA helicity, due to electrostatic 
interactions between the phosphate groups at the positively charged metal complex. In 
addition, a remarkable change in the positive peak at 275 nm was observed, associated 
with a modification of the overall base stacking of the double helix. Moreover, the 
presence of Auoxo6 also induced a weak CD band at 345 nm, indicative of the 
formation an Auoxo6/DNA adduct.  
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Figure 60. AuOxo6 complex.66b 
 
2.1.3.2.  G-quadruplex DNA structures. Interaction with Gold(III) complexes. 
 G-quadruplexes are higher-order DNA and RNA structures formed from G-rich 
sequences that are built around tetrads of hydrogen-bonded guanine bases.67 These are 
four-stranded helical DNA (or RNA) structures, comprising stacks of G-tetrads, which 
consist of four guanine bases aligned in a co-planar arrangement stabilized by 
Hoogsteen hydrogen-bonding and monovalent cations, such as K+ or Na+ (Figure 61).68a  
 
Figure 61. G-quadruplex structure. 
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The structure is stabilized through the presence of stacking interactions between the 
stacked strands. In addition, the presence of monovalent cations increases the stability 
of the structure because of the strong electrostatic interactions produced between 
guanidine O6 and cations.68b 
In 1989, Williamson et al.69 reported that these sequences form quartets in vitro. In 
1992, Kang et al.70 reported the crystal structure of four-stranded Oxytricha telomeric 
DNA, the first example of a G-quadruplex structure. This structure demonstrates that 
two Oxytricha DNA strands can associate to form a G-quadruplex structure. (Figure 
62). 
 
     
Figure 62. Diagram of the four residues G1-G4 viewed perpendicular to base planes.70  
In 1998, the structures of quadruplexes formed by two different DNA oligonucleotides 
were reported, as well as the localization and effect of cations on these structures. The 
presence of these cations played an important role in the stabilization and folding of 
quadruplexes71,72 through the electrostatic interactions established with the guanidine 
carbonyl groups.  
Hundreds of ligands based on different structures have been tested for their affinity 
toward the telomeric G-quadruplex. Recently, great interest has been focused on the 
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development of novel metal-based agents directed towards this target.73 Some metal 
complexes have shown high effectiveness in the stabilization of G-quadruplex 
structures.74-76 Some of the metal complexes that have exhibited an interaction with 
DNA area are generally supported by a planar aromatic ring, where the metal centre 
responsible for neutralization of the central electron-dense is generated by the carbonyl 
oxygen of the paired guanines.73 
Despite the strong interest in targeting DNA G-quadruplexes with metal complexes, 
only very few examples concern gold complexes have been reported. In 2010, Vilar et 
al.77a reported a pyridine pyrazolate complex [Au-(pzpy)2]Cl (Figure 63) as the first G-
quadruplex DNA inhibitor. This complex was tested against Human telomer (HTelo) 
and c-myc, a proto-ontogene, (group of genes that cause normal cells to become 
cancerous when they are mutated78a) that plays an important role in growth control, 
differentiation and apoptosis (programmed cell death, carried out by the cell itself once 
it is not longer needed78b), being considered one of the most affected genes in human 
cancers.77b This complex showed a strong interaction with quadruplex DNA, giving 
DC50 values of 0.34 µM for c-myc, and 1.03 µM for Htelo, which were similar to the 
values found for a range of good quadruplex DNA binders.77b 
 
 
 
 
 
 
Figure 63. Chemical structure of [Au-(pzpy)2]Cl. 
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In 2015, Bazzicaluppi et al.79 analyzed the interactions of three gold(III) complexes 
called Aubipyc, Au2bipyc and Auoxo679 (Figure 64) with human telomeric DNA G-
quadruplexes, making use of a variety of physico-chemical methods, such as DNA 
melting or circular dichroism. 
 
	  
 
Figure 64. Chemical structure of of Aubipyc (a), Au2bipyc (b) and Auoxo6 (c).79 
Although these three complexes binded to the G-quadruplex form of human telomeric 
DNA, their DNA binding modes show differences. Circular dichroism (CD) 
spectroscopy revealed that both Aubipyc (a) and Au2bipyc (b) bind to telomeric G-
quadruplex Tel22 (d[AG3(T2AG3)3]) in similar efficiency at room temperature. In 
contrast, Auoxo6 (c) showed the most remarkable binding affinity for human telomeric 
G-quadruplex (Figure 65). 
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Figure 65. CD spectra of 4 µM Tel22 in the presence of Aubipyc, Au2bipyc and Auoxo6. 
Spectra were acquired in 10 mM Tris, 50 mM KCl (panel A) or 50 mM NH4Cl (panel 
B), pH 7.5, 25 °C.79 
As it is shown in Figure 65, both Aubipyc and Au2bipyc have presented an increase of 
the positive peak at 290 nm, indicative of interaction between these Au(III) complexes 
and Tel22 DNA structure. Regarding Auoxo6, the positive peak at 290 nm was more 
pronounced, and also a negative peak about 260 nm was also observed, indicating that 
this complex is presenting the most significant binder to Tel22 DNA. 
 
2.1.3.3.   i-motif DNA structures. Interaction with Gold(III) complexes. 
In 1993, Gehring and co-workers80 found that the DNA sequence d(C5T) can form a 
special four stranded intermolecular nucleic acid secondary structures, maintained by 
formation of hairpins stabilized by intercalated cytosine-cytosine+ base pairs at N3, 
bonded by three hydrogen bonds, intercalated to each other in an antiparallel 
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orientation. This structure was called the “i-motif” (Figure 66). The name i-motif refers 
that is probably the only nucleic acid structure with intercalated base pairs.  
 
 
Figure 66. A hemiprotonated cytosine–cytosine+ base pair that intercalate to the form 
i-motif structure. 
 
The arrangement of C·CH+ pairs may involve four C tracts of cytosine separated by 
stretches of other bases, folding into an intramolecular i-motif. These sequences have 
been found in the promoter regions of several oncogenes.81a  
In general terms, the stability of the genomic intramolecular i-motif sequences depends 
directly on the length of their loops. i-Motif with long loops have demonstrated to be 
more stable due to the extra stabilizing interactions of the longer loops.82a However, in 
2015, Brazier et al.82b demonstrated that short loops stabilize more stable structures than 
long loops. With longer loops, the structure reaches more flexibility, but the interactions 
become weaker. They reported that forming intramolecular interactions would be the 
way to stabilize long loop regions, because it would limit the flexibility. 
However, the C tracts may be presented in two or four independent nucleic acid strands, 
producing intermolecular i-motif structures. These C tracts are then arranged as a 
tetramer composed of two parallel-stranded duplexes that are intercalated in an anti-
parallel way. The hemiprotonated configuration C-C+ plays an important role in 
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increasing the stability of the structure by increasing the strength of the stacking 
interactions, which is achieved by formation of C-H...O83a,83b   C-rich telomeric repeats 
fold into a stable i-motif at slightly acidic pH.83,84 However, Rajendran et al.85 reported 
that the i-motif structure can be formed even at neutral and slightly basic pH. Recently, 
Brazier et al.82b reported that i-motif structure can be formed in a range of pH from 5.5 
to 7, and this stabilization will depend on the composition and length of the loops. 
Stabilization of i-motif structures by gold-based complexes is still unknown. Gold 
nanoparticle-DNA conjugates have shown a wide use for nanoscience and 
nanotechnology. The combination of both the size-dependent properties of gold 
nanoparticles and the molecular recognition and biological function of DNA can 
provide important applications in the sensitive detection of DNA,85 proteins,86 and 
metal ions.87 
In this chapter, we report the interaction of secondary DNA structures with bi- and tri-
dentate gold (III) complexes functionalized by alkynyl ligands. In our investigations, we 
have studied the activity of gold(III) complexes stabilized by ligands of the type C^N 
and C^N^C. The use of this type of ligand can provide redox and thermodynamic 
stability to the cyclometallated gold(III) complexes. In addition, these ligands can 
modify the steric properties of the complexes, increasing the lipophilic character and 
stability in physiological media of the synthesized complexes, the primary condition 
required for biological testing.  
In this project, the interaction of gold(III) complexes functionalized by amino ester 
derivatives with DNA secondary structures has been studied. The proposal of this has 
been focused on the well-known idea that the amino acids are overexpressed in tumour 
cells and may be able to deliver gold atoms to biological targets.53  
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Our research has focused on the interaction of gold complexes with different DNA 
secondary structures. DNA interaction is the most recognized anti-tumour target for 
metallic complexes. Accordingly, the interaction of these complexes with different 
human secondary DNA structures was investigated, as a preliminary study of 
cytotoxicity.  
 
2.2.   RESULTS AND DISCUSSION. 
In our investigations, the complexes 4, 5, 6, 7, 11, 12, 13, 14 and 15 previously reported 
in chapter 1, were studied (Figure 67).  
 
Figure 67. Chemical structure of complexes 4, 5, 6, 7, 11, 12, 13, 14 and 15. 
In this chapter, we report the interaction of secondary DNA structures with bi- and tri-
dentate gold (III) complexes functionalized by alkynyl amino ester ligands. These 
complexes are stabilized by ligands type C^N and C^N^C. The use of this type of 
ligand can provide redox and thermodynamic stability to the cyclometallated gold(III) 
complexes, as well as increasing its lipophilic character and its stability in physiological 
media, the primary condition required for biological testing.  
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The interaction of these complexes with DNA secondary structures has been studied 
making use of different instrumental techniques, such as Fluorescence Resonance 
Energy Transfer (FRET) melting, circular dichroism, FRET-based titration experiment 
and UV difference spectroscopy.  
-­‐ Förster Resonance Energy Transfer (FRET) melting: This method provides a 
semi-quantification of the interaction between a gold complex and a quadruplex 
structure by measuring the increase in the melting temperature (temperature in degrees 
Celsius in which 50% of all molecules of a given DNA sequence are hybridized into a 
double strand, and 50% are present as single strands) of a quadruplex induced by the 
presence of the studied gold complex. 
-­‐ Circular dichroism (CD) spectroscopy: This method allows us to study the 
effect caused by the gold complexes over the folding and the structural conformation of 
the employed secondary DNA structures. 
-­‐ FRET titration experiment: This technique provides an easy and quick method 
to observe and quantify the folding of the DNA sequence in real time, studying the 
distance between the donor and acceptor fluorophores labeled in the DNA sequence.  
-­‐ UV difference spectrum: This technique provides a rapid method of structural 
characterization of DNA through the observed difference in terms of UV absorbance 
spectroscopy between the unfolded and folded states.  
 
2.2.1. Förster Resonance Energy Transfer (FRET) melting. 
The theorethical analysis of this technique was developed by Theodor Förster. A photon 
will induce the excitation of one donor molecule and its consequent relaxation to the 
ground state. This process implies the emission of energy. If the acceptor molecule is 
not far from the donor, it can take this energy causing its excitation, followed by its 
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relaxation to the lowest energy state, causing a photon emission. This phenomenon is 
the main background of the FRET melting technique. Accordingly, this technique let us 
to measure the distance between the donor and acceptor groups in a biological 
molecule, for example a DNA sequence. Focused on our field, this technique will allow 
us to measure if the presence of gold complexes causes a variation of the donor-
acceptor distance, which may indicate that the interaction between our complexes and 
DNA sequences is produced. 
Regarding the way to present the results, this technique measures the change of 
temperature with the fluorescence intensity. As we will see in the graphs, the end of the 
experiment is reached when we observe the formation of plateau status, which means 
that all the molecules of the DNA sequence are unfolded. In contrast, at the beginning 
of the graph all the molecules of the DNA sequence remains folded. The intermediate 
point in our graph marks the melting temperature Tm, which it will be explained later in 
the section. 
The most relevant parameters of study in FRET melting experiments are both the FRET 
efficiency (EFRET) and the melting temperature (Tm). FRET efficiency is defined as the 
fraction of energy transferred for each donor excitation: 
 
EFRET = 1 – (FID / FIDo), where: 
FID : Fluorescence in presence of complex. 
FIDo : Fluorescence in absence of complex. 
FRET efficiency (EFRET) depends on different factors: 88 
-­‐ The intensity of the donor in absence and presence of the acceptor. 
-­‐ Fluorescence lifetime of the donor molecule in presence and absence of acceptor 
(τDA and τD, respectively). 
 142  
-­‐ Fӧrster distance (R0) and distance between the energy donor molecule and the 
energy acceptor (r0). 
-­‐ Fluorescence intensity of the energy donor molecule in presence and absence of 
acceptor. 
In second place, the melting point is defined as the temperature in degrees celsius where 
50% of all the molecules of a DNA sequence are hybridized as a double strand and 50% 
are present as single strands. Variations of the melting temperature before and after 
addition of complexes may indicate that the distance between fluorophore has changed.  
In our investigations, the aim of this experiment is to study if the presence of gold 
complex can induce a conformational change of the DNA sequence, producing a 
variation of the distance between fluorophores, causing folding or unfolding of the 
DNA sequence compared to the melting profiles of the control sample (in absence of 
gold complex). 
 
2.2.1.1.  FRET melting experiments employing 50, 10 and 1 µM solutions of 
complexes 4 – 7 and 11 – 14. 
In principle, complexes 4 – 7 were tested against HTeloG, Hif-1-α, c-mycC and HTeloC 
DNA sequences at 50 µM. FRET melting profiles were recorded in presence and 
absence on complex. As we can observe in Figure 68, the presence of complexes 4 – 7 
did not induce remarkable changes in terms of melting temperature compare to the 
melting profile in absence of complexes. In addition, variations of fluorescence were 
not observed, indicating that the presence of these complexes did not cause any 
significant variation of the distance between fluorophores, meaning that their presence 
did not induce conformational modifications of the studied DNA sequences. 
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Figure 68. FRET melting graphs of HTeloG (A), Hif-1-α (B), c-mycC (C) and HTeloC 
(D) DNA sequence in absence and presence of complexes 4 – 7 at 50 µM concentration 
in a 50 mM sodium cacodylate buffer at pH 7.4, 7.2, 6.6 and 6, respectively. 
In presence of complexes 11 – 14, fluorescence intensity of c-mycC (B), HTeloC (C) 
and Hif-1-α (D) DNA sequences (Figure 69) remained apparently folded during the 
whole experiment, i.e, all the molecules of the DNA remained hybridized as double 
strands. This result may indicate two options: The first one, 50 µM concentration of 
complexes 11 – 14 stabilize these DNA sequences, remaining them folded during the 
whole experiment. The second one is that precipitation of the complex may have 
occurred under the employed experimental conditions.  
A	   B	  
C	   D	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In case of HTeloG DNA sequence, fluorescence intensity remained folded up to 80 °C. 
At this temperature, fluorescence intensity started to increase, reaching melting 
temperatures higher than the measurable in the experimental conditions. This result 
indicates that, in presence of complexes 11 – 14, HTeloG DNA sequence reaches a 
melting temperature higher than the measurable 95 °C (higher temperature reported on 
the employed experimental conditions), becoming needed to change the experimental 
conditions in order to be able to identify the melting temperature. 
HTeloC (C), HTeloG (A) and Hif-1-α (D) DNA sequences in presence of complex 15 
did not show noticeable variations of fluorescence at 25 °C compared to the melting 
profile in absence of complex, indicating that the presence of complex 15 did not cause 
an additional folding of these sequences. In addition, the melting point remained 
unchanged in presence of complex 15, supporting the theory that no interaction between 
sequences A, C and D and complex 15 has been produced.  
In contrast, c-mycC (B) sequence in presence of complex 15 underwent a decrease in 
fluorescence intensity at 25 °C, which may indicate that the presence of this complex 
causes that fluorophores in c-mycC (B) sequence are closer each other, due to the 
additional folding of the structure. However, fluorescence intensity remained then 
folded during the whole experiment, which may also indicate precipitation of complex 
under the employed experimental conditions.  
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Figure 69. FRET melting graphs of HTeloG (A), c-mycC (B), HTeloC (C) and Hif-1-α 
(D) DNA sequence in absence and presence of complexes 11 – 15 at 50 µM 
concentration in a 50 mM sodium cacodylate buffer at pH 7.4, 6.6, 6 and 7.2, 
respectively. 
The experiment was repeated at lower concentration of complex, in order to obtain 
more conclusive results. The labelled oligonucleotides HTeloG, Hif-1-α, c-mycC and 
HTeloC previously prepared as a 400 nM solutions in a 50 mM sodium cacodylate 
buffer (pH 7.4, 7.2, 6.6 and 6, respectively) were employed. However, concentration of 
complexes 11 – 14 was modified, preparing 10 µM solutions (instead of the 50 µM 
A	   B	  
C	   D	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solutions of the previously used) in a 50 mM sodium cacodylate buffer at pH 7.4, 7.2, 
6.6 and 6, and a 50 mM sodium cacodylate buffer and 100 mM of NaCl at pH 7.4. 
 
Figure 70. FRET melting graphs of HTeloG (A), c-mycC (B), HTeloC (C) and Hif-1-α 
(D) DNA sequence in absence and presence of complexes 11 – 15 at 10 µM 
concentration in a 50 mM sodium cacodylate buffer at pH 7.4, 6.6, 6 and 7.2, 
respectively. 
The use of lower concentration (10 µM) of complex 15 showed that the presence of this 
complex did not induce remarkable variations in the melting profile of HTeloG, HteloC 
and Hif-1-α DNA sequences. As is shown in Figure 70 A, C and D, melting profiles in 
presence of complex 15 remained fluorescence intensity unchanged compared to the 
control sample (in absence of complex), indicating that the presence of this complex 
A B 
C D 
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does not cause an additional approchement of the fluorophores, which means that its 
presence does not induce a different folding than the one shown by the control sample 
(in absence of complex). These observations were supported by the melting point, 
which became unchanged compared to the control sample, confirming that complex 15 
does not interact with HTeloG, HteloC and Hif-1-α DNA sequences.  
FRET melting profiles of HTeloG (A), C-mycC (B), HTeloC (C) and Hif-1-α (D) DNA 
sequences in the presence of complexes 11 – 14 underwent a decrease in fluorescence 
intensity at 25 °C. This result may indicate that complexes 11 – 14 are able to interact 
with these DNA sequences, causing that fluorophores are closer each other and folding 
more the DNA sequence compared to the one in absence of complex (control sample). 
The melting profiles of remained apparently quenched up to 85 °C, when fluorescence 
intensity started to increase, indicating that melting temperatures are reached over 95 °C 
(the maximum temperature employed in our experiments) becoming needed to change 
the used concentration of gold complex. However, there are other possibilities to 
explain these results, such as precipitation of complex has taken place under these 
conditions or an experimental error has been produced. Accordingly, we need more 
experiments in order to confirm these results.  
A particular result was observed for HTeloC DNA sequence in presence of complex 13. 
At temperatures over 60 °C, the melting profile underwent a drastic decrease, which 
may be due to, at temperatures higher than 60 °C, the energy starts to transfer efficiently 
from the fluorophore to the metal; producing fluorescence quenching.88d This effect may 
be a result of precipitation of the complex.  
The experiments to study the interaction of complex 11 – 14 were carried out making 
use of 1 µM concentration of these complexes instead of the 10 µM concentration 
previously used (Figure 71). 
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Figure 71. FRET melting graphs of HTeloG (A), c-mycC (B), HTeloC (C) and Hif-1-α 
(D)  DNA sequence in absence and presence of complexes 11 – 15 at 1 µM 
concentration in a 50 mM sodium cacodylate buffer at pH 7.4, 6.6, 6 and 7.2, 
respectively. 
The introduced change in the experimental conditions (1 µM instead of 1 µM 
concentration of complexes 11 – 14) allowed us to obtain clearer results. As it is shown 
in Figure 71 A, the addition of complexes 11 – 14 did not represent significant a 
variation of fluorescence intensity, indicating that the presence of them does not cause 
that the fluorophores are closer each other than the status on absence of complexes, 
which means that they do not induce additional folding of the sequence. The observed 
results for fluorescence intensity were supported by the unchanged melting temperature, 
A	  
B	  
C	   D	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indicating that there is not interaction between the studied complexes and HTeloG DNA 
sequence. 
FRET melting profiles of c-mycC and HTeloC DNA sequences (Figure 71 B and C, 
respectively) in presence of complexes 11 – 14 showed a slight increase of fluorescence 
intensity, which indicates that these complexes promote slightly the folding of the DNA 
structures, causing that chromophores are closer each other. However, this weak effect 
observed may be explained because of an error within the experiment. This effect was 
slightly more pronounced for HTeloC DNA (C) in presence of complex 13.  
FRET melting profiles of Hif-1-α DNA sequence exhibited the most promising results 
(Figure 71 D). In presence of complexes 11 – 14, fluorescence intensity decreased 
noticeably at room temperature, being more pronounced in presence of complex 13. 
This decrease indicates that, complexes 11 – 14 are able to interact with Hif-1-α DNA 
sequence, causing an approchement of the fluorophores, increasing the folding of the 
sequence. In addition, these results were supported by the considerable change of 
melting temperature in presence of complex 13 (ΔTm = 10 °C, Table 31), indicating 
that, the presence of complex 13, causes a considerable change of the temperature in 
which 50% of all molecules of the DNA sequence are hybridized into a double strand, 
and 50% are presented as single strands, indicative that complex 13 is interacting with 
Hif-1-α DNA sequence. In contrast, melting temperature did not undergo striking 
changes in presence of complexes 11, 12 and 14.  
In order to check if the observed effect of complex 13 in the stabilization of Hif-1-α 
DNA sequence (observed in the previous experiment through the change of melting 
temperature) was due to an experimental error, we repeated the experiment only for 
complex 13, making use of the same experimental conditions. 
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Table 31. Data of ΔTm of Hif-1-α in absence and presence of 1 µM concentration of 
complexes 11 – 14. 
 Tm (°C) ΔTm (°C) 
Hif-1-α (Control) (first measure) 43.5 n/a 
Hif-1-α (Control) (second measure) 33.8 n/a 
Complex 13 (first measure) 55.8 12.3 
Complex 13 (second measure) 44.8 11 
ΔTm (°C) Average 11.65  
   
As it is showed in table 31, the average of ΔTm (°C) values for the two taken 
measurements is 11.65. In order to determinate the error of the experiment, we 
calculated the standard deviation of this values according to the average. Accordingly, 
the obtained value will be 11.65+/-0.65, where the standard deviation (σ) is 0.65. As we 
have observed in Table 31, the difference between each measurement and the average is 
lower than 2σ, which may be a proof of the reliability of the measurements. However, 
because of the samples were high diluted, it would be necessary to carry out the 
repetition of the experiment in order to verify the results. 
Following the FRET melting profiles, our investigations have focused on the study of 
the interaction of complex 13 with Hif-1-α DNA sequence. However, the interaction of 
complex 13 with c-mycC and HTeloC DNA sequences, as well as complex 11, 12 and 
14 with Hif-1-α, c-mycC and HTeloC may have also shown interesting results in terms 
of stabilization of folding DNA structure. For this reason, it may be worthwhile 
targeting for future investigations, as well as repeating the conducted experiments to 
check if the reproducibility of the obtained results. 
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2.2.2. Circular dichroism (CD) experiments. 
Circular dichroism is based on the difference of absorption of right- and left-handed 
circularly polarized light exerted by chiral molecules. Circular dichroism (CD) 
measurements have been used for over 20 years to study the conformations of nucleic 
acids in solution.89 The quantity used to describe circular dichroism is called ellipticity. 
CD spectroscopy is a powerful method for studying DNA-conformational properties, 
providing many advantages over other methods of conformational analysis: 90 
-­‐ Extremely sensitive, letting work with very low concentrations of DNA (20 
µg/ml).  
-­‐ This technique allows working with both short and long molecules. 
-­‐ The samples can easily be titrated with various agents, such as salts, alcohols or 
acids, which induce conformational isomerization in DNA.  
-­‐ CD spectroscopy distinguishes two-state conformational isomerization between 
distinct conformers from gradual changes within arrangements characterized by 
a single energetic minimum.91 
-­‐ Circular dichroism can be also employed to make correlations between infrared 
spectroscopy and X-ray diffraction, because of its ability to analyze DNA 
sequences.92  
-­‐ Circular dichroism can provide fast and inexpensive measurements.  
The promising results obtained in FRET melting experiments of Hif-1-α in presence of 
complex 13 encouraged us to employ circular dichroism spectroscopy (CD), in order to 
study the effect of complex 13 on the folding and conformational changes of DNA.  
As it is shown in Figure 72, the CD spectrum of annealed Hif-1-α DNA at pH 7.2 shows 
a negative signal at 256 nm and a positive signal at 288 nm, which may indicate the 
formation of cytosine–cytosine+ base pairs, corresponding to an i-motif structure. DNA 
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strands rich in cytosine generate quadruplexes, which consist of two parallel 
homoduplexes connected through hemiprotonated C-C+ pairs. These duplexes are 
mutually intercalated in an anti-parallel orientation.93 Cytosine quadruplexes generate a 
characteristic CD spectrum with a dominant positive band over 290 nm, and the 
presence of antiparallel orientation is indicated by a negative peak over 260 nm.94a  
 
 
 
 
 
 
Figure 72: CD spectrum of 10 µM concentration of annealed Hif-1-α in 50 mM sodium 
cacodylate buffer at pH 7.2 (black) with 5 µM (green), 10 µM (red), 20 µM (yellow) and 
50 µM (blue) of complex 13. 
As it is shown in Figure 73, the presence of complex 13 caused a decrease of amplitude 
of the bands. This result may indicate that the presence of complex 13 has a little effect 
in the stabilization of i-motif conformation, causing unfolding of the DNA sequence, or 
even giving rise a slight formation of an unstructured poly d-(Cn) single strand.94b 
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However, DNA sequences consisting of GC-rich trinucleotides repetitions, such as the 
studied one, can adopt B-form duplex and hairpin, being able to transform between 
them. Hairpin is a variant of B-duplex form, which also contains a single stranded loop. 
CD spectra of B-forms are characterized by a positive wavelength between 260 – 280 
nm, and a negative peak over 245 nm. The position of these bands depends of the 
sequence. The transition from B-duplex to hairpin is observed in the CD spectrum by a 
decrease of amplitude of these bands, mainly due to the single-stranded loop. According 
to this, there is a possibility that Hif-1-α DNA sequence fold a B-duplex conformation 
and, in presence of complex 13, this DNA sequence undergoes a conversion to Hairpin 
conformation, which is reflected in the CD spectrum by a decrease in amplitude of the 
bands. This conversion has been more pronounced with the increase of concentration of 
complex 13, indicating that the conversion may be an effect of dilution. In order to 
check if the observed conversion is an effect of dilution, an alternative experiment 
making use of higher concentrations of complex 13 should be conducted. In this point, 
FRET titration is a high selectivity method that would offer us the possibility to work in 
a high range of concentrations, providing more accurate results than circular dichroism. 
 
2.2.3. FRET titration experiment. 
FRET methods provide a powerful tool to observe the dynamic structural changes of 
biomolecules, as well as of subpopulations in a heterogeneous mixture.95 In a FRET 
experiment, a secondary DNA sequence is labelled with donor and acceptor 
fluorophores at different positions. FRET titration experiment provides an easy and 
quick method to observe if the two fluorophores are closer (characteristic of the folding 
of the sequence) or further apart (characteristic of unfolding).  
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In our research, we have decided to use FRET titration experiment because of its high 
sensitivity and selectivity, allowing us to work over a large concentration range. This 
method can provide us more information and conclusive results than the ones observed 
from the CD experiment, letting us to check the possibility if the observed results in 
previously mentioned experiment were effect of dilution. In addition, the most intense 
fluorescence is observed in compounds containing aromatic functional groups with low-
energy π –> π* transition levels, which may make this experiment a useful tool to 
identify if complex 13 induces folding of DNA, due to this complex being stabilized by 
an aromatic ligand type C^N. 
FRET-based titration experiments using the labeled oligonucleotide Hif-1-α at pH 7.2 
were carried out. The FRET efficiency (EFRET) was calculated by 1-(FId/FId0), where 
FId0 is the fluorescence intensity of the donor in the absence of the acceptor. The 
experiment was carried out by addition of 0 – 6 µM concentration of complex 13. As is 
shown on the Figure 74, in presence of 0 – 2 µM of complex 13, we observed that 
FRET efficiency exhibited negative values, which may be an indicative of precipitation 
of complex. At > 2.0 µM concentrations of complex 13, EFRET increased steadily, 
indicative that the fluorophores are closer each other, consistent with the folding of 
DNA. However, EFRET only reaches a maximum value of 0.3, when it would be 
expected to reach values closer than 1 for folded structures. As is observed in Figure 73, 
FRET efficiency has not reached a plateau status. This status is reached when, after 
addition of a certain concentration of complex, FRET efficiency remains steady, 
indicating that DNA is completely folded. In our case, the FRET efficiency has not 
reached a plateau, because its values are still increasing. This fact made not possible to 
confirm if the presence of complex 13 induce the folding of DNA sequence or the 
presence of complex 13 causes destabilization of DNA sequence. Accordingly, it would 
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be needed to repeat the experiment employing higher concentrations of complex 13 
until plateau is reached, in order to obtain conclusive results.  
 
Figure 73: FRET efficiency of 0.1 µM Hif-1-α DNA in 50 mM sodium cacodylate buffer 
at pH 7.2 with 0–6 µM of complex 13 titrated in. The error bars represent the standard 
deviation from the mean of two experiments. 
 
2.2.4. UV difference spectrum. 
The stability of the different conformational forms that DNA sequences are able to 
adopt can be measured by a thermal denaturation experiment. Heating a structured 
nucleic acid leads to variations in its ultraviolet absorbance, causing a conformational 
change of the molecule in solution, in particular, because of a disruption of base-
stacking interactions.96 Recording the ultraviolet absorbance spectrum of the unfolded 
and folded states at different temperatures provides a rapid and inexpensive method of 
structural characterization of DNA. The difference between these two spectra is called 
thermal difference spectrum (TDS). In our experiments, the recorded differential 
spectrum has been isothermal, recording the absorbance of the folded and the unfolded 
states at the same temperature.  
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We used UV difference spectroscopy in order to complement the CD experiments as a 
useful tool for the characterization of nucleic acids in solution and, in our case, 
determine the type of structure that Hif-1-α sequence can fold after addition of complex 
13. The UV absorbance measurements were only considered in the range from 200 to 
300 nm, which are exclusively due to transitions of the planar purine and pyrimidine 
bases.96 
As it observed in Figure 74, the UV difference spectrum of the folded and unfolded 
states at room temperature exhibit a negative differential absorbance peak at 297 nm, 
which may be due to n→ π* transition moments, parallels to the helix axis. This result 
is linked to an increase of the base stacking, indicative of formation of a folded 
structure. As it was reported by Mergny et at., 96 this negative peak may be the result of 
the partial cytosine deprotonation upon unfolding, corresponding to the formation of i-
motif DNA structure. However, if the DNA sequence is folding as an i-motif structure, 
this peak should exhibit a negative absorbance over -0.6 for this band. In addition, a 
positive peak over 240 nm, consistent with i-motif DNA structure, should be also 
observed. As it is represented in Figure 75, although the spectrum presents the highest 
UV positive absorbance peak in that region, it is not possible to identify precisely the 
wavelength corresponding to the maximum peak in that region. According to these 
results, three possible outcome have been presented: 
a) One possibility is that the presence of complex 13 induces unfolding of Hif-1-α 
DNA sequence. However, the presence of a negative absorbance peak at 297 nm 
justify that complex 13 is inducing folding of the Hif-1-α sequence. This 
negative peak is the result of base stacking, which is associated with the 
formation of a folded structure.  
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b) Secondly, it is possible that Hif-1-α DNA sequence may fold in an i-motif 
structure. The negative peak at 297 nm, which may indicate a partial cytosine 
deprotonation, corresponding to the i-motif structure. However, the absorbance 
nearer to 0, compared to the expected one over -0.6 for this band, and the no 
identification of the positive peak over 240 nm (this area is shown distorted in 
Figure 75, exhibiting several absorbance peaks, which may be due to an error in 
the experiment) made not possible to confirm that Hif-1-α DNA sequence folds 
an i-motif structure. 
c) Another possibility is that the presence of complex 13 induces the folding of a 
hairpin conformation, instead of an i-motif like structure. This result may be 
represented by the decrease of the absorbance amplitude, observing an 
absorbance near to 0 for the band at 297 nm (corresponding to the partial 
cytosine deprotonation), compared to the expected one for i-motif 
conformations, over -0.6. This change in absorbance may be an effect of the 
single stranded loop of the hairpin conformation. 
               
wavelength (nm) 
Figure 74. UV difference spectrum of Hif-1-α DNA in presence of 100 µM 
concentration of complex 13. 
Absorbance 
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According to the observed spectrum, an electrophoretic mobility experiment may be a 
suitable technique in order to determinate the conformation that the Hif-1-α DNA 
sequence is folding in the presence of complex 13. Based on mobility, which depends 
on both molecular weight and size of the molecules, this technique would allow us to 
determine if folding is occurring in an i-motif97 conformation or even if it is unfolded.97 
This experiment would be conducted in a polyacrylamide gel, which has been employed 
previously to determinate i-motif conformations97. The comparison of the migration 
distance between Hif-1-α in absence of complex 13 (which have been proven to fold an 
i-motif structure) and Hif-1-α in presence of complex 13, would show to us if the 
studied DNA sequence is folding in an i-motif conformation in presence of complex 13. 
If the migration distances exhibit differences, Hif-1-α DNA sequence in presence of 
complex 13 would be folding a different conformation. This technique would also help 
us to determine if Hif-1-α DNA sequence in presence of complex 13 is folding in a 
hairpin structure, carrying out a comparative electrophoretic mobility experiment 
against a structure capable to form a hairpin conformation, for instance the DNA 
sequence 5´-d[CTC-TCT-TCT-CTT-CAT-TTT-TCA-ACACAA-CAC-AC]-3´.98 
 
2.3. CONCLUDING REMARKS AND PERSPECTIVES. 
In this chapter, the interaction of guanidine and cytosine rich DNA structures with bi- 
and tri-dentate gold (III) complexes functionalized by alkynyl ligands has been reported 
using complexes 4, 5, 6, 7, 11, 12, 13 and 14.  
The interaction of these complexes with the DNA structures was studied making use of 
different instrumental techniques, such as Fluorescence Resonance Energy Transfer 
(FRET) melting experiments, circular dichroism (CD), FRET-based titration experiment 
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and UV difference spectroscopy. FRET melting experiments revealed that the most 
remarkable interaction was produced between complex 13 and Hif-1-α DNA sequence. 
However, the interaction of complex 13 with c-mycC and HTeloC DNA sequences, as 
well as with complexes 11, 12 and 14 with Hif-1-α, c-mycC and HTeloC may have also 
shown interesting results in terms of stabilization of folding DNA structure, which may 
be a worthwhile target for future investigations. In contrast, complexes 4 – 7 did not 
show any remarkable DNA stabilization, which may be due to the rigidity of the ligand 
framework (diphenylpyridine derivative).  
In the absence of metal complexes, the Hif-1-α DNA sequence can fold in an i-motif 
structure, which was indicated in the circular dichroism profiles by a negative peak at 
256 nm and a positive peak at 290 nm, which are characteristics of an i-motif structure. 
In presence of complex 13, a decrease of the positive peak was observed, which 
indicated that this complex interacts with Hif-1-α DNA, promoting the formation of 
poly-d(Cn) single-stranded structure or even causing unfolding of the DNA. 
FRET titration experiments showed that, in presence of complex 13, an increase of 
EFRET was observed, indicating that the fluorophores are closer to each other, which is 
consistent with the folding of the DNA structure. However, FRET efficiency has not 
reached a plateau status. Accordingly, it has not been possible to confirm whether the 
DNA structure reaches a complete folding and, if it happens, at what concentration this 
is achieved. It will therefore be necessary to repeat this experiment using higher 
concentrations of complex 13 in order to reach plateau status. 
Finally, isothermal UV difference spectroscopy exhibited negative peaks at 244 nm and 
295 nm, and a positive peak at 270 nm. Despite the fact that the negative peak at 295 
nm may indicate partial cytosine deprotonation upon unfolding, corresponding to the 
formation of i-motif DNA structure, it was not possible to confirm the stabilization of 
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this structure because there was no positive absorbance at 240 nm, which is taken to be 
characteristic of folding in an i-motif structure. In addition, the absorbance near to 0, 
observed for the 270 nm band, may indicate the folding in a hairpin structure, a 
possibility that was already suggested by the results in the CD spectrum. 
Future work of this project will focus on carrying out additional experiments, such as 
electrophoretic mobility, in order to determine the conformation in which Hif-1-α DNA 
is folding in presence of complex 13. In addition, this work should be extended to the 
study of the interaction of complex 13 with other secondary structures, such as c-mycC, 
which has shown a slight modification of the melting temperature in presence of 
complex 13.  
The effects induced by complex 13 may be explained by an aquation mechanism, 
similar than the one showed for cisplatin in Figure 52. The presence of chloride atom in 
complex 13 may cause its aquation, forming an aqua derivative, which may lead the 
interaction with DNA.  
A future work may be focused on the design and synthesis of other gold complexes 
functionalized with specific groups that allow us to increase the affinity and specificity 
of the molecule for a type of DNA secondary structure.  
 
2.4. EXPERIMENTAL  
The labelled oligonucleotides hTeloG (FAM-5’-GGGTTAGGGTTAGGGTTAGGG-3’-
TAMRA), Hif-1-α (FAM-5’-CGC-GCT-CCC-GCC-CCC-TCT-CCC-CTC-CCC-GCG-
C-3’-TAMRA), hTeloC (5’-FAM-d[TAACCCTAACCCTAACCCTAACCC]-
TAMRA-3’) and c-mycC were the object of our studies. They were purchased from 
Eurogentec and HPLC purified. The solid DNA samples were initially prepared as a 
stock solution in MilliQ water (10 µM for HTeloG, HTeloC, Hif-1-α and c-mycC) and 
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dilutions were carried out in the appropriate buffer, according to the pH in which these 
DNA structures are stable. In our investigations, sodium cacodylate was chosen as 
buffer. This buffer has been chosen for DNA interaction studies previously 
reported,99,100 mostly due to its ability to remain the pH constant under isothermal 
conditions. Accordingly, 50 mM sodium cacodylate buffers at pH= 7.4, pH= 7.2, pH= 
6.6 and pH= 6 were prepared.  
 
2.4.1. FRET melting experiment. 
The labelled oligonucleotides hTeloG, Hif-1-α, hTeloC and c-mycC were prepared as a 
400 nM solution in a 50 mM sodium cacodylate buffer (pH 7.4, 7.2, 6.6 and 6, 
respectively). The samples were then thermally annealed by heating in a heat block at 
95°C for 5 minutes and then allowed to reach room temperature overnight.  
Complexes 4 – 7 and 11 – 15 were prepared as 50 µM solution in a 50 mM sodium 
cacodylate buffer at pH 7.4, 7.2, 6.6 and 6. The fluorescence from 25 °C to 95 °C, as 
well as the temperature at which half of the DNA base pairs dissociate (melting 
temperature, Tm) were monitored. Fluorescence melting curves were determined in a 
QIAgen Rotor-Gene Q-series PCR machine, using a total reaction volume of 20 µL 
charged in Strip-tubes (QIAgen). Measurements were carried out with excitation at 483 
nm and detection at 533 nm. Final analysis of the obtained data was carried out using 
QIAgen Rotor-Gene Q-series software. 
Complexes 4 – 7 and 11 – 15 were prepared as solutions (50 µM, 10 µM and 1 µM) in a 
50 mM sodium cacodylate buffer at pH 7.4, 7.2, 6.6 and 6. The fluorescence from 25 °C 
to 95 °C, as well as the temperature at which half of the DNA base pairs dissociate 
(melting temperature, Tm) were monitored.  
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2.4.2. Circular dichroism (CD) spectroscopy. 
CD spectra were recorded on a Jasco J-810 spectropolarimeter, using a 1 mm path 
length quartz cuvette. Human telomeric DNA sequence (Hif-1-α, FAM-5’-CGC-GCT-
CCC-GCC-CCC-TCT-CCC-CTC-CCC-GCG-C-3’-TAMRA) was diluted in a buffer 
containing sodium cacodylate (50 mM, pH 7.2) to achieve a total volume of 200 µL. 
The scans were performed at 20°C over a wavelength range of 200-480 nm with a 
scanning speed of 200 nm/min, a response time of 1 s, 0.5 nm pitch and 2 nm 
bandwidth. A blank sample containing only buffer was treated in the same manner and 
subtracted from the collected data. Solutions of complex 13 were added in small 
aliquots from 10 to 50 µM concentrations. The CD spectra at the different 
concentrations represent an average of three scans and are zero corrected at 320 nm.  
 
2.4.3. FRET titration experiment. 
Fluorescence titration experiments were performed on a Perkin-Elmer LS-55 
fluorescence spectrometer and recorded using a 1 cm path length quartz cuvette. 
Hypoxia-inducible factor 1-alpha (Hif-1-αFRET, FAM-5’-CGC-GCT-CCC-GCC-CCC-
TCT-CCC-CTC-CCC-GCG-C-3’-TAMRA) was diluted in a buffer containing sodium 
cacodylate (50 mM, pH 7.2) to achieve a concentration of 0.1 µM and a total volume of 
200 µL. The DNA was not annealed and used immediately after dilution. Solutions of 
complex 13 were added in small aliquots to the desired proportions. The overall dilution 
was less than 10%. Excitation of the donor fluorophore was performed at 490 nm and 
the emission spectra were recorded over a wavelength between 500 and 650 nm at 20 
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°C. The experiment was carried out in duplicate, and the error bars represent the 
standard deviation. 
 
2.4.4. UV difference spectroscopy. 
UV spectroscopy experiments were performed on an Agilent Technologies Cary 60 
UV-Vis spectrometer and recorded using a low volume quartz cuvette. Hypoxia-
inducible factor 1-alpha i-motif (Hif-1-α, FAM-5’-CGC-GCT-CCC-GCC-CCC-TCT-
CCC-CTC-CCC-GCG-C-3’-TAMRA) was diluted in a buffer containing sodium 
cacodylate (50 mM, pH 7.2), to achieve a concentration of 2.5 µM and a total volume of 
200 µL. The DNA annealed and used immediately after dilution. A solution of 13 was 
added in small aliquots up to 100 µM. Spectra were recorded over a wavelength range 
of 400 - 200 nm at 20 °C in the absence of any 13 and then in the presence of up to 100 
µM of 13.  
We recorded the UV spectrum either in absence and presence of complex 13 at room 
temperature, carrying out the differential spectrum between them. This spectrum was 
calculated by subtraction of the spectrum in absence of 13 from the spectrum in the 
presence of 13, and normalized as it is reported on the literature.101 
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CHAPTER 3 
MISCELLANEOUS RESULTS 
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3.1. INTRODUCTION 
Cyclometallated Au(III) complexes are remarkable for their thermal stability and 
resistance to reduction.8a Cycloauration reactions provide products containing five- or 
six membered ring systems, containing a gold(III)–aryl bond. The use of these ligands 
has been proven to provide a considerably stabilization to the gold(III) metallic centre, 
avoiding the reductive elimination step. The ligand has a strong influence on the 
conditions under which this reaction takes place. The use of nitrogen and oxygen donor 
ligands has played an important role in order to reach this stabilization against reductive 
elimination. In 1939, an example of O-type chelates, such as κ2-acetylacetonato (acac) 
ligands, was reported to stabilise Me2Au+ substituents.102 In the last years, the use of 
heterocyclic ligands, such as phenylpyridine, 2-anilinopyridines, 2-
benzoxypyridines,103a, 2-phenoxypyridines103b terminal anilides, acetylides and cis-
diarylgold(III) species6,7 (Figure 75) have been proven to conduct successfully 
cycloauration reactions by activation of an ortho C-H bond, forming products 
containing five- or six membered ring systems characterized by high stability against 
reductive elimination. In recent years, our research group has reported the synthesis of a 
variety of gold(III) complexes supported by 2,6-diphenylpyridine derivatives. The 
conformation of this ligand is suitable to avoid reductive elimination, and also the 
presence of two phenyl groups surrounding the gold metallic centre provides a high 
stability to the complex from a thermodynamic point of view, mainly due to the 
presence of two thermodynamically stable Au – C bonds. 
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Figure 75. Examples of gold(III) centers stabilized by chelating ligands. 
 
In 2012, Bochmann et al.30 reported the synthesis of the first neutral gold (III) hydroxide 
complex (Figure 76). This complex exhibited an excellent reactivity as a mild metal 
base, being able to activate C–H and N–H bonds.  
 
Figure 76. ORTEP diagram of (C^N^C)Au(III)OH. 
The excellent reactivity of this complex as mild base resulted in smooth reactions with 
boronic acids and protic reagents under neutral conditions, to give a variety of gold 
aryls, alkynyls and heteoaryls, allowing C–H or N–H activation (Scheme 28). These 
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complexes are thermally very stable. The distribution of the aromatic groups in these 
complexes played an important role in order to avoid reductive elimination processes. 
However, the rigid tridentate ligand framework made these complexes reduce 
considerably the reactivity of these systems. In order to generate more reactive 
complexes capable of bearing two functionalisable substituents X or L, the synthesis of 
alternative cyclometallated complexes has been attempted (Figure 77). 
 
 
 
 
 
 
 
 
 
 
Figure 77. Examples of mono- and di- anionic gold(III) complexes stabilized by 
bidentate type ligands, which has been studied in this project. 
 
3.2. RESULTS AND DISCUSSION 
3.2.1.  Synthesis of ligand L5. 
Our first attempt was focused on the synthesis of ligand L5. This is C-,N- dianionic 
ligand, and its synthesis was planned because, as a more flexible ligand framework, it 
may be able to be functionalized by two substituents once is coordinated to gold(III) 
atom, offering more possibilities of functionalization. The coordination of ligand L5 to 
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gold(III) centre will allow the synthesis of neutral complexes type (C^N)AuX2 or 
(C^N)AuX(L). 
The planned method of synthesis focused on the synthetic pathway based on Suzuki 
cross-coupling, followed of C–N coupling based on the Buchwald – Hartwig amination. 
Accordingly, this route involves two reaction steps. The first one involves the Suzuki 
cross-coupling of the commercially available 2,6-dibromoaniline and 4-tertbutyl-
boronic acid, and employing Pd(PPh3)4 as a catalyst, to yield intermediate L5 (Scheme 
28).104 The second step involves a Buchwald – Hartwig cross coupling reaction, 
employing Pd(dba)2 as precursor104 and diphenylphosphinobinapthyl (BINAP), a 
sterically hindered phosphine which has shown high catalytic activity as a ligand in the 
Buchwald – Hartwig amination.105 
 
 
Scheme 28:  Synthesis of the ligand L5. 
Ligand L5 
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In 2012, a similar ligand than ligand L5 was synthesized by Ishihara et al.106 (Figure 78), 
the only difference being the absence of tert-butyl groups in the para position on the 
phenyl rings bonded to the aniline derivative in 1 and 5 positions. In our investigations, 
we decided to decorate the pro-ligand with tert-butyl groups in order to increase the 
solubility of the ligand and also to facilitate the identification of chemical shifts by 1H-
NMR spectroscopy. 
 
Figure 78. Chemical structure of N-(2,6-diisopropylphenyl)-2,4,6-
triisopropylaniline.106 
Characterization of ligand L5 was only carried out by 1H-NMR spectroscopy (Figure 
79, Table 38). 
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Figure 79. 1H–NMR spectrum of ligand L5 in CDCl3. 
Table 38. 1H–NMR data of ligand L5 in CDCl3, δ(ppm) and multiplicity. 
Pro – ligand L5 ASSIGNMENT 1H (ppm) 
 
 
a 0.96 (d, J = 6.8 Hz, 12 H) 
b 1.09 (d, J = 6.9 Hz, 6 H) 
g 1.25 (s, 18 H) 
h 2.58 – 2.67 (m, 1 H) 
i 2.96 – 3.06 (m, 2 H) 
c (s, 2H) 
d (t, 1 H) 
f 7.08 (d, J = 7.5, 2 H) 
j – m (overlapping) 7.17 (m, 8 H) 
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3.2.2. Metalation attempts of ligand L5. 
A. Metalation of ligand L5 via mercuration pathway. 
Ligand L5 has been subjected to mercuration experiments using both Hg(OAc)2 and 
Hg(OAcF)2 as organomercury reagents, following the experimental procedure reported 
by Parish et al.13 in 2000. Mercuration of ligand L5 was monitored by 1H-NMR 
spectroscopy over the course of one week, and no changes in the chemical shifts of the 
aromatic region regarding ligand L5 were observed. In addition, the characteristic 
singlet resonance corresponding to the acetate group, once is coordinated, was not 
showed in the 1H-NMR spectrum.  
This result encouraged us to use Hg(OAcF)2, a more reactive organomercury reagent 
than the previously employed Hg(OAc)2. 1H-NMR spectroscopy showed that 
mercuration of ligand L5 was produced after three days, when no signals corresponding 
to ligand L5 were observed in the 1H-NMR spectrum (Figure 80). 
 
Figure 80. 1H-NMR spectrum of mercuration product (blue spectrum) and ligand L5 
(red spectrum) in CDCl3. 
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Figure 81 showed remarkable changes in the chemical shifts of the mercuration product 
(blue spectrum) compared to ligand L5 (red spectrum). However, the absence of a triplet 
signal corresponding to the aromatic proton located in para position to the nitrogen 
atom may be an indicative that the desired ortho-mercuration product was not produced. 
The synthesized complex was subjected to metathesis by LiCl to yield the 
corresponding organomercury(II) derivative (17), which was recrystallized in the solid 
state in dichloromethane/methanol by a single crystal X-Ray diffraction (Figure 81). 
 
Figure 81: Molecular structure of complex organomercury (II) substrate (17). (50% 
probability ellipsoids shown). Hydrogen atoms and the dichloromethane solvent 
molecule have been omitted for clarity. The heavy atoms Cl and Hg were refined 
anisotropically and the smaller atoms C and N were refined isotropically (structure 
defined by Dr. Mark Schormann). 
As is shown in ORTEP diagram of organomercury (II) derivative (17) (Figure 81), the 
mercury atom is coordinated in para position to the nitrogen atom, and not coordinated 
to the N atom as it was expected. We discarded to use this complex as starting material 
because of the position in where mercury was coordinated did not offer us any 
successful possibility in terms of gold(III) transmetallation. 
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Table 32. Most representative angles (°) and bond distances (Å) of complex 17. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 31. Synthesis of organomercury (II) substrate (17). 
One hypothesis to explain this result may be the steric hindrance caused by the 
isopropyl groups, which could promote the activation of the carbon atom located in 
para position to the nitrogen, forming C – Hg bond. In addition, according to the 
mesomeric resonance forms, a positive charge on N induces a negative charge on the C 
located in para position, which would be preferentially attacked by Hg2+. Another 
hypothesis is related to the well-known high stability of C – Hg bond compared to N – 
Hg bond. In the mercuration step, trifluoroacetate tends to attack to the more acidic 
proton of the –NH- group. Nevertheless, the molecular structure after salt metathesis 
indicated the formation of a C – Hg bond in para position to the nitrogen. Accordingly, 
BOND LENGHTS (Å) ANGLES(°) 
Hg1 – C1 2.05(3) C4 – N1 – C21 132(2) 
Hg1 – Cl1 2.321(8) C1 – Hg1 – Cl1  175.2(7) 
N1 – C4  1.34(3)    
N1 – C21 1.39(3)   
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it may be possible that the formation of an equilibrium between A and B species was 
produced (Scheme 32), which would tend to be shifted to the more stable B species, in 
which contains the carbon atom located in para position to the nitrogen atom is the one 
activated. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 32. Proposed mechanism of synthesis of organomercury (II) substrate (17). 
The obtained results encouraged us to study the synthesis of the organomercury 
substrate of ligand L5 from another different route. In this route, we decided to 
synthesize a new pro-ligand derived from L5, including a tert-butyl group in para 
position to the nitrogen atom (Figure 82). The aim of this new pathway was to study if 
mercuration, as well as the activation and formation of C – Hg bond takes place when 
the carbon atom located in para position to the nitrogen atom is substituted by a bulky 
tert-butyl group. 
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Figure 82. Synthesis of new pro – ligand derived from L5 (L5´), where the carbon atom 
located in para position to the nitrogen atom is substituted by tert-butyl group. 
 
The synthesis of this ligand, called L5´, has been carried out by the usual two steps 
route. The first step involves a Suzuki cross coupling of the commercially available 4-
tert-butyl-2,6-dibromoaniline and 4-tertbutyl-boronic acid, employing Pd(PPh3)4 as a 
catalyst. The second step involves a Buchwald – Hartwig cross coupling reaction, 
employing Pd(dba)2 as precursor and diphenylphosphinobinapthyl (BINAP) as catalyst 
(Scheme 33). 
 
Scheme 33: Synthesis of ligand L5´.  
Ligand L5´ was subjected to mercuration using Hg(OAcF)2 as organomercury reagent. 
1H-NMR spectrum did not show any variation on the aromatic region compared to the 
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starting starting material. In addition, the 19F-NMR spectrum only showed the singlet 
resonance of the trifluoroacetate group corresponding to the non-coordinated 
organomercury reagent.  
 
B. Metalation attempts of ligand L5 via lithiation step. 
The failed attempts of metalating ligand L5 via the conventional mercuration route 
brought us to study an alternative pathway to synthesize the expected product. This 
route involved the inclusion of a lithiation step, previous to mercuration reaction. The 
aim of this new step was to lithiate the NH group and, in this way, try to orientate the 
following mercuration in order to active the formation of N – Hg bond via metathesis 
employing a mercury reagent. 
A solution of nBuLi 1.6M in hexanes was added dropwise to a solution of ligand L5 in 
THF at -78 °C. The mixture was allowed to stir for 1 hour at this temperature. HgCl2 
was added at room temperature. The mixture was allowed to stir at room temperature, 
monitoring the progress of the experiment by 1H-NMR spectroscopy. 1H-NMR 
spectrum showed the initial pro-ligand L5 as only product (Scheme 34). 
 
 
Scheme 34. Mercuration experiment of ligand L5 
 
Ligand L5 
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The only way to obtain ligand L5 back is through a hydrolysis reaction (Scheme 34). 
Therefore, the most probable explanation to justify this result may be the presence of 
water during any of the reaction steps. 
 
3.2.3. Synthesis of ligand L6. 
According to the obtained results for pro-ligand L5 and the failure attempts to metalate 
it, we decided to investigate an alternative C-,N- dianionic ligand framework suitable to 
be coordinated to the gold(III) centre, allowing the synthesis of complexes type 
(C^N)AuX2 or (C^N)AuX(L). Accordingly, we decided to choose ligand L6, a known 
compound, which has been reported in the last years by different research groups, 
reporting its synthesis by different routes. In our investigations, the synthesis of the 
known ligand L6 has been carried out via Buchwald – Hartwig cross-coupling, in two 
reaction steps (Scheme 35), following the experimental procedure reported in the 
literature.107  
 
Scheme 35: Synthesis of ligand L6. 
 
Because of ligand L6 has been already reported in the literature, its characterization was 
only carried out by 1H-NMR spectroscopy (Figure 83), by comparison with the 1H-
NMR data reported in the literature. In order to check if the experiment had been carried 
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out successfully, the main difficulty we found was the similarities between 1H-NMR 
spectrum of the intermediate bis(4-tert-butyl-phenylamine) and ligand L6. The signal 
corresponding to the –NH group from bis(4-tert-butyl-phenylamine) was the key point 
that allowed us to identify that that ligand L6 was properly synthesized. Figure 110 
shows a comparison between 1H-NMR spectrum of the intermediate bis(4-tert-butyl-
phenylamine) (red spectrum) and ligand L6 (blue spectrum). As it is reported in the 
literature,108 the chemical shift corresponding to the proton from –NH of bis(4-tert-
butyl-phenylamine) is shown at δ 5.50, which is observed in the red spectrum 
corresponding to the intermediate ligand. As it is observed in Figure 84, this signal is 
not observed in the blue spectrum (corresponding to ligand L6), which indicated that 
ligand L6 had been synthesized.  
 
Figure 83. Comparison between 1H–NMR spectrum of bis(4-tert-butyl-phenylamine) 
(red spectrum) and ligand L6  (blue spectrum) in CDCl3. 
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3.2.4. Metalation of ligand L6. 
A. Metalation attempts of pro-ligand L6 via mercuration step. 
Ligand L6 has been also subjected to mercuration experiments using both Hg(OAc)2 
and Hg(OAcF)2 as organomercury reagents, following the experimental procedure 
reported by Parish et al.13 
The mercuration reaction of ligand L6 was first attempted employing excess Hg(OAc)2 
(1:2 ratio) as organomercury reagent. The reaction was monitored by 1H-NMR 
spectroscopy. No changes in the chemical shifts of the aromatic region of the starting 
material were observed. Moreover, the characteristic singlet resonance corresponding to 
the coordinated acetate group was not shown, indicating that the mercuration step had 
not taken place. We therefore employed the more reactive reagent Hg(OAcF)2 which 
was used in excess (1:4 ratio). However, monitoring of the reaction by 1H-NMR and 
19F-NMR spectroscopy showed that, once again, no mercuration had taken place, and 
only the resonances corresponding to the starting material were observed.  
 
B. Metalation attempts of ligand L6 via lithiation step. 
In 1992, Schleyer et at.108 reported the synthesis of 1,5 – dilithiated arenes, which 
exhibit a remarkable synthetic utility109 in different fields, such as the preparation of six 
membered heterocycles by reaction with bifunctional electrophiles.110 They report the 
use of TMEDA (Me2N-CH2CH2-NMe2) as an reagent capable to increase the reactivity 
of nBuLi to promote the lithiation step.  
Accordingly, we attempted the metalation of ligand L6 via lithiation in presence of 
TMEDA, as reported in the literature, in order to maximize the effect of nBuLi. Our aim 
was to prepare a gold complex from ligand L6 where Au(III) atom is bonding to two 
phenyl groups. This chelating ligand would provide two negative charges and the gold 
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centre would have one functionalization site available. However, our different attempts 
of metalation of ligand L6 by this route were failed.  
 
3.2.5. Phenylpyridine derivative ligands: ligands L7 and L8. 
The failed attempts of metalation of the two C,-N- dianionic ligands previously 
synthesized (ligand L5 and ligand L6) encouraged us to change the approach and study 
the synthesis of C-,N monoanionic ligands, other type of ligands which can also allow 
us the synthesis of species with two functionalization positions, capable to provide high 
reactivity to the gold(III) complex. Accordingly, ligand L7 was planned as an alternative 
C-,N monoanionic ligand. Although the synthesis of ligand L7 has been reported in the 
literature via Kumada–Corriu Cross-Coupling,111 we have conducted the synthesis of 
this ligand via a Suzuki cross-coupling between a boronic acid derivative (4-tert-
butylphenylboronic acid) and 2-bromo-6-methylpyridine, employing Pd(PPh3)4 as 
catalyst (Scheme 36). 
 
Scheme 36: Synthesis of ligand L7. 
1H-NMR spectroscopy indicated that pro-ligand L7 have been successfully synthesized 
by comparison with the 1H-NMR spectrum data reported in the literature for this 
ligand.111 
The commercially available 2-(4-methylphenyl)pyridine (pro-ligand L8) (figure 84) was 
also considered in our investigations as an example of a C-,N monoanionic ligand. 
ligand L7. 
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Figure 84. Chemical structure of 2-(4-methylphenyl)pyridine (pro–ligand L8). 
3.2.6. Synthesis of five membered ring cycloaurated complexes 10 and 18. 
The synthesis of the five membered ring cycloaurated complexes 10 and 18 (Figure 85) 
has been studied through two different pathways. The first one involves the direct 
auration of ligands L7 or L8 with H[AuCl4]. The second via involves the mercuration 
step, making use of Hg(OAc)2 as organomercury reagent, and the consequent 
transmetallation, employing K[AuCl4]. 
 
 
 
 
Figure 85. Five membered ring cycloaurated complexes 10 and 18. 
The first route involves the reaction of ligand L8 with H[AuCl4] in MeOH, to give the 
corresponding N-bonded derivative. When this product was heated in an aqueous 
acetonitrile solution, the corresponding cyclometallated derivative (N-C)AuCl2 10 was 
obtained in moderate yield (35%, scheme 37).  
 
 
Scheme 37. Synthesis of cyclometallated gold (III) complexes 10 by direct auration. 
10	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The second route involves an initial mercuration reaction of ligands L7 or L8 using 
Hg(OAc)2 as organomercury agent, and the consequent transmetallation reaction 
employing K[AuCl4].  
The synthesis of the corresponding organomercury derivative has been carried out 
according to the experimental procedure reported on the literature.13 Ligands L7 and L8 
have been subjected to mercuration with Hg(OAc)2 or Hg(OAcF)2 (Scheme 38) 
followed by salt metathesis with LiCl to yield the corresponding organomercury(II) 
derivative (N ̶ C)HgCl. The synthesized mercury derivative undergoes then 
transmetallation and C – H activation with KAuCl4 to yield the (N ̶ C)AuCl2 derivatives. 
Nevertheless, this pathway involves partial reductive elimination to gold(0). 
 
Scheme 38. Synthesis of cyclometallated gold (III) complexes 10 and 19 by 
transmetallation reaction. 
The known complex 10 has been characterized by comparison with the 1H-NMR data in 
DMSO-d6 reported in the literature. Complex 19 has been characterized by 1H-NMR 
spectroscopy (Figure 86, Table 33) and X-Ray diffraction (Figure 88).   
 
 
 
 
 
 
 184  
Table 33. 1H–NMR data of complex 19 in CD2Cl2, δ(ppm) and multiplicity. 
Complex 19 ASSIGNMENT 1H (ppm) 
 
 
a 1.35 (s, 9 H) 
b 3.20 (s, 3 H) 
c (overlapped with CHCl3) 7.23 (m, 1 H) 
d, g 7.37 (d, J = 0.8 Hz, 2 H) 
f 7.67 (d, J = 7.9 Hz, 1 H) 
e 7.90 (t, 1 H) 
h 8.00 (s, 1 H) 
 
 
Figure 86. 1H-NMR spectrum of complex 19 in CDCl3. 
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Figure 87. Molecular structure of complex 19. (50% probability ellipsoids shown). 
(Structure defined by Dr. David Hughes). 
As it shown in Figure 87, the gold atom is four-coordinated in a rather distorted square-
planar fashion. The metal atom is displaced 0.14 Å out of the mean-plane of the N1, C8, 
Cl3, Cl4 atoms. The N – C ligand is tilted 25° from this plane. In the N^C ligand, both 
the pyridyl and phenyl rings are tilted 9° from the central N1, C5, C8, C12 mean-plane.  
The observed distortion of the molecular structure of complex 19 (Figure 88) is a 
phenomenon that has been also observed for another (C^N)Au(III) derivatives reported 
in the literature.13 Complex 19 gives a distorted square-planar geometry, characteristic 
of d8 metal complexes, resulting of coordination of N-AuCl2 donor set, producing a C-
Au-N angle of 81.28° about the gold(III) metal center, found to deviate from the ideal 
90° angle of the bidentate C^N ligands. Au – N and Au – C bonds lengths of 2.075(3) 
and 2.008(4) Å, respectively, are found in the observed range for another similar 
compounds. Au – Cl(3) and Au – Cl(4) bond lengths are found to be 2.2726(9) and 
2.3849(9) Å respectively. This difference may be explained because of the trans 
influence to C(8) bonded to gold centre.  
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Table 34. Most representative angles (°) and bond distances (Å) of complex 19. 
 
 
 
 
 
 
 
 
 
 
 
Our first approach focused of C-,N- dianionic ligands, in order to synthesize and study 
the reactivity of new (C^N)AuX2 and (C^N)AuX(L) derivatives. Ligands L5 and L6 
were chosen as ligand frameworks. For both of them, the ligand was successfully 
synthesized, but the different mercurations attempts failed. This results brought us to 
explore an alternative system, in particular C,N- monoanionic ligands, which have been 
reported in the literature.13 Ligands L7 and L8 were chosen as ligand frameworks and, 
for both of them, either mercuration and transmetallation steps were successfully 
achieved, to afford the complexes 19 and 10, respectively. In particular, complex 10 
was the starting material employed on this thesis to synthesize C,N- monoanionic 
ligands functionalized by amino ester derivatives, in order to study the interaction of 
them with DNA secondary structures, as is reported in chapters 1 and 2. 
 
 
 
BOND LENGHTS (Å) ANGLES(°) 
Au – Cl(3) 2.2726(9) C(8) – Au – N(1)    81.28(14) 
Au – Cl(4) 2.3849(9) N(1) – Au – Cl(3) 171.95(9) 
Au – N(1) 2.075(3) N(1) – Au – Cl(4) 99.69(9) 
Au – C(8) 2.008(4) C(8) – Au – Cl(3) 91.06(11) 
  C(8) – Au – Cl(4) 168.56(10) 
  Cl(3) – Au – Cl(4) 87.32(3) 
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3.3. EXPERIMENTAL 
3.3.1. GENERAL CONSIDERATIONS. 
Unless otherwise stated, all experiments were performed in air using bench solvents. In 
such exceptions, manipulations were performed using standard Schlenk techniques 
under dry nitrogen or a Saffron Scientific glovebox. Nitrogen was purified by passing 
through columns of supported P2O5, with moisture indicator, and activated 4 Å 
molecular sieves. Anhydrous solvents were freshly distilled from appropriate drying 
agents. Ligand L5 was prepared using literature methods.105,107 4-tert-butylphenyl-2-
methylpyridine (ligand L7) was prepared using literature methods. Complex 17, 18 and 
19 were also prepared according to literature methods.13,31 2–para–tolylpyridine 
(Aldrich), Hg(OAc)2 (Aldrich) and LiCl were commercially available and used as 
received. 1H and 13C{1H} spectrum were recorded using a Bruker DPX300 
spectrometer. 1H–NMR spectrum (300.13 MHz) were referenced to the residual protons 
of the deuterated solvent used. 13C{1H}–NMR spectrum (75.47 MHz) were referenced 
internally to the proton-decoupled 13C resonances of the NMR solvent.  
 
3.3.2. N-(2,6-tert-butylphenyl)-2,4,6-triisopropylaniline (Ligand L5). 
                           
1H–NMR assingments 
Ligand L5 was prepared employing literature methods reporting.105,107 1H–NMR (300 
MHz, CDCl3) δ 7.17 (Hj – Hm (overlapping), m, 8 H), 7.08 (Hf, d, J = 7.5, 2 H), (Hd, t, 1 
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H), (Hc, s, 2H), 2.96 – 3.06 (Hi, m, 2 H), 2.58 – 2.67 (Hh, m, 1 H), 1.25 (Hg, s, 18 H), 
1.09 (Hb, d, J = 6.9 Hz, 6 H), 0.96 (Ha, d, J = 6.8 Hz, 12 H).  
 
3.3.3. N-(2,6-tert-butyl-4-(HgCl)-phenyl)-2,4,6-triisopropylaniline (Complex 
17). 
 
                             1H–NMR assingments 
Hg(OOCCF3)2 (76.0 mg, 0.60 mmol) was added to a solution of pro-ligand L5 (300 mg, 
0.54 mmol) in ethanol (10 ml). The mixture was refluxed for 24 hours.  The suspension 
was filtered in hot over a solution of LiCl (46 mg, 1.08 mmol) in degassed metanol. The 
suspension was refluxed for one hour and chilled overnight. The solvent was filtered off 
and the white precipitate was dried under vacuum. The precipitate was purified by 
recrystallization in dichloromethane/metanol, to yield transparent crystals (50 mg, 0.063 
mmol, 12%). Very low yield. It is necessary to repeat this reaction in order to carry out  
a full characterization of the complex by mass spectroscopy and 1H–NMR (300 MHz, 
CD2Cl2) δ 7.16 (Hj – Hm, dd, J = 21.5, 8.3 Hz, 8H), 6.99 (Hf, s, br, 2H), 6.55 (Hc, s, 1H), 
2.90 – 2.99 (Hi, m, 2H), 2.58 – 2.67 (Hh, m, 1H), 1.25 (Hg, s, 18 H), 1.08 (Hb, d, J = 6.9 
Hz, 6H), 0.97 (Ha, d, J = 6.8 Hz, 12H). 
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Table 35. X-ray crystallography data of complex 17. 
        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compound 17 
Reference angel1 
Formula weight 879.8 
Crystal system triclinic 
Space group P - 1 
Unit cell dimensions. a (Å) 9.529(2) Å 
b 12.609(4) Å 
c 18.005(4) Å 
α (°) 101.18(2)° 
β 103.09(2)° 
γ 102.15(2)° 
Volume (Å3) 1992.5(9) 
Z 2 
Calculated density (mg/m3) 1.466 mg/m3 
F(000) 888 
Absorption coefficient µ(mm-1) 4.092 mm-1 
Crystal size (mm3) 0.15 x 0.06 x 0.06 
θ Range (°) 2.82 to 25.35 
No. of unique reflections, Rint 7280 [R(int) = 0.2848] 
Data/Retrains/Parameters 7280 / 0 / 209 
Final R indices (observed data) R1 = 0.1575, wR2 = 0.3129 
Final R indices (all data) R1 = 0.2792, wR2 = 0.3924 
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3.3.4. (6-(4-tert-butylphenyl)-2-methylpyridyl)HgCl (Complex 18). 
 
    
             1H–NMR assingments       13C{1H}–NMR assingments 
Hg(OAc)2 (7.41 g, 23.00 mmol) was added to a solution of pro-ligand L8 (5.00 g, 23.00 
mmol) in etanol (30 ml). The mixture was refluxed for 48 hours.  The suspension was 
filtered in hot over a solution of LiCl (1.46 g, 34.5 mmol) in metanol (10 ml). The 
precipitate was filtered off and washed with cold metanol. The residue was dried under 
vacuum, to yield a white solid (6.64 g, 14.43 mmol, 63%). (170 mg, 0.34 mmol, 64%). 
1H–NMR (300 MHz, CDCl3) δ 7.94 (Hf, d, J = 8.3 Hz, 1H), 7.73 – 7.65 (Hd, Hh 
(overlapped), m, 2H), 7.57 (Hg, d, J = 2.1 Hz, 1 H), 7.42 (Hc, dd, J = 8.3, 2.1 Hz, 2 H), 
7.17 (He, d, J = 6.9, 1.4 Hz, 1 H) 2.73 (Hb, s, 3 H), 1.36 (Ha, s, 9 H). 13C{1H}–NMR (75 
MHz, CDCl3) δ 158.3 (CAr), 155.1 (CAr), 152.8 (CAr), 147.5 (CAr), 139.3 (CAr), 138.1 
(CAr), 134.8 (CAr), 126.8 (CAr), 125.9 (CAr), 123.0 (CAr), 117.3 (CAr), 34.9 (Cc), 31.2 
(Cb), 23.9 (Ca).  
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Figure 88. 1H-NMR spectrum of complex 18 in CDCl3.  
 
Figure 89. 13C{1H}–NMR spectrum of complex 18 in CDCl3 
*Both the 1H-NMR and 13C{1H}–NMR (Figures 88 and 89) are shown in the 
experimental section as they are not reported in the results and discussion. 
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3.3.5. (6-(4-tert-butylphenyl)-2-methylpyridyl)AuCl2 (Complex 19). 
 
   1H–NMR assingments 
Pro-ligand L8 (200.0 mg, 0.93 mmol) was added to a solution of KAuCl4 (350 mg, 0.93 
mmol) in acetonitrile/dichloromethane (1:1). The mixture was allowed to stir 16 hours. 
The solvent was removed under vaccum and the residue was extracted two times with 
10 ml of dichloromethane. The solvent was removed to afford a yellow solid (170 mg, 
0.34 mmol, 64%). 1H–NMR (300 MHz, CD2Cl2) δ 8.00 (Hh, s, 1 H), 7.90 (He, t, 1 H), 
7.67 (Hf, d, J = 7.9 Hz, 1 H), 7.37 (Hd, Hg, d, J = 0.8 Hz, 2 H), 3.20 (Hb, s, 3 H), 1.35 
(Ha, s, 9 H).  
Table 36. X-ray crystallography data of complex 19. 
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Compound 19 
Reference angelbs5b 
Formula weight 492.18 
Crystal system monoclinic 
Space group C2/c 
Unit cell dimensions. a (Å) 17.0592(3) 
b 8.05458(13) 
c 23.8050(5) 
α (°) 90 
β 100.815(2) 
γ 90 
Volume (Å3) 3212.82(11) 
Z 8 
Calculated density (mg/m3) 2.035 
F(000) 1872 
Absorption coefficient µ(mm-1) 9.480 
Crystal colour, shape yellow-green block 
Crystal size (mm3) 0.40 x 0.26 x 0.14 
θ Range (°) 3.18 to 30.00 
No. of unique reflections, Rint 4689 [R(int) for equivalents = 
0.056] 
Data/Retrains/Parameters 4689 / 0 / 182 
Final R indices (observed data) R1 = 0.028, wR2 = 0.054 
 
Final R indices (all data) R1 = 0.029, wR2 = 0.055 
 
Largest diff. peak and hole (e Å3) 1.73 and -1.02 
 194  
ANEXE 1: X-RAY CRYSTALLOGRAPHY INFORMATION OF COMPLEXES 
5 and 19. 
Refinment and solving of compounds 5 and 19 were carried out by Dr. David Hughes at 
the University of East Anglia. Crystals of each sample were mounted in oil on glass 
fibres and fixed in the cold nitrogen stream on a diffractometer. Diffraction intensities 
for compounds 5 and 19 were recorded at 140(2)K on an Oxford Diffraction Xcalibur-
3/Sapphire3-CCD diffractometer, equipped with Mo-Kα radiation and graphite 
monochromator. Data were processed using the CrysAlisPro-CCD and -RED 
programs.112 The structure was determined by the direct methods routines in the 
SHELXS program113 and refined by full-matrix least-squares methods, on F2's, in 
SHELXL.113 The non-hydrogen atoms were refined with anisotropic thermal 
parameters.  Hydrogen atoms were included in idealised positions and their Uiso values 
were set to ride on the Ueq values of the parent carbon atoms.  Computer programs used 
in this analysis have been noted above, and were run through WinGX114 on a Dell 
Optiplex 755 PC at the University of East Anglia.  
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